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Abstract 
Initially, this work examines clinical Campylobacter isolates obtained 
from a single health trust site in Nottingham. These results reveal novel 
sequence types, and identified a previously undescribed peak in 
incidence that is observable across national data. By utilising a read 
mapping approach in combination with existing comparative methods, 
the first instance of case linkage between sporadic clinical isolates was 
demonstrated. This dataset also revealed an instance of repeat patient 
sampling, with the resulting isolates showing a marked level of diversity. 
This generated questions as to whether the diversity that Campylobacter 
exhibits can be resolved to an intra-population level. 
 
To study this further, isolates from the dominant clinical lineage –  
C. jejuni ST-21 – were analysed using a deep sequencing methodology. 
These results reveal a number of minor allele variations in chemotaxis, 
membrane and flagellar associated loci, which are hypothesised to 
undergo variation in response to selective pressures in the human gut. In 
an expansion of this work, additional datasets were generated to include 
other clinically relevant CC’s, including the C. coli lineage ST-828. These 
results revealed a similar pattern of diversity, with common loci 
identified as undergoing variation in multiple samples, and in some 
instances the same amino acid residue. In general, ST-21 isolates 
exhibited more non-synonymous mutations, distributed across fewer 
loci, suggesting that this lineage may have a repertoire of alleles that is 
more adapted to the human host.  
 
To investigate whether the observed diversity is generated during 
infection, or is maintained from a diverse infectious source, isolates from 
fresh retail chicken were analysed. These samples revealed a marked 
decrease in overall diversity, as well as diﬀerences in the functions of 
variable loci. These results show that infections occurring from the 
consumption of retail chicken (the largest single source of 
campylobacteriosis) arise from genetically uniform populations, and that 
the diversity observed in clinical cases is generated within - and 
furthermore may be specific to - the human host.
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Campylobacter spp. are environmentally ubiquitous, and yet have 
paradoxically specific growth requirements with a notable sensitivity to 
heat, cold and ambient atmospheric conditions.  
 
Despite this, Campylobacter spp. are highly successful, opportunistic 
human pathogens, and exist as the leading cause of bacterial enteritis in 
the developed world. In the EU, approximately 1 in 50 citizens will be 
aﬀected by Campylobacter each year, at an estimated cost of €2.4 billion. 
1.1. History 
Campylobacter was originally known as a member of the Vibrio genus, a 
lack of suitable culture techniques limited comprehensive study of the 
organism and its impact on human health until the 1970’s. However, the 
first notes on Campylobacter can be traced back to almost a century 
beforehand.  
 
In 1886, Theodore Escherich published a series of articles in the German 
journal: Münchener Medizinische Wochenschrift (Escherich, 1886). 
Escherich discovered microscopic evidence of spiral shaped bacteria 
whilst examining colonic tissue from infants that died of cholera 
infantum; Escherich would also later find the same bacteria in the stool 
of children with gastroenteritis, but traditional culture methods failed to 
produce viable growth (Butzler 2004). The organisms were not 
aetiologically linked in either instance, and as such were largely ignored. 
It wasn’t until a full century later that researcher M. Kist (1986), 
postulated that these articles likely described the earliest historic 
account of Campylobacter infection in humans. 
 
Campylobacter was identified by veterinary researchers long before any 
links to human health were discovered; In 1906, McFadyen and 
Stockman described isolation of Campylobacter during an investigation 
into unusually high abortion rates amongst sheep flocks (McFadyen and 
Stockman, 1913). The researchers had expected to find a diﬀerent 
organism: Brucella abortus – which happened to have similar growth 
 3 
requirements to Campylobacter. At first they believed they had indeed 
found B. abortus; However, microscopic inspection revealed the same 
spirular bodies identified by Escherich, which at the time Fadyen 
classified as spirochetes (Skirrow 2006). Whilst conducting similar 
research into epizootic bovine abortions, Smith and Taylor again found 
the same ‘vibrionic’ bacteria, and were the first to formally designate 
them as Vibrio fetus (Smith & Taylor 1919).  
 
More than a decade later, Jones et al. (1931), described another Vibrio 
species – this time found to be causing dysentery in calves. Isolated from 
the calf jejunum tissue, the new species was dubbed Vibrio jejuni. In 
1938, Vibro jejuni was identified in the first well documented case of a 
campylobacteriosis outbreak in an American prison (Levy, 1946). 357 
prisoners fell ill across two adjacent sites, with microscopy confirming 
the presence of V. jejuni in blood and stool samples. The source of the 
outbreak was attributed to an accidental delivery of raw milk in lieu of 
the institutions’ regular pasteurised order - the supplier produced and 
bottled both products in identical, unlabelled 10-gallon jugs 
 
In 1963, Sebald and Véron published a comprehensive study in the 
Annales de l’Institut Pasteur; their aim was to delineate members of the 
growing Vibrio genus. Chromatographic analysis of Vibrio fetus and 
bubulus yielded a GC content of 30-34% - far lower than other species - 
leading to the creation of a new genus: Campylobacter. From the Greek 
words kampylos and bact – meaning curved and rod respectively (Joshi, 
2014.). Campylobacter spp. would be expanded in 1973 by Véron and 
Chatelain to include C. jejuni, C. coli and C. sputorum, beating other 
researcher’s classification schemes to be accepted in the Approved List of 
Bacterial Names (1980).  
 
Perhaps the most important breakthrough in Campylobacter research 
came from the formulation of a selective supplement containing 
vancomycin, trimethroprim and polymixin B – which is still in use today 
(Skirrow 1977, Urumova et al. 2014, Cean et al. 2013). This supplement 
oﬀered a great improvement over the arduous filtration methods it 
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replaced, allowing laboratories to routinely isolate Campylobacter with 
ease and igniting novel interest in research of the genus. In the years 
following the deployment of this supplement, 12 new species were 
discovered and many more papers published. Figure 1.1 shows the drastic 
increase in published research following the introduction of the 
supplement.  
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Figure 1.1 - Number of publications* with ‘Campylobacter’ in the title before and after the introduction of 
Skirrow’s Supplement 
*Including only publications indexed by NCBI PubMed and PubMed Central databases. 
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1.2. Campylobacteraceae 
Campylobacteraceae belong to the epsilon class of the Proteobacteria, 
and consists of three genera; Campylobacter, Arcobacter and 
Sulfurospirillum (Vandamme et al. 2008). 
 
Since its initial description in 1963, the Campylobacter genus has 
undergone extensive change. Many organisms were spuriously included 
into the genus due to the biochemical heterogeneity of true 
Campylobacter spp., which prevented a clear diﬀerentiation between 
Campylobacter and organisms with similar biochemical reactivity. As 
molecular techniques evolved, the genus was corrected and refined 
(Vandamme et al. 1991, Gebhart et al. 1985, Lawson et al. 1981, 
Kiehlbauch et al. 1991, Totten et al. 1985, Veron & Chatelain 1973, Tanner 
et al. 1981).  
 
As of 2013, the Campylobacter genus contains 23 species and 4 
subspecies, 18 of which have been associated with human disease (On 
2013). Several sources cite a varying number of species within the genus 
(On 2001, Fitzgerald & Nachamkin 2011, Fernández et al. 2008). Even the 
most accurate species list will quickly become obsolete as novel 
Campylobacter spp. continue to be frequently isolated and described; C. 
hepaticus, C. iguanorium and C. geochelonis have all been proposed as 
potential additions to the genus over the past two years (Crawshaw et al. 
2015, Van et al. 2016, Gilbert et al. 2015, Piccirillo et al. 2016).  
 
Campylobacter spp. exhibit a high degree of variability in both 
phenotype and clinical relevance; Two thermotolerant species, C. jejuni 
subsp. jejuni and C. coli, are the main causes of human disease. C. fetus – 
the genus’ type species – commonly causes epizootic abortion, though 
has in rare cases been linked to cases of human abortion (Lastovica & 
Allos 2008). Other notable species that are uncommonly involved in 
human pathogenesis include C. upsaliensis, C. lari, C. hyointestinalis, C. 
jejuni subsp. doylei and C. sputorum (Lastovica & Allos 2008), a list of 
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Campylobacter species and their associated source is provided in Table 
1.2. 
Table 1.1 – Species* of the Campylobacter genus and their major associated 
sources† 
Taxon Major Associated Host 
Campylobacter avium Poultry 
Campylobacter canadensis Whooping cranes 
Campylobacter coli Pigs, poultry, ostriches, ruminants 
Campylobacter concisus Humans, domestic pets 
Campylobacter cuniculorum Rabbits 
Campylobacter curvus Humans 
Campylobacter fetus subsp. fetus Cattle, sheep, reptiles 
Campylobacter fetus subsp. 
venerealis Cattle, sheep 
Campylobacter gracilis Humans 
Campylobacter helveticus Dogs, cats 
Campylobacter hominis Humans 
Campylobacter hyointestinalis  
subsp. hyointestinalis Cattle, deer, pigs, hamsters 
Campylobacter hyointestinalis  
subsp. lawsonii Pigs 
Campylobacter insulaenigrae Seals, porpoises 
Campylobacter jejuni subsp. doylei Humans 
Campylobacter jejuni subsp. jejuni Poultry, cattle, pigs, wild birds 
Campylobacter lanienae Cattle 
Campylobacter lari subsp. concheus Shellfish 
Campylobacter lari subsp. lari Wild birds, dogs, poultry, shellfish,  
Campylobacter mucosalis Pigs 
Campylobacter peloridis Shellfish 
Campylobacter rectus Humans 
Campylobacter showae Humans 
Campylobacter sputorum Humans, pigs, ruminants 
Campylobacter subantarcticus Birds in the subantarctic 
Campylobacter upsaliensis Dogs, cats 
Campylobacter ureolyticus Humans 
Campylobacter volucris Black-headed gulls 
* - Taxa listed in bold have been shown to cause disease in humans.  
† - Table adapted from (On, 2013). 
 
The advent of next generation sequencing and progressive reduction in 
associated costs have allowed robust phylogenetic analyses, starting with 
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simpler methods based on one or many genes to whole-genome 
methods. The 16S rRNA gene is ubiquitous amongst prokaryotes and has 
a clock-like mutation rate. It contains both variable and conserved 
regions that aid in both target amplification and diﬀerentiation, making 
it an ideal candidate for amplicon sequencing (Mizrahi-Man et al. 2013). 
The level of variation present across the gene’s nine assigned (V1-9) 
regions is suﬃcient to delineate taxa and can provide a basic level of 
phylogeny. Figure 1.2 shows the maximum likelihood phylogeny of all 
Campylobacter spp. 16S regions available at the time of analysis.  
 
Figure 1.2 - Phylogenetic analysis of Campylobacter 16S rRNA regions 
The evolutionary history of the 16S rRNA gene was inferred using the maximum likelihood 
method (Tamura & Nei 1993). The tree with the highest log likelihood (-6409.8617) is shown. 
The tree is rooted to Campylobacteraceae family member Arcobacter butzleri, with bootstrap 
values represented by diameter-relative circles.  
Accession numbers of the gene sequences used in this analysis provided in Appendix 9.1 
 
The Campylobacter genus consists of fastidious, non-sporulating, Gram 
negative bacteria. They are relatively small organisms (0.2-0.8 µm wide x 
0.5-5 µm long), which under optimal growth conditions exist as spiral or 
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‘S’ shaped rods (Vandamme et al. 2008, Silva et al. 2011). Campylobacter 
spp. are capnophillic and thrive in atmospheres containing between  
3-5% O2, and 3-15% CO2.  
 
Campylobacter have single or dipolar unsheathed flagella which can be 
2-3x larger than the length of the cell (Lous et al. 2011, Vandamme et al. 
2008). This - along with their helical morphology - generates 
Campylobacter’s characteristic corkscrew motility, conferring the ability 
to attach and invade to intestinal epithelial cells (Lugert et al. 2015). The 
only exceptions to this are C. gracilis – a non-motile Campylobacter spp. 
– and C. showae, which has multiple flagellar (Etoh et al. 1993, 
Vandamme et al. 1995).  The majority of species reduce fumarate to 
succinate, reduce nitrate, yield a negative methyl red reaction, produce 
indole and acetoin and (excluding C. jejuni) do not hydrolyse hippurate 
(Garénaux 2008). 
 
Campylobacter spp. are also pleomorphic; as cells approach stationary 
phase – or under stress conditions – they take on a coccoid form. Whilst 
the cells still retain their flagellar in this configuration, they lose their 
motility and thus their ability to invade host cells (Ikeda & Karlyshev 
2012). This form has also been linked to the production and maintenance 
of biofilms (Ikeda & Karlyshev 2012, Walker et al. 1986). 
1.2.1. Thermotolerant Species 
Camypylobacter jejuni subsp. jejuni – hereon referred to as C. jejuni 
unless specified otherwise – and Campylobacter coli are responsible for 
the majority of human disease. These organisms preferentially grow 
between 37 and 42°C and as such are referred to as thermotolerant 
species (Levin 2007, Silva et al. 2011).  Whilst other species (e.g. C. lari, C. 
upsaliensis) are also thermotolerant, this chapter will focus on C. jejuni 
and C. coli specifically. 
 
Thermotolerant Campylobacter spp. are microaerophillic organisms, 
with an atmospheric optima of 5% O2, 10% CO2 and 85% N2. Under 
ambient atmopheric conditions, an accumulation of cellular peroxides - 
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mostly reactive oxygen species (ROS) - inhibits growth and proliferation 
(Garénaux 2008). In vitro studies have shown exposure to ambient 
atmosphere and temperature results in a significant loss of viability from 
as little as 10 minutes (Davis & DiRita 2008). 
 
Campylobacter spp. are fastidious, non-fermentative organisms. C. jejuni 
lacks the ability to catabolise glucose due to the absence of  
6-phospofructokinase, and instead relies on citric acid cycle 
intermediates and a handful of amino acids acquired in the gut (Kelly 
2001, J Parkhill et al. 2000, Stahl et al. 2012). Typically C. jejuni utilises 
amino acids sequentially: serine, aspartate, asparagine and glutamate, in 
order of preference. Many of these amino acids are major components of 
chicken excreta (Garénaux 2008).  
 
During the process of colonisation, Campylobacter must compete with 
the natural intestinal flora for nutrients. Iron catalyses several 
biochemical reactions and is an essential component in microbial 
metabolism; free iron availability in host-tissues is limited, with most 
iron bound in protein complexes such as haemaglobin (Naikare et al. 
2013). C. jejuni has multiple siderophore mediated iron uptake systems 
that allow it to access suﬃcient iron, including enterobactin, haem, 
transferrin and rodotorulic acid (Miller et al. 2009, Naikare et al. 2013). 
1.2.1.1. Isolation  
Under optimal conditions, Campylobacter spp. can produce growth on 
basal media, however in food and clinical laboratories it is generally 
necessary to use a supplemented media to provide a suﬃciently pure and 
substantial recovery (Garénaux 2008).  
 
Historically, isolation of Campylobacter spp. would require a round of 
membrane filtration followed by growth on a blood-based agar. The 
addition of blood serves to quench toxic oxygen metabolites and 
subsequently reduce the level of oxidative stress exerted on 
Campylobacter spp. (Corry, Atabay, Forsythe, & Mansfield, 2003). 
Supplementing agar with blood provides a challenge in itself, as the 
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laboratory has to ensure that suﬃciently fresh and sterile stocks are 
constantly available. 
 
Modern Campylobacter media replaces the oxygen quenching action of 
blood with anhydrous chemical alternatives (e.g. ferrous sulphate, 
sodium pyruvate), which  greatly simplifies the media preparation 
process. The International Organisation for Standardardisation 
methodology (ISO 10272) for isolating Campylobacter spp. from food and 
clinical samples recommends the use of ‘Modified Cefaperazone 
Charcoal Deoxycholate Agar’ (mCCDA) . This agar uses Nutrient Broth as 
a base and contains charcoal, casein, sodium pyruvate, sodium 
deoxycholate and ferrous sulphite. The media is supplemented with 
Cefaperazone (a cephalosporin that thermophilic Campylobacter is 
resistant to) and Amphotericin B to inhibit bacterial and fungal growth 
respectively.  
 
A pre-enrichment stage can also be used to increase the recovery of sub-
lethally injured cells; liquid culture in a suitable broth (e.g. Müeller-
Hinton) prior to plating on mCCDA has been shown to increase the 
consistency of isolation from several sample types, including food, 
faeces and water (Jokinen et al. 2012, Humphrey 1989). 
 
1.2.1.2. Identification 
The appearance of Campylobacter spp. can vary depending on the 
medium used. Typically, Campylobacter produces a flat to slightly 
convex, irregular, eﬀuse growth and swarming is observed if the media is 
suﬃciently moist (Garénaux, 2008; Skirrow & Benjamin, 1980). Initially, 
colonies are transparent in appearance, transitioning to a metallic grey 
as the culture matures (Garénaux, 2008; Skirrow & Benjamin, 1980).  
 
In addition to a Gram stain, suspected colonies should be further 
identified via biochemical tests. Several clinically relevant 
Campylobacter spp. are oxidase positive (Garénaux 2008). C. jejuni can 
be diﬀerentiated from other species using a hippurate hydrolysis test 
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(positive). Colonies that produce typical Campylobacter growth 
characteristics, a negative Gram stain and a positive oxidase result can be 
clinically reported as Campylobacter for diagnostic purposes (Barrow, 
2003; MacFaddin, 1980).   
 
To remove any degree of ambiguity, a definitive and rapid method for 
identification and speciation of Campylobacter spp. is PCR. Several 
schemes have been developed, based on amplicons of the 16S rRNA 
sequence, hipO hippuricase and ipxA acyltransferase genes (Linton et al. 
1997, Klena et al. 2004, Linton et al. 1996).  
1.3. Clinical manifestations of Campylobacter 
Infection with Campylobacter spp. is known under the generic 
description campylobacteriosis (Coker et al. 2002). Due to the 
overwhelming proportion of cases that manifest as gastroenteritis, the 
term campylobacteriosis has become widely synonymous with 
Campylobacter enteritis and will be referred to as such hereafter (Georg 
Kapperud et al. 1992, Bokkenheuser et al. 1979, Guerrant et al. 1978, 
Eberhart-Phillips et al. 1997, Mossong et al. 2016, Pearson et al. 2000, 
Frost 2001, Wilson et al. 2008, Wingstrand et al. 2006, Olson et al. 2008).  
 
1.3.1. Campylobacteriosis 
Campylobacter jejuni is widely accepted as the main causative agent of 
campylobacteriosis and is responsible for ~80-90% of all reported cases, 
with C. coli implicated in ~7-12% (Gillespie et al. 2002, Chen et al. 2011, 
Olson et al. 2008). Both species produce identical clinical presentation, 
which in itself is indistinguishable from enteritis mediated by other 
enteropathogens (Acheson & Allos 2001).  
 
Campylobacter has a low infectious dose; It has been previously 
demonstrated in volunteer studies that an intestinal infection can be 
propagated following ingestion of just 800 organisms (Black et al. 1988). 
Similarly, Robinson (1981) reported a dysenteric episode following self-
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administration of an inoculum containing 500 organisms. The infectious 
dose is much lower than other common enteropathogens, for example 
Salmonella spp. and some strains of E. coli which have infectious doses 
in the 105 – 109 range (Kothary & Babu 2001).  
 
Following ingestion, Campylobacter undergoes an incubation stage 
typically lasting for 1-7 days - notably longer than other intestinal 
infections (Silva et al. 2011). On average this period will last 72 hours, 
though periods in excess of 7 days have also been reported, which may be 
linked to the consumption of fewer viable organisms (Janssen et al. 
2008, Silva et al. 2011, Walker et al. 1986). 
 
In 30% of campylobacteriosis cases, the diarrhoeal phase of the illness is 
preceded by a prodromal stage (Blaser & Engberg 2008). Prodromal 
patients may present in a flu-like condition up to 24-48 hours before 
developing diarrhoea, with symptoms including pyrexia, myalgia, 
malaise and abdominal pain. The occurrence of this prodrome prior to 
gastrointestinal symptoms indicates that the initial inflammatory 
response to the infection occurs before intestinal epithelial cell function 
is diminished (Wassenaar & Blaser 1999).  
 
Campylobacteriosis is characterised by an inflammatory dysenteric 
episode which generally lasts between 2 and 7 days. At the peak of the 
diarrhoeal stage, patients will pass 8-10 stools per day; stools are profuse 
and watery, and in ~15-30% of instances contain visible frank blood 
(Blaser et al. 1983, Gillespie et al. 2006). Irrespective of blood visibility, 
faecal leucocytes and erythrocytes are present in the majority of cases 
indicating colonic and rectal tissue invasion (Blaser et al. 1979). 
Abdominal pain is reported in >85% of cases and can mimic appendicitis 
due to its severity and duration. Vomiting is reported in ~35% of cases 
and is generally associated with a longer illness and greater likelihood of 
hospital admission (Gillespie et al. 2006).  
 
In the majority of cases, the disease is self-limiting with a gradual relief 
of symptoms over several days, and at most may only require supportive 
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treatment (i.e. isotonic hydration). However, the severity of the disease 
varies greatly, with some patients exhibiting a mild, short term diarrhoea 
and others experiencing far more severe and enduring symptoms. This is 
likely a multifactorial eﬀect due to strain pathogenicity, number of 
viable organisms consumed and host immune response (Silva et al. 2011).  
 
In more severe cases of campylobacteriosis, where patients exhibit a high 
fever, excessively bloody stools or have a prolonged (i.e. >7 days) illness, 
antibiotic treatment should be administered. Previously Campylobacter 
infections were treated with fluoroquinolones, however a global increase 
of fluoroquinolone resistance amongst Campylobacters mean physicians 
now typically administer macrolides such as erythromycin or 
clarithromycin (Cody et al. 2012). 
 
With the exception of patients treated with antibiotics, Campylobacter 
will continue to be faecally shed for several weeks following symptom 
relief, with a mean excretion period of 37.6 days (Blaser, MJ; Engberg 
2008). Whilst transmission from convalescent excretion of 
Campylobacter has yet to be demonstrated, relapses have been reported 
to occur in 15-25% of cases (Kapperud et al. 1992; Blaser & Engberg 2008).  
 
1.3.2. Extraintestinal Complications 
Whilst uncommon, infection with Campylobacter can be complicated by 
extraintestinal localisation. Case studies reveal instances of 
campylobacteriosis resulting in cholecystitis, pancreatitis, nephritis, 
myocarditis and hepatitis (Korman et al. 1997, Cunningham et al. 2003, 
Op den Winkel et al. 2010, Udayakumar & Sanaullah 2009). 
 
Bacteraemia is a more common – albeit still relatively rare – 
complication, with an incidence of 1.5-8 in 1,000 cases. Bacteraemia 
occurs predominantly in elderly and immunocompromised (e.g HIV 
positive) cohorts, with the latter group often exhibiting no 
gastrointestinal symptoms (Skirrow et al. 1993, Fernández-Cruz et al. 
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2010, Georg Kapperud et al. 1992). It is postulated that transient 
bacteraemia may occur more frequently than the reported incidence 
would suggest, particularly in febrile patients. The true occurrence is 
diﬃcult to determine as blood cultures are rarely obtained from patients 
with acute gastroenteritis and detection methods are not necessarily 
sensitive to Campylobacter species, which are inherently weak to serum 
(Tee & Mijch 1998, Pacanowski et al. 2008, Shandera et al. 1992).  
1.3.3. Guillain-Barré Syndrome 
Guillain-Barré syndrome (GBS) is the most common cause of acute 
flaccid paralysis in countries where poliomyelitis has been eradicated, 
with annual incidence ranging from 0.6-4/100,000 people (Shahrizaila & 
Yuki 2016). It is characterised by a symmetrical ascending weakness that 
develops over the course of 2-3 weeks; most patients present with 
hypoflexia and weakness in the legs or arms. The severity of the paralysis 
varies, with some patients requiring ventilation within days and others 
not experiencing any loss of ambulation (Dimachkie & Barohn 2013).  
 
In 40-70% of cases, GBS is preceded by an antecedent infection 
(McGrogan et al. 2009). In ~30% of cases that antecedent is C. jejuni, 
which is the most common aetiological agent of GBS. It is estimated that 
~0.1% of campylobacteriosis cases will develop into GBS (Nachamkin et 
al. 1998). It is hypothesised that campylobacteriosis propagates the 
development of antibodies to lipooligosaccharides which exhibit cross 
reactivity with peripheral nerve gangliosides. This is supported by 
research that demonstrates antiganglioside antibody depletion by  
C. jejuni LOS, and anti-LOS antibody depletion by gangliosides (Ang et 
al. 2002, Godschalk et al. 2004). 
1.3.4. Transmission  
Campylobacter spp. can be isolated from a wide range of host species, 
including cattle, sheep, pigs and birds (Silva et al. 2011). There is 
evidence that suggests Campylobacter acts as a commensal organism in 
some hosts, and acts as an opportunistic pathogen in others 
(Waldenström et al. 2002, French et al. 2009, Açik & Çetinkaya 2006, 
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Stanley & Jones 2003, Wesley et al. 2000, Young et al. 2000, Padungton & 
Kaneene 2003).  
 
Human infections with Campylobacter spp. are considered to be food-
borne, with contaminated meat or other animal-sourced products (e.g. 
milk) responsible for the majority of cases. In general, during the 
slaughter process intestinal contents and bacteria on the skin surface of 
the animal come into contact with the meat, equipment, surfaces and 
process water, with contamination persisting throughout the processing 
chain to the end consumer. Improper handling or consumption of 
undercooked meat products provides an ample opportunity for infection 
to develop (Skarp et al. 2016). 
1.3.4.1. Poultry 
Poultry is the main food source – and therefore largest single source - of 
human campylobacteriosis (EFSA 2014, Skarp et al. 2016). Chicken 
(Gallus gallus) constitutes 70-80% of poultry meat production (Skarp et 
al. 2016), with turkey and duck meat also included in this category.  
 
Due to the sporadic nature of Campylobacter infections, the exact 
attribution rate is diﬃcult to determine, however several 
epidemiological studies have shown a significant association between 
handling or consuming raw or improperly prepared poultry and 
contraction of Campylobacter enteritis (Vellinga & Van Loock 2002, Stern 
et al. 2003). In 1999, Belgium had to withdraw chicken meat from sale 
due to contamination with dioxin. During the withdrawal period there 
was a 40% reduction in campylobacteriosis cases (Vellinga & Van Loock 
2002). Similarly, in 1996 Icelandic chicken sales shifted largely from 
frozen to fresh cuts, which also coincided with a large peak 
campylobacteriosis incidence (Stern et al. 2003). 
 
Campylobacter has specific molecular tropisms that favour the 
colonisation of the avian gut; its preferred nutrient sources are abundant 
in chicken ceca and it thrives in the warm (42°C), microaerobic 
atmosphere of lower intestinal tract (Newell & Fearnley 2003). 
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Colonisation in chickens has been experimentally achieved with a dose 
as low as 40 CFU (Cawthraw et al. 1996), and in one instance, 8 CFU 
(Hendrixson et al. 2001). Once established, Campylobacters are rapidly 
detected in excreta, and reach as many as 109 CFU in the caecal contents 
(Hermans et al. 2011, Stern et al. 2001). The faecal shedding of 
Campylobacter and coprophagic nature of chickens leads to a rapid 
dissemination amongst commercial flocks, with whole-flock positivity 
occurring within 7 days of the initial point-zero colonisation (Hermans et 
al. 2012). Campylobacter is therefore understandably profuse amongst 
commercial flocks; 75-90% of all British flocks sampled are found to be 
colonised (FSA & BBSRC 2013, EFSA 2014, Wilson et al. 2008) 
 
At slaughter, Campylobacter contaminates meat via the spillage of 
intestinal contents. Campylobacter can also be found on the feathers, in 
the air of ‘unclean zones’ (e.g. hanging room, eviscerating room) and on 
processing equipment across the production line (Berndtson et al. 1996). 
EFSA estimate that decreasing the Campylobacter load on poultry 
products by 1 log could reduce the risk of human disease by 50-90% 
(EFSA 2011a). As a consequence, several biosecurity measures at the farm 
level and subsequent interventions at slaughter have attempted to 
achieve this, with varying levels of success (EFSA 2011; Food Standards 
Agency 2016).  
 
Despite significant eﬀorts, the level of Campylobacter that persists in the 
processing chain to retail remains high. In 2014, an average of 71% of 
retail chicken was found to be contaminated with Campylobacter - 21.8% 
of those samples were shown to harbour in excess of 1000 CFU/g (Food 
Standards Agency 2016). 
 
The massive prevalence of Campylobacter enteritis can in part be 
explained by examining consumer eating habits. The British public 
consume over 30 kg of poultry per capita each year, the highest of all 
European countries (FAO 2016). In 2014, the UK spent £4.29 billion on 
chicken alone, and consumption is continually increasing (Key Note 
2015). There is also a strong appetite for poultry meat on a global scale; 
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Saint Vincent for example consumes 74 kg per capita per year. Global 
consumption is rising independently of population growth by 
approximately 2.6% annually (FAO 2016). 
 
Poultry is an inexpensive protein source, and is consistently one of the 
cheapest meats available in terms of cost per kilogram. In a period 
covering 1987-2014, poultry prices rose by just ~45% compared to beef, 
lamb and pork at ~120%, ~190% and ~135% respectively (Key Note 2015). 
This, combined with the versatility and familiarity of poultry means 
household reliance and consumer preference is sustained. 
1.3.4.2. Livestock 
Other food-animals are also a potential source of Campylobacter 
infection. Beef – particularly beef liver – has been shown to harbour 
Campylobacter (Osano & Arimi 1999, Noormohamed & Fakhr 2013), with 
38% of bovine faeces containing C. jejuni (Inglis et al. 2003). 
Approximately 10% of clinical campylobacteriosis is attributable to beef 
(Dearlove et al. 2015). Pork is generally associated with a higher 
prevalence of C. coli compared to C. jejuni, though the reservoir as a 
whole is only estimated to be responsible for 1% of campylobacteriosis in 
the UK (Dearlove et al. 2015).  
 
1.3.4.3. Companion animals 
Campylobacter can be isolated from household animals which may not 
display typical campylobacteriosis symptoms. Dogs and cats – 
particularly puppies and kittens – have often been shown to harbour 
several Campylobacter spp., the most common being C. upsaliensis (an 
emerging human pathogen), C. jejuni and C. coli (Gras et al. 2013, Skirrow 
1977, Baker et al. 1999). Whilst pet ownership increases the risk of 
contracting campylobacteriosis, basic hygiene methods prevent any 
significant transmission in all but the youngest groups (0-2 years). 
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1.3.4.4. Milk 
Raw milk has historically been implicated in a number of Campylobacter 
outbreaks (Fahey et al. 1995, Porter & Reid 1980, Wood 1992). Whilst the 
increased use of pasteurisation has largely eliminated such occurrences, 
failure in the pasteurisation process, cross contamination or indeed 
continued reliance on raw milk products still pose a threat to public 
health, particularly in developing countries (Heuvelink et al. 2009, 
LeJeune & Rajala-Schultz 2009, Fahey et al. 1995). 
1.3.4.5. Other sources 
The number and variety of Campylobacter sources is vast, though all 
share the commonality of faecal contamination. The environmental 
ubiquity and diverse commensality of Campylobacter spp. provides a 
multitude of potential vectors. 
 
Whilst uncommon, direct contact with domesticated animals shedding 
Campylobacter is a noted risk factor in disease transmission, particularly 
amongst veterinary workers (e.g. farmers, veterinarians) (On 2001). 
 
Water has been attributed to some incidences of Campylobacter 
transmission. Drinking from or swimming in lakes or diving in waters 
approximate to sewage outflow pipes are both noted examples (Obiri-
Danso & Jones 1999, Jones 2001). In the developed world, sanitary 
treatment eradicates drinking water as a potential source of 
Campylobacter acquisition, however accidental consumption of 
untreated water has historically been linked to outbreaks (Vogt et al. 
1982, Broczyk et al. 1987). In developing countries where treated water is 
scarce, water sources are still frequently identified as a major 
environmental source (Ashbolt 2004). 
 
Given the frequent isolation of Campylobacters from wild birds 
(Yogasundram et al. 2013, Waldenström et al. 2010), faecal 
contamination of water is common; whilst this commonality does not 
directly result in a significant number of transmission events it does 
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serve to spread the organism to other hosts that bathe in or drink from 
the water source. Muscid flies (e.g. Musca domestica) have been proposed 
as potential mechanical vectors (Ekdahl et al. 2005) that serve to spread 
Campylobacter to broiler flocks, work surfaces, and water bodies. 
1.3.5. Incidence and Prevalence 
Campylobacter is the leading cause of bacterial enteritis in the developed 
world. In the United Kingdom, it is responsible for approximately 22,000 
hospitalisations and more than 100 deaths each year; it is also a 
significant burden to the UK economy, costing tax payers £900 million 
per annum (DEFRA & FSA, 2013).  
 
In 2013, Public Health England received 66,575 reports of 
campylobacteriosis (DEFRA 2015). Whilst this is 11.1% higher than the 10-
year average (~60,593) it is an 8.2% reduction from 2012’s incidence 
(72,592), which holds the highest number of cases recorded since the 
surveillance scheme was introduced (PHE & DEFRA 2013, DEFRA 2015, 
DEFRA & PHE 2015). Preliminary data from England and Wales suggests 
that incidence was largely unchanged in 2014 and 2015 (Public Health 
England, 2015; 2016). 
1.3.5.1. Under-reporting 
Campylobacteriosis is a severely under-reported condition. This may be 
in part due to milder manifestations of the disease, both in terms of 
duration and symptom severity. In several documented outbreaks the 
percentage of infected persons who sought medical attention ranges 
from 1-50% (Pearson et al. 2000, Inns et al. 2010, Korlath et al. 1985, Frost 
2001, Fahey et al. 1995); in sporadic cases – which constitute the majority 
of Campylobacter infections - it is much harder to extrapolate. 
 
Several studies have tried to calculate the degree of under-reporting, 
which varies greatly across the world. In the United Kingdom it is 
estimated that only 1 in 9.3 cases are reported to the relevant authorities 
(Tam et al. 2012).This means in 2013, the total number of Campylobacter 
infections across the UK was closer to ~620,000. 
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Similar data from the Netherlands and the United States of America 
show a reporting ratio of 1:12.1 and 1:30.3 respectively (Scallan et al. 2011, 
Havelaar et al. 2012). Figure 1.3 shows estimated incidence range of 
Campylobacter across 28 European Union member states based on 
individually calculated reporting ratios and illustrates how variable 
Campylobacter incidence can be; adjacent states display a largely 
diﬀerent incidence due to various socioeconomic and dietary factors, as 
well as diﬀerences in pathogen surveillance schemes.  
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Figure 1.3 -  Incidence rates of Campylobacter infections in European countries based on 
individually calculated reporting ratios* 
*Data obtained from the EFSA (2014), accounts for underreporting of community based infections. 
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1.3.5.2. Case Linkage 
Infections with Campylobacter spp. are highly sporadic, with very few 
cases of epidemiologically related cases identified outside of notified 
outbreaks (Blaser 1997, Olson et al. 2008). This is in part due to the vast 
genomic diversity of Campylobacter spp., and the variances in symptom 
severity and by extension, reporting frequency.  
 
1.3.5.3. Outbreaks 
In 2010, Campylobacter displaced Salmonella as the leading cause of 
foodborne infectious disease outbreaks in England and Wales, with 21 
occurrences accounting for 18.3% of reported outbreaks. Table 1.2 shows 
the number of outbreaks and their resolved source in the UK from 2010-
2013; the majority (79.1%) of outbreaks were traced to poultry meat, with 
chicken liver pâté implicated in particular across numerous cases.  
 
A similar number of outbreaks occur annually in other parts of the world; 
In the USA, there are on average 28 outbreaks of campylobacteriosis per 
year, with dairy products identified as the most common source (Taylor 
et al. 2012). In 2013, the EFSA received 414 reports of Campylobacter 
outbreaks across 16 European Union member states, which accounted for 
8% of all food-borne outbreaks that year (EFSA 2014).  
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Table 1.2 - Source attribution of outbreaks reported to national surveillance 
schemes in the United Kingdom from 2010-2013 
Source 
Number of Outbreaks/Year 
% of Cases 2010 2011 2012 2013 
Poultry meat 16 17 6 14 79.1% 
Red meat 2 0 1 1 6.0% 
Composite foods 2 0 0 0 3.0% 
Milk/Dairy 0 0 0 1 1.5% 
Potable water 1 0 0 0 1.5% 
Unidentified 0 3 0 3 9.0% 
Total outbreaks 21 20 7 19   
Table compiled from data provided by Public Health England and the Department for 
Environment, Food and Rural Affairs (Health Protection Report, 2010; Health Protection 
Report, 2011; Zoonoses Report, 2012; Zoonoses Report, 2013). 
1.3.5.4. Developing countries 
In developing and tropical countries, Campylobacter is hyperendemic 
and presents a notably diﬀerent epidemiology. Incidence amongst 
children under 5 years of age is significantly higher, with estimates 
ranging from 40,000 to 60,000/100,000, compared to 300/100,000 in 
the USA and other industrialised nations (Coker et al. 2002, Kotloﬀ et al. 
2013, Lee et al. 2013, Janssen et al. 2008).  
 
Infection rates peak in childhood and decline with age, in contrast to the 
United Kingdom where infection rates peak in the over 60 group(FSA & 
DEFRA 2010). Additionally, asymptomatic carriage is more common in 
regions where Campylobacter infection is endemic. Conversely, 
outbreaks are far less common. It’s postulated that these diﬀerences may 
be a result of developing immunity due to frequent exposure (Havelaar et 
al. 2012, Blaser et al. 1985). 
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1.3.5.5. Traveller’s Diarrhoea 
The risk of contracting diarrhoea whilst travelling is approximately 7% in 
developed nations, and ranges from between 20-50% in the developing 
world (Ardley & Wright 2010). The majority of Campylobacter infections 
are not formally investigated in the United Kingdom and data for 
whether Campylobacter was contracted internationally or domestically 
is limited.  
 
In 2013, the UK reported 66,465 cases of Campylobacter infections to the 
EFSA - 15.9% of those cases had place-of-acquisition data. Of this subset, 
~6.3% of campylobacteriosis cases were travel-related (EFSA 2014). A 
total of 7 EU member states report on the travel/domestic status of all 
notified Campylobacter infections (Table 1.3); on average 4.27% are 
acquired internationally, which validates the extrapolation of UK data.  
 
 
Table 1.3 - Reported place of campylobacteriosis acquisition amongst EU 
member states that provided data for all notified cases in 2013 
Country No. cases International Domestic 
Austria 5,726 9.3% 90.7% 
Czech Republic 18,267 1.6% 98.4% 
Estonia 382 4.7% 95.3% 
Germany 63,271 8.2% 91.8% 
Netherlands 3,702 5.5% 94.5% 
Poland 552 0.2% 99.8% 
Slovakia 5,845 0.4% 99.6% 
EU Total 97,745 4.27% 95.73% 
Table compiled from data provided by EFSA, exclusively including states that had 0% of 
cases demarked as undetermined and more than 100 reported cases (EFSA 2014). 
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1.3.5.6. Epidemiology 
Campylobacter epidemiology has a bimodal distribution, mainly 
aﬀecting children under 4 years of age, and adults over 60 (FSA & DEFRA 
2010). The high prevalence amongst young children mimics the 
epidemiology of other enteric pathogens (e.g. Yersinia enterolitica) and 
may be due to a number of factors (Rosner et al. 2010, Tam et al. 2012). 
Children generally have a lower level of hygiene, and their immune 
system is still naïve and underdeveloped. Additionally, a higher portion 
of cases will likely be reported than in other age groups due to parental 
concern (Gillespie et al. 2009, Schielke et al. 2014). In recent years, 
incidence amongst elderly cohorts has increased, this is thought to be 
due to the general ageing of the underlying population base (Nichols et 
al. 2012). 
 
The number of Campylobacter cases reported per year is higher amongst 
males than females. This increased incidence is observed across all age 
groups at a 1.14 M/F ratio, suggesting an inherently greater susceptibility 
rather than involvement in risk related behaviours (Nichols et al. 2012, 
Louis et al. 2005).  
 
1.3.5.7. Seasonality 
Campylobacter displays a distinct seasonality, with infection rates 
soaring during the summer months. Whilst incidence varies by region, a 
peak from weeks 18-22 (May-June) is consistently observed across the 
entirety of the UK, with the highest number of cases occurring in June 
(Nichols et al. 2012, Louis et al. 2005). The forces driving Campylobacter 
seasonality are ill defined, but many hypotheses have been presented, 
including agricultural activities, weather, increased poultry 
contamination and an increase in the population of flies (Ekdahl et al. 
2005, Nichols et al. 2012, Louis et al. 2005). 
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1.3.5.8. High Risk Groups 
Elderly and immunocompromised groups are disposed to a higher risk of 
contracting campylobacteriosis; C. jejuni incidence is 40-100X higher 
amongst AIDS aﬄicted persons (Sorvillo et al. 1991, Larsen et al. 2011). 
These groups are also at greater risk of experiencing complications and 
as such have a higher mortality rate than other cohorts. 
 
Gastric acidity is one of the first defensive barriers to infection, and is 
particularly eﬀective against Campylobacter. However, patients that are 
taking proton pump inhibitors – for example Omeprazole, which is now 
available over the counter – are at greater risk of contracting 
campylobacteriosis (Neal et al. 1996). 
 
1.3.6. Pathogenesis 
Despite a substantial amount of research, the mechanisms underpinning 
Campylobacter pathogenesis are still poorly understood. Following 
ingestion of a suﬃcient quantity of bacteria, Campylobacter must survive 
the host environment and migrate to their target organ, the small 
intestine. Campylobacter utilises its motility and chemotactic apparatus 
to reach its primary destination - the intestinal mucus layer - which 
serves as a base for host-cell adhesion and invasion.   
 
1.3.6.1. Motility  
Campylobacter exhibits a corkscrew-like pattern of motility conferred by 
a single flagellum at one or both poles. The flagellum filament is 
composed of a flagellin subunit polymer and encoded by the flaA and 
flaB genes. Mutagenesis studies have shown that flaA knockout produces 
a truncated flagella that completely disrupts motility, whereas flaB 
knockout only yields a slight decrease, indicating that flaA is the major 
flagellin component (Wassenaar et al. 1991, Wassenaar et al. 1993, 
Wassenaar et al. 1994). The larger flagella complex contains multiple 
units, including a motor, basal body, and stator ring complex. 
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Campylobacter has a particularly powerful motor complex that allows it 
to bore through intestinal mucus and between epithelial tight-junctions 
(Beeby et al. 2016).  
 
Campylobacter’s flagella is unusual in that it lacks several microbe-
associated molecular patterns (MAMPs) that are highly conserved 
amongst other bacterial flagellins (De Zoete et al. 2010) These MAMPs are 
recognised by Toll-like receptors, and a play a key role in antigen 
recognition by the innate immune response (Smith et al. 2003). The 
Campylobacter flagellin is also heavily glycosylated, producing a 6kDa 
shift from the protein’s predicted molecular mass. A total of 19 
serine/threonine residues – all of which are located on the surface 
exposed domain – have modified glycosyl residues, with several 
modifications involving pseudaminic acid derivatives mediated by the 
pseA-I genes (Thibault et al. 2001). 
1.3.6.2. Chemotaxis 
Chemotaxis is the directional movement mediated by the presence of 
attractive or repulsive gradients. Prokaryotes have a chemosensory 
pathway referred to as the histidine aspartate phosphorelay (HAP), 
which is able to modulate the direction in which the flagellar motor spins 
– and thus generate random directional change – in response to 
chemotactic stimuli (Wadhams & Armitage 2004). 
 
The Campylobacter chemoreceptor system is composed of transducer 
like proteins (Tlps), a membrane-associated histidine kinase (CheA), a 
linker protein (CheW) and cytoplasmic response regulator (CheAY) (Yao 
et al. 1997, Lertsethtakarn et al. 2011). Genomic analysis has also revealed 
additional subunits involved in chemotaxis, notably including CheV, 
which is homologous to CheW (Alexander et al. 2010, Marchant et al. 
2002). Campylobacters response regulator CheAY is atypical in that it 
features a response regulator domain (homologous to the CheY protein) 
and the C-terminus of CheA subunit (Zautner et al. 2012).  
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C. jejuni has 10 identified transducer-like proteins (Tlp1-10) and two 
aerotaxis genes (Aer1, 2) belonging to 3 groups which are responsible for 
ligand binding. Group A Tlps (Tlp1-4, 7 and 10) - responsible for the 
sensing of extracellular ligands - are highly conserved across C. jejuni 
strains and consist of distinct cytoplasmic, periplasmic and 
transmembranous regions (Zautner et al. 2012). Group B contains the 
singular Tlp9, which is also referred to as CetA for Campylobacter energy 
taxis A; CetA lacks any ligand-binding domain and instead acts as a 
signal transducer to the aerotaxis proteins Aer1/2.  Group C (Tlp5, 6 and 
8) are purported to be responsible for cytoplasmic signal detection 
(Zautner et al. 2012, Lertsethtakarn et al. 2011, Walker et al. 1986, Young 
et al. 2007). 
 
CheW is a scaﬀolding protein that links Tlps to CheA in the quaternary 
Tlp-CheW-CheA complex and is involved in signal transduction. Upon 
formation of the oligomeric quaternary structure, CheA undergoes 
autophosphorylation (Gegner et al. 1992, Korolik et al. 2008). CheY then 
binds to CheA and the phosphoryl group is transferred. CheY 
phosphorylation permits interaction with FliM – a motor switch protein 
– and changes the direction in which the flagellar filament is rotated 
(Korolik et al. 2008). 
 
During host colonisation in both commensal and pathogenic contexts,  
C. jejuni initially establishes itself in the mucus layer covering the 
intestinal epithelium (Young et al. 2007). The intestinal mucus layer is 
formed by the secretion of mucin glycoproteins from epithelial cells. A 
major component of these glycoproteins is L-fucose, which is located in 
the terminal position of the oligosaccharide chain (Becker & Lowe 2003, 
Lindén et al. 2008). L-fucose acts as a chemoattractant for 
Campylobacter, and is hypothesised to mediate chemotaxis towards the 
mucus layer in C. jejuni infections (Stahl et al. 2012). Additionally, a 
number of Campylobacters’ preferred nutrient sources (i.e. amino acids 
and TCA-cycle intermediates) also produce a chemotactic response and 
are common components of the gut environment. C. jejuni  attractants 
include, but are not limited to L-fucose, L-cysteine, L-glutamate,  
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L-serine, L-aspartate, succinate, fumarate, pyruvate, α-ketoglutarate  
and malate (Hugdahl et al. 1988). 
1.3.6.3. Adhesion 
Following localisation to the intestinal mucus, Campylobacter must 
adhere to host cells to overcome peristaltic motion and excretion (Baqar 
et al. 2008). Unlike other Gram-negative enteropathogens, adhesion is 
not mediated by the production of fimbrial structures, and instead relies 
on a complex network of cellular surface structures known as adhesins 
(Guerry 2007).  
 
Campylobacter has several suspected adhesins, including 
lipooligosaccharides, outer-membrane proteins, and flagella, however 
there are only a handful of examples that have been confirmed via in 
vitro study (Flanagan et al. 2009, Golden & Acheson 2002). For example, 
two genes - cadF and jlpA – have been shown to specifically bind to host 
fibronectin receptors, with mutagenesis studies showing reduced 
adhesion in mutant phenotypes (Golden & Acheson 2002, Flanagan et al. 
2009). C. jejuni adhesion is thought to occur at the apical surface of 
epithelial cells in the perijunctional area prior to host-cell invasion (Hu & 
Kopecko 2008). The amount of unconfirmed adhesins is far greater and 
continues to be a keen topic of research (Ramirez-Hernandez et al. 2015, 
Lugert et al. 2015, Boehm et al. 2015).  
1.3.6.4. Invasion 
There is conclusive evidence from human biopsies, animal infection 
models and intestinal epithelial cell lines that Campylobacter invades 
host cells (Poly & Guerry 1989, Yao et al. 1997, Szymanski et al. 1995).  
Several mechanisms of cell entry have been described, and are largely 
impacted by strain and cell line, the pathway described has been studied 
in C. jejuni 81-176 (Hu & Kopecko 1999).  
 
Campylobacter initiates invasion by secreting eﬀector proteins; a study 
identified that a minimum of 8 novel C. jejuni  proteins are synthesised 
following cellular adhesion; in particular, the ciaB gene was identified as 
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a key component of the secretion pathway, with a total loss of adhesion-
dependant protein secretion in knockout mutants (Konkel et al. 1999). 
The secreted proteins function by triggering the depolymerisation of 
actin filaments, leading to the formation of microtubule based 
protrusions and ultimately leads to endocytosis (Kopecko et al. 2001, 
Lugert et al. 2015). 
 
Internalised C. jejuni cells are contained within a membrane bound 
vacuole (Lugert et al. 2015). The mechanism underpinning cellular entry 
limits the number of endocytosed bacteria to one or two organisms per 
cell, though limited intra-vacuole replication has been shown to occur 
(Hu & Kopecko 1999). The vacuole then translocates along intracellular 
microtubules to the basolateral cell surface using a dynein motor 
protein. At the basal surface, cells are exocytosed in as little as 15 minutes 
following invasion and are able to regain entry to the epithelium 
basolaterally (Hu & Kopecko 2008). 
 
Diarrhoea symptoms are purportedly generated due to a collection of 
factors. During the adhesion and invasion process, there is an increase in 
intracellular Ca2+ and activated protein kinase C which has been linked to 
an increase in fluid secretion (Hu et al. 2005). Additionally, 
Campylobacter has been shown to secrete a number of proteins 
(Wassenaar 1997). Amongst the more well defined proteins is a cytolethal 
distending toxin (CDT) that arrests the cell cycle and leads to intestinal 
cell death. CDT-mediated cytotoxicity activates inflammatory pathways 
via the induction of IL-8 secretion, which coupled with the increased 
fluid secretion and impaired absorption capacity of the damaged 
intestinal epithelium leads to diarrhoeal stools (O Cróinín & Backert 
2012, Nielsen et al. 2012). 
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Figure 1.4 - A brief overview of Campylobacter pathogenesis 
(1) Campylobacter cells present in the mucus layer adhere to intestinal epithelium perijunctional regions, mediated by surface bound adhesins (e.g. CadF).  
(2) Bacteria secrete proteins that propagate cellular invasion (e.g. CiaB). (3) In response to the secreted invasion effectors, a cascade is triggered that results 
in the endocytosis of Campylobacter cells, which are engulfed in a vacuole. (4) The bacterium moves along microtubule filaments to the basal surface where it 
is exocytosed. C. jejuni has also been shown to disrupt the tight junctions linking the intestinal epithelium. It is hypothesised that Campylobacter may exhibit 
paracellular invasion via translocation of the disrupted junctions. Figure design based on (Kopecko et al. 2001).  
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1.3.7. Genomics 
The first complete Campylobacter genome sequence of C. jejuni clinical 
isolate NCTC 11168 was published in 2000, using a combination of dye-
terminator sequencing and PCR verification (J Parkhill et al. 2000). This 
genome was re-annotated in 2007 to include up-to-date references and 
methodologies (Gundogdu et al. 2007). In the past decade several 
additional complete genomes have been sequenced, including C. jejuni 
isolates NCTC 11828, 81-176, RM1221, and CG8486 (Hofreuter et al. 2006, 
Pearson et al. 2007, Poly et al. 2007b, Fouts et al. 2005). 
 
The genome of NCTC 11168 is 1,641,481 bp in length; it has a relatively low 
G+C content of 30.6%, and is configured in a single circular chromosome. 
Campylobacter has a particularly dense genome, with 94.3% of 
nucleotides distributed across 1643 CDSs. C. jejuni’s genome is unique in 
that it does not contain insertion sequence elements, or transposons (J 
Parkhill et al. 2000). 
 
The complete genome sequence of another Campylobacter jejuni isolate - 
RM1221 - was published in 2005 (Fouts et al. 2005) and showed a number 
of diﬀerences to the genome of 11168. RM1221’s genome is notably longer, 
at 1,777,831 bp in length and has a total of 1,884 predicted CDSs. The 
major diﬀerence is that RM1221 has four integrative elements, including 
an inducible Campylobacter Mu-like phage (CMLP) and C. jejuni 
integrated elements 1-3 (CJIE) (Clark & Ng 2008). With the exception of 
CJIE3, several CDSs within these genomic islands are putatively 
identified as phage-related. Bacteriophages are vectors for horizontal 
gene movement which can confer an increase in fitness and virulence 
(Hendrix et al. 2000). 
 
During the sequencing of C. jejuni isolate 81-176 - the same isolate used in 
the human trials by Black in 1981 – two plasmids were identified: pVir 
and pTet (Hofreuter et al. 2006). Between 19-53% of C. jejuni strains have 
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been shown to contain plasmids, with many being exclusively 
transmissible amongst Campylobacter spp. (Bacon et al. 2000). The pVir 
plasmid in the 81-176 genome is 37,468 bp in length with 35 open reading 
frames. Several genes within the plasmid are homologous to type IV 
secretion system proteins. The plasmid diﬀers from typical C. jejuni DNA 
in that only 83% of the DNA spans coding information, and has a lower 
GC content at 26%. pVir has been significantly associated with the 
presence of blood in patient stools, which may reflect an increased level 
of invasion (Tracz et al. 2005). 
 
The Campylobacter genome contains several instances of hypervariable 
mononucleic polyG/C tracts. Ranging from 8-13 bp, these tracts mediate 
on/oﬀ expression of phase-variable genes (known as contingency genes) 
via slipped-strand mispairing, with a similar system observed in 
Neisseria (J. Parkhill et al. 2000). A number of genes controlled in this 
manner are located in regions responsible for surface structure and likely 
reflect the mechanism that underpins Campylobacter’s diverse surface 
configurations. 
1.3.7.1. MLST 
Multilocus sequence typing (MLST) is a genotypic method that 
unambiguously groups genetically homologous isolates based on the 
nucleotide sequences of several highly conserved ‘housekeeping’ genes 
(Maiden et al. 1998).  
 
The MLST scheme for Campylobacter was established in 2001 and 
utilises seven loci: aspA, glnA, gltA, glyA,  pgm, tkt and uncA (Dingle et al. 
2001). This scheme assigns each loci with an arbitrary allele number 
based on iterative diﬀerences in the gene sequence. The combination of 
allele numbers forms a unique allele profile that is assigned to a 
sequence type (ST). Sequence types can be grouped into larger, 
epidemiologically related lineages known as clonal complexes (CC) that 
are derived from a single common ancestor (Maiden et al. 1998). 
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For a novel sequence type to be assigned to an existing Campylobacter 
CC it must share a common allele profile at least 4 of the 7 loci. Each CC 
is labelled with the founding sequence type identifier, for example CC 
ST-21 originated with a single ST-21 isolate that in itself was assigned a 
novel sequence type due to diﬀerences in 4 or more loci when compared 
to other isolates within the database (Jolley & Maiden 2010, Dingle et al. 
2001). 
1.3.7.2. Molecular Epidemiology 
The introduction of MLST allowed characterisation of Campylobacter at 
the population level, and has revealed a number of attributed sources of 
clinical infection. Several studies have shown members of the ST-21 
complex as the most frequently isolated lineage in clinical samples 
across multiple countries (Sheppard et al. 2009, Kovanen et al. 2014, 
Cody et al. 2012, Schielke et al. 2014). The ST-21 lineage has been 
described as a supercomplex due to an abundance of constituent 
sequence types (Dingle et al. 2001). At the time of analysis, 684 unique 
sequence types were assigned to the ST-21 complex, which accounts for 
17.4% (7858) of all isolates submitted to the PubMLST database (Jolley & 
Maiden 2010). 
 
Members of the ST-21 lineage – and other common clinical sequence 
types such as ST-45 and C. coli ST-828 - have been isolated from a variety 
of hosts. Rapid transmission events between these reservoirs (and the 
large number of sequence types within some complexes) erodes signals 
of host-association (Dearlove et al. 2015), however the frequency at which 
certain complexes are isolated from clinical samples suggests that some 
isolates have niche adaptations that favour the development of human 
pathogenesis (Olson et al. 2008). Figure 1.5 shows the distribution of 
clinical cases attributed to the major CC’s submitted to BigsDB as of 
October, 2016.  
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Figure 1.5 - Total number of isolates from identified clonal complexes submitted to BigsDB isolated from human stool 
Figure produced from public data listed on the PubMLST database for C. jejuni and C. coli. Inclusive of clonal complexes with more than 50 
isolates, matching sources: human stool, blood culture, CSF and unspecified (Accessed 12/06/17).  
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1.3.7.3. Genetic Diversity 
Genetic diversity, and by extension bacterial evolution as a whole, is 
dominated by two key factors: the rate of mutations that arise as a result 
of DNA damage or replication error, and the acquisition of external 
variation via horizontal or lateral gene transfer. The former produces a 
gradual clonal divergence, with diversity accumulating over a long 
period of time, whilst the latter can import a dramatically diﬀerent 
stretch of DNA in a single genetic event, significantly altering any single 
clone (Sheppard & Maiden 2015).  
 
C. jejuni displays a dramatic genotypic diversity which is largely thought 
to be due to its propensity for both inter and intraspecies recombination. 
Campylobacter is naturally competent, and is able to import and 
incorporate environmental DNA into its genome. More than 40 bacterial 
species are naturally competent, including Neisseria gonorrhoeae and 
Helicobacter pylori (Sparling 1966, Tsuda et al. 1993). Campylobacter’s 
ability to share genomic DNA is well documented (Iraola et al. 2014, 
Wells & Bennik 2003, Wassenaar et al. 1995), As a result, the population 
structure is weakly clonal, and generally grouped into larger 
epidemiologically related lineages.  
 
Sheppard et al. (2008), demonstrated that Campylobacter has undergone 
a recent increase in bidirectional recombination between C. jejuni and C. 
coli, which may be resulting in the convergence of the two species. This 
is particularly apparent in C. coli, which undergoes asymmetric gene 
flow and was demonstrated to import C. jejuni alleles across all identified 
loci (Sheppard et al. 2008). This increase is likely as a result of 
agricultural activities, which have removed ecological barriers and 
allowed the two species to interact.  This highlights Campylobacters 
ability to rapidly evolve as a result of its proclivity for recombination. 
 
The amount of diversity observed in Campylobacter spp. may mask its 
epidemiology. Studies have identified the presence of genetic diversity 
through repeated sampling of a single infected person (Cody et al. 2013). 
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All isolates were of the same sequence type, and therefore assumed to be 
the same clone of Campylobacter responsible for initiating the infection. 
In some patients, variants in as many as 14 loci were detected. The same 
study aimed to identify instances of related cases amongst a dataset of 
379 clinical isolates. The researchers assigned the cut oﬀ value for 
describing a case as linked at 20 loci. 
 
As this study is based on wgMLST, whereby each loci is allocated an 
allele number by the same mechanism as ST assignation, the measure of 
variable loci is only quantitative. A single polymorphism in any loci 
would be suﬃcient to generate a diﬀerent allele and thus categorise a 
locus as variable, which is indistinguishable from a loci containing 
multiple polymorphisms. It is therefore unclear as to how this 
methodology would compare to other measures of diversity such as 
single nucleotide polymorphism (SNP) typing. For example, if an isolate 
contains X number of called variable loci (X<20) and Y number of 
polymorphisms, the isolate may be considered as related via SNP typing 
where X=Y, or drastically diﬀerent if Y is suﬃciently greater than X. 
Equally, isolates with 21 SNPs in unique loci would be suﬃcient to 
discount linkage via wgMLST methods. Given the vast diversity observed 
amongst clonal isolates derived from a single patient, and the propensity 
of Campylobacter to transfer genes, it is not unreasonable to assume that 
case linkage may occur and is simply  
not detected. 
1.3.8. Study Rationale 
The majority of Campylobacter infections are thought to be sporadic in 
nature, and epidemiological studies have not definitively identified any 
instances in which case linkage has been observed. However, these 
studies have relied on comparative techniques that exclusively rely on de 
novo genomic assembles.  
 
As a product of the de novo assembly process, the resulting genome is a 
consensus estimate sequence that has been collapsed to a depth of 1x. 
Microbial genomic reads typically have a coverage depth of 
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approximately 30x – that is to say that any given position in the genome 
has been sequenced 30 times. By comparing these read files to a target de 
novo assembly (i.e. read mapping), a more thorough and definitive 
measure of variation between an isolate pair can be obtained. 
 
Read mapping approaches produce a list of genomic positions at which a 
non-congruent base call occurs. A variation at a given base position is 
known as a single nucleotide polymorphism (SNP). At a superficial level, 
the quantity of polymorphisms observed between two isolates can be 
used as an indication of homology, with fewer polymorphisms indicating 
a greater degree of similarity. The individual positions of the 
polymorphisms and their distribution across the genome can also be 
used to delineate case linkage, which is currently not possible with 
wgMLST. For example, by the wgMLST scheme, an isolate pair may 
contain several hundred polymorphisms across 19 loci and be considered 
to be linked. By the same methodology, an isolate pair could contain just 
21 polymorphisms in unique loci and be assigned as non-linked. 
 
This study aims to utilise a read mapping approach to identify any 
potential linkage from a set of human clinical campylobacteriosis cases, 
which may otherwise be missed via conventional (i.e. wgMLST) genomic 
methods. Utilising a read mapping approach will provide a thorough and 
objective methodology for comparing genomic sequences, and 
definitively identify any potential instances of case linkage. It will also be 
sensitive to variation at intergenic positions, which is not possible via 
wgMLST analysis. 
 
Additionally, at present the abundance of CC’s is thought to be equally 
representative of the United Kingdom as a whole.  As there have been no 
genetic epidemiology studies of Campylobacter in Nottingham, the wider 
population structure of clinical Campylobacter across Nottinghamshire 
will be elucidated using phylogenetic analyses. This will provide an 
insight into the abundancies of clinically associated complexes and allow 
comparison between genomic studies elsewhere.  
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2. Chapter Two: Methods 
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2.1. Bacterial Strains 
All bacterial isolates were obtained from Nottingham University 
Hospital’s Queen's Medical Centre (QMC) - a large health trust that 
services the greater Nottinghamshire area. Their pathology lab processes 
approximately 800 Campylobacter spp. isolates annually, and for the 
purposes of this study have captured both the original stool sample and a 
frozen stock culture of the organisms.  
 
All analysed strains were obtained from cryopreserved samples stored at 
-80°C, which were prepared directly from an initial stool culture on a 
mCCDA based selective agar. All isolates were transported on ice from 
QMC to the CL2 laboratory at Clifton Campus, Nottingham Trent 
University in less than 30 minutes, and again stored at -80°C until use. 
 
Both the initial cryopreserved samples and sub-stocks were stored using 
Microbank™ Preservation Beads (Prolab Diagnostics, United Kingdom, 
PL.170). These preservation beads are chemically coated to promote 
bacterial adhesion, and are suspended in a cyropreservative that is 
optimised for fastidious organisms. 
2.2. Sampling 
Queen’s Medical Centre provided monthly reports on all Campylobacter 
isolates collected by their microbiology department. These reports 
included a sample identifier, the date of sample collection, and the date 
on which the sample was received.  
 
The sampling period covered a 365-day range from January 1st – 
December 31st 2014, and included all isolates with a collection date 
within that time frame. An approximate, raw number of isolates to be 
sampled each month was determined using local historic incidence data 
supplied by QMC from recent previous years (provided in Appendix 9.2) 
using the equations listed on the following page. 
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The average daily incidence observed in 2014 was compared to the 
historic data to obtain a suitable sample size that accounted for any 
deviation or natural fluctuation in isolation numbers, and allow the 
sequencing capacity to be distributed appropriately. A daily average was 
used over monthly average to account for and normalise leap years. 
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2.3. Culture Media 
Isolates were cultured directly onto Campylobacter Blood-Free Selective 
Agar Base (Oxoid, United Kingdom, CM0739) – a modified Charcoal-
Cefoperazone-Deoxycholate agar - supplemented with 16mg/500ml of 
Cefoperazone and 5mg/500ml of Amphotericin B (Oxoid, United 
Kingdom, SR0115).  
 
The agar was prepared by suspending 22.75 g of the agar base in 500 ml 
of distilled water and mixed using a magnetic stirrer. The solution was 
sterilised by autoclaving at 121°C for 15 minutes, and stored at 55°C until 
required. Before pouring, the agar was again magnetically stirred whilst 
cooling.  
 
The selective supplement was prepared by reconstituting the powdered 
antibiotics (stored at 4°c) in 2 ml of sterile distilled water and added to 
the cooled agar before a final round of magnetic stirring. Plates were 
poured immediately under aseptic conditions and used within 48 hours.  
 
2.3.1. Culture Conditions 
The cryopreserved bacterial cultures were removed from the -80°C 
freezer and thawed on ice for approximately 10 minutes before use. Care 
was taken to ensure a minimal amount of freeze thawing occurred, and 
that samples were not thawed for longer than necessary.  
 
A single Microbank preservation bead was transferred from the storage 
tube onto pre-prepared mCCDA plates. A 10 µl inoculation loop 
(Scientific Laboratory Supplies, United Kingdom, SLS2010) was used to 
smear the bead across the surface of the plate in a simple streak pattern. 
 
Isolates were incubated for approximately 48 hours at 37°C in an 
anaerobic workstation (Don Whitley Scientific, United Kingdom, DG250), 
configured with a microaerobic gas canister (5% O2, 10% CO2 and 85% N2, 
BOC, United Kingdom).  
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Samples that failed to produce suﬃcient growth were re-cultured in 
Mueller Hinton Broth (Oxoid, United Kingdom, CM0405), which was 
supplemented with the previously described selective formula (Oxoid, 
United Kingdom, SR0115).  
 
The broth was prepared by mixing 10.5 g of the broth base with 500 ml of 
distilled water and sterilised by autoclaving at 121°C for 15 minutes. The 
broth was allowed to cool before adding the reconstituted selective 
supplement and subsequently aliquoted into sterile 15 ml conical tubes 
(Sarstedt, Germany, 62.554.002). 
 
A single Microbank preservation bead was transferred directly into a 
conical tube containing 10 ml of MHB. The tubes were sealed and 
transferred to a shaking platform inside the anaerobic workstation; once 
all tubes were seated correctly, the conical tube lids were loosened to 
allow suﬃcient gas permeability and the shaking platform was set to 100 
rpm. Isolates were incubated for 24 hours and then sub-cultured onto 
mCCDA for a further 24 hours as previously described. 
 
Samples that continued to yield insuﬃcient growth following pre-
enrichment were discarded and an alternative sample was used. Figure 
2.1. gives a summary of the isolation process. 
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Figure 2.1- Summary of sample preparation and DNA qualification process. 
Cultures that failed to produce sufficient growth during the first round of culture were preenriched in MHB. Isolates that continued 
to provide insufficient growth were discarded. DNA was qualified based on the absorption ratio of the bulk sample, with an 
A260/280 ratio of 1.8-2.0 treated as acceptable for WGS. 
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2.4. DNA Isolation 
DNA was prepared for whole genome sequencing (WGS) using the 
QIAmp DNA Mini Kit (Qiagen, Netherlands, 51306). The standard assay 
protocol provided in the QIAmp DNA Mini and Blood Mini Handbook 
(Qiagen, Netherlands, HB-0329-004) - summarised in Figure 2.2– was 
modified to account for Campylobacter biology. 
 
Due to the presence of numerous endonucleases in Campylobacter, it 
was important to ensure protein denaturation occurred quickly after cell 
lysis to prevent nucleic acid degradation. Initial cell lysis with ‘Buﬀer 
AW’ was limited to 30 minutes, followed by a 60-minute incubation with 
proteinase K (20 mg/ml, 600 mAU/ml). 
 
During the proteinase K incubation stage, the sample was frequently 
vortex mixed to ensure eﬃcient enzyme-substrate binding. Vortexing 
also helped to disassociate tightly bound pellets that formed as a result of 
autoagglutination. At the end of the 60-minute incubation period 
samples were checked for homogeneity. Any samples that were not fully 
digested (i.e. if a visible mass was still present) were returned for 
incubation and reassessed in 10 minute intervals. 
 
The digested solution was treated with 20 µl of 20 mg/ml RNAse A 
solution (Sigma Aldrich, United Kingdom, R6148) and incubated at room 
temperature for 15 minutes.  
 
To avoid mechanical shearing, the DNA extraction was transferred to the 
silica columns by gently pouring the bulk of the tube contents. 
Remaining excess solution was pipetted across using a P1000 tip. 
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Figure 2.2 - Qiagen QIAmp DNA Mini Kit DNA Isolation Workflow 
Green boxes contain processes related to bacterial cell lysis and digestion, blue 
relate to processes wherein DNA is bound to the silica columns and orange to 
DNA elution and handling.  
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As the elution buﬀer provided in the kit (Buﬀer AE) contains EDTA – an 
inhibitor of downstream sequencing applications – ultrapure sterile 
distilled water was used in its place. DNA was eluted in a reduced volume 
(65 µl vs. recommended 200 µl) to increase stock concentration, and 
allow re-elution of DNA from the column if any contamination was 
subsequently observed. DNA was stored in sterile 1.5ml Eppendorf tubes 
at -20°C.  
 
2.4.1. DNA Qualification 
The quality of DNA extractions was initially verified using the Nanodrop 
2000 spectrophotometric platform (ThermoFisher Scientific, USA, ND-
2000) to identify samples with suﬃcient yield, quality and purity. The 
Nanodrop assesses quality based on the absorption spectra of nucleic 
acid, with acceptable quality thresholds inferred from absorption ratios. 
DNA extractions that had a 260:280 nm ratio of between 1.80-2.00 and a 
260:230nm ratio of between 2.00 and 2.20 were deemed to be suﬃciently 
pure for WGS. 
 
Any samples with abnormal ratios or a non-uniform curve were 
diagnosed for likely contaminants. Where suitable, the elution stage of 
the DNA extraction step was repeated to yield a purer preparation. 
Extractions that did not meet the quality threshold after troubleshooting 
were discarded and repeated. 
 
The Nanodrop platform also quantitates DNA. As the quantification is 
non-specific for DNA, and instead reports on all substances that absorb 
at 260 nm (e.g. RNA), the quantification was only used to ensure 
preparations had suﬃcient approximate yield. DNA preparations in 
excess of 30 ng/µl were treated as appropriately concentrated. 
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2.4.2. DNA Quantification 
To obtain an accurate quantification of double-stranded DNA (i.e. 
sequencable material), samples were measured using the Qubit 
fluorometric platform (Thermofisher Scientific, USA, Q33217). This assay 
uses a dye that specifically binds to ds-DNA, forming a complex that is 
highly fluorescent.  
 
For initial stock measurements, 2 µl of DNA was measured using the 
broad-range assay kit (Thermofisher Scientific, USA, Q32850) rated at a 
range of 2-1000 ng (i.e. measurable concentration range 1-500 ng/µl).  
 
Subsequent measurements of dilutions at low concentrations utilised the 
high sensitivity assay kit (Thermofisher Scientific, USA, Q32851). This kit 
is rated at a range of 0.2-100 ng, and is less accurate at the extremes of 
that range. When diluting to the required input concentration for WGS 
(0.2 ng/µl), the amount of DNA was increased to 10 µl to increase the 
accuracy and sensitivity of the assay. 
 
2.5. Whole Genome Sequencing 
Whole genome sequencing was conducted on the MiSeq platform 
(Illumina, USA) in two tranches, one of which was conducted externally 
by Ben Bascoe and Samuel Sheppard at Swansea University. The 
methodology described herein is largely representative of both tranches, 
though minor variations may exist.  
 
Prior to library generation, a subset of DNA samples was verified using 
gel electrophoresis to ensure no degradation had occurred during freeze 
storage. Samples were treated as intact if the electrophoresis produced 
high molecular weight, non-smeared bands. The DNA was then 
transferred into a 96-well plate (Corning, Netherlands, AXP470) and 
diluted to 0.2 ng/µl using ultrapure sterile distilled water.  
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Genomic libraries were prepared using Illumina’s NextEra XT kit 
(Illumina, USA, FC-131-1024) according to the protocol described in the 
Nextera XT DNA Library Prep Reference Guide (Illumina, USA, 15031942 
v01). Briefly, the dilute DNA samples were incubated with a dual tn5 
transposase mix that fragments dsDNA and adds an adaptor sequence 
required for PCR amplification. Libraries were indexed using Illumina’s 
Nextera XT Index Kit V2 (Illumina, USA, FC-131-2001), with resulting PCR 
products cleaned using Agencourt AMPure XP beads (Beckman Coulter, 
USA, A63880).  
 
In lieu of the bead based normalisation method provided with the library 
preparation kit, libraries were normalised manually. The bead 
normalisation protocol requires a high concentration of DNA, and uses 
the total amplification product. Manual normalisation allowed a finer 
control over the final library concentration and produced a greater 
number of successful library preparations, as well as providing excess 
product for QC and contingency purposes. 
 
To manually normalise the libraries, concentration of the cleaned PCR 
product was determined using the Qubit HS Assay Kit as previously 
described. Average library insert size was determined by running a 
subset of samples on an Agilent 2200TapeStation (Agilent Technologies, 
USA, G2964AA) using a D1000 high sensitivity ScreenTape and reagents 
(Agilent Technologies ,USA, 5067-5582 + 5067-5583). The average insert 
size provided by the TapeStation was used to inform the molar 
conversion (i.e. ng/µl to nM) using the following equation:  
 
 
 !"#$%#&'(&)"#	)#	#+/µ.	(660	g/mol	×	78%'(+%	9#:%'&	;)<%)	×	10? 
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The libraries were diluted to 4nM and denatured using sodium 
hydroxide as described in the MiSeq System Denature and Dilute 
Libraries Guide (Illumina, USA, 15039740 v01). Due to the required depth 
of coverage for 96 Campylobacter genomes, libraries were loaded onto a 
MiSeq Reagent Cartridge v3-600 (Illumina, USA, MS-102-3003) at a final 
concentration of 20 pM. The MiSeq was configured to run paired end 300 
bp reads in ‘FastQ generation’ mode.  
 
2.5.1. Estimating Sequencing Coverage 
Expected sequencing coverage can be estimated using the equation 
given below. The MiSeq’s V3 chemistry specification gives an 
approximate coverage of 47.98 vs. 23.99 on the V2 chemistry. Multiple 
factors such as the number of clusters passing filter and resulting per 
base quality will impact the final usable coverage; coverage is also not 
distributed equally across the length of the genome, and as such the V3 
chemistry was selected to err on the side of caution. 
 
 @%(A	B%#+&ℎ	×	DEFG%'	"H	@%(A:I%#"F%	B%#+&ℎ	×	DEFG%'	"H	B)G'(')%: 	= !"8%'(+% 
 
 
 K);%L	M2	!ℎ%F):&'O:	 250	×	15, 000, 0001, 628, 115	×	96 	= 23.99 
 
 
 K);%L	M3	!ℎ%F):&'O:	 300	×	25, 000, 0001, 628, 115	×	96 	= 47.98 
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2.5.2. Genomic Read Curation 
Following FastQ generation, the run performance was analysed using 
Sequence Analysis Viewer (Illumina, USA) to provide an overview of the 
general read quality. Aspects such as the overall and per-cycle % of bases 
>Q30, the percentage and distribution of reads mapped to an index ID, 
and channel intensity were used to judge the run quality.  
 
FastQC was used to produce individual sample reports (Andrews, 2010). 
Samples that exhibited a drastically declining read quality were 
processed using Sickle, a paired-end, sliding window quality trimmer 
(Joshi and Fass, 2011). Samples that showed residual adapter sequences – 
that are typically removed during the FastQ generation process – were 
processed using Trimmomatic (Bolger et. al., 2014).  
 
2.5.3. Genome Assembly and Annotation 
Reads were assembled using SPAdes 3.5.0 (Nurk, Bankevich et al., 2013) 
due to its computational eﬃciency and strong performance with small 
genomes. A script (AutoSPAdes  Appendix 9.3) was developed to 
automatically invoke SPAdes on large FastQ datasets, and produce a 
collection of final assemblies named according to the sample ID. SPAdes 
was configured to utilise the ‘careful’ flag, which runs a mismatch 
corrector to reduce errors and short indels. Draft assemblies were 
subsequently processed using QUAST, which generates a report on 
assembly statistics such as number of contigs and N50 that were used to 
assess the quality of the assembly (Gurevich et al., 2013).  
 
Annotation was performed using Prokka (Seeman, 2014) under default 
settings. A script (AutoProkka, Appendix 9.4) was developed to 
automatically invoke Prokka on a directory of assemblies. The script 
collects and renames the gﬀ annotation files from each sample into a 
user specified directory and greatly reduces the hands-on time usually 
required to annotate large datasets. 
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2.5.4. MLST Profiling 
Draft assemblies were initially analysed using ‘mlst’ to gain MLST allele 
numbers and sequence types (Seeman, 2014). Isolates were also 
referenced against the PubMLST Campylobacter database (Jolley and 
Maiden, 2010), to provide information on Clonal Complex. At the time of 
analysis there were 8389 MLST profiles defined in the database. 
 
Sequences from isolates belonging to the same complex and sequence 
type were then aligned to identify SNPs as an indication of genetic 
homology. Alignment was performed using SMALT 0.7.5 (Welcome Trust 
Sanger Institute), and the subsequent files were processed using the 
SAMTools suite of utilities (Li et al., 2009). Pairwise distance matrices 
were produced using MEGA 6 (Tamura et al., 2013) to quantify sequential 
distance as a raw number of polymorphisms. For highly similar isolates, 
allele profiles for all identified loci were scored using all available loci 
deposited to BigsDB and compared in a pairwise manner. 
 
2.5.5. Core Genome Phylogeny 
Phylogeny was reconstructed using the Harvest software suite (Treangen 
et al., 2014) using NCTC11168 (ST-21) as a reference genome. Parsnp – 
part of the Harvest suite – performs a core genome alignment based on 
MUMer identity scores. Parsnp was configured to treat genomes as 
‘curated’ to force inclusion of as many isolates as possible. 
 
Maximum-likelihood trees were produced from the intra-lineage 
alignments using RAxML (Stamatakis, 2014). The resulting phylogenetic 
data was visualised using FigTree (Rambaut, 2007) and manually 
annotated to identify CC types of the major clades.  
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2.5.6. Deep Sequencing  
Several isolates from the clinical dataset were also sent for Deep 
Sequencing (i.e. sequencing to a much higher level of coverage) and 
analysed using a workflow described by Lieberman et al. (2014). The 
marked increase in coverage provided far greater resolution at a read-by-
read basis, and allowed distinction of minor allelic variation that would 
otherwise be undetectable by conventional SNP typing.  
 
Greater detail is given in chapters 3 and 4, however briefly; FastQ files 
containing raw sequencing reads were initially filtered using Sickle 
(Joshi and Fass, 2011). This discarded any reads below 50bp in length, 
and with a quality score of <20. The filtered reads were subsequently 
processed with Bowtie2 (Langmead and Salzberg, 2012), which aligned 
reads to a reference; in this instance, deep-sequenced isolates were 
mapped against assemblies of their own genome. Bowtie was configured 
to discard any fragment length (inclusive of gaps) >2000bp in length and 
any reads in which the frequency of ambiguous characters exceeded 1%. 
The data was then parsed through the Samtools software suite (Li et al., 
2009) removing reads with aberrantly high depth and any alignments 
that did not have a Q-score of > 30. Due to the inaccuracies of Illumina’s 
SBS technology, insertion and deletion events were discarded. 
 
Samtools’ mpileup package produces several statistical metrics by which 
each called allele was further assessed. More than 3% of reads had to 
support a minor allele, with at least 15 reads mapping the variant 
(defined by the AF1 value and DP4 value respectively). Strand bias and 
tail distance bias were also considered, discarding called alleles with P-
values of < 10-5. This process filtered any false positive polymorphisms or 
strand asymmetry introduced by misalignments in the computational 
pipeline. Figure 2.3 provides an overview of the deepsequencing 
pipeline. 
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Figure 2.3 - Overview of the deep sequencing analysis pipeline 
Software names highlighted within red boxes in bold, with key optional changes to default parameters listed below. 
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3. Chapter Three: Genetic epidemiology of 
clinical Campylobacter spp. 
57 
	
3.1. Abstract 
Current molecular studies of clinical Campylobacter epidemiology are 
limited to a small number of sites, with population diversity assumed to 
be representative of that across the United Kingdom. Additionally, links 
between sporadic cases are yet to be established, with the majority of 
infections thought to be generated from genetically distinct isolates. 
However, the techniques employed to study case linkage have thus far 
relied on incomplete molecular methods (e.g. wgMLST) and as such may 
miss fine scale associations. 
 
Using a higher resolution of analysis at the whole genome level, 158 
clinical isolates from the greater Nottinghamshire area were analysed to 
assess the local population structure and investigate potential case 
linkages. The distribution of major dominant CC’s identified amongst the 
Nottinghamshire dataset was in agreement with other sites in the UK, 
verifying the extrapolations from previous studies. Three isolates yielded 
novel MLST allele profiles, and displayed a core-genome homology to 
poultry associated ST-573 isolates. 
 
Four instances (2.5%) of case linkage were observed across the dataset 
when analysed using a read mapping approach. This is the first use of 
read-mapping as a measure of Campylobacter genetic epidemiology. 
When assessed using previously employed methods alone, several 
additional instances of case linkage are inferred. However, read mapping 
reveals a large level of diversity within these isolates that suggests they 
are not genetically homologous.  
 
During the course of the study, an unusually high incidence was 
observed during February, 2014. The majority of cases during this month 
occurred in two week-long tranches that followed Chinese New Year and 
Valentine’s Day. Additional isolates were collected from the infections 
following Valentine’s day, revealing two instances of case linkage. This 
represented 12% of sequenced tranche isolates, implying that case 
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linkage may be enhanced following social events. An increase in 
Campylobacter isolation rates during February is also demonstrable in 
nationally reported data across multiple years, perhaps suggesting an 
additional recurring peak in incidence that has not been previously 
described. 
 
In conclusion, though rare, case linkage is observable amongst isolates 
that are otherwise considered sporadic in nature.  Whilst wgMLST is a 
useful method of analysis when time or expertise are limited, it is not 
sensitive enough to truly delineate isolate linkage. Rather, a combination 
of wgMLST as a guide for investigation, followed by iterative read 
mapping of related isolates provides a more robust measure of linkage by 
quantifying variation at the sequence level. 
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3.2. Introduction 
More than a decade ago, Roche released the first commercial NGS 
platform – the 454 Genome Sequencer (Margulies et al. 2006). Whilst 
crude by today’s standards, the 20Mb output provided laboratories with 
a previously impossible access to genome sequencing. In the years 
following the 454’s release, several companies introduced their own 
systems based on competing chemistries, with Illumina/Solexa’s 
‘Sequencing-By-Synthesis’ (SBS) releasing in 2006 and Applied 
Biosystems/Life Technologies’ ‘Sequencing-by-Oligo-Ligation-Detection’ 
(SOLiD) in 2007 (Valouev et al. 2008, Voelkerding et al. 2009).  
 
Whilst initially an expensive venture, several improvements to the 
chemistry, hardware and software of sequencing platforms as well as 
advances in library generation have greatly reduced the per-base cost of 
WGS. For example, Illumina’s HiSeq X Ten platform is capable of 
producing a human genome at a relative  
cost of $1000, which represents a 10,000x reduction from 2004 (Van Dijk 
et al. 2014). 
 
At a smaller scale, the advances and reduction in costs associated with 
sequencing have revolutionised the study of bacterial genomics. The first 
bacterial genome was sequenced in 1995. At 1.8Mb in length, the 
resolution of the Haemophilus influenzae was a culmination of eﬀorts – it 
took eight technicians three months to perform the necessary 
sequencing reactions, with an estimated labour-inclusive cost in excess 
of $85,000 (Fleischmann et al. 1995). Today – based on the cost of 
reagents and consumables at the time of writing - a single technician 
could sequence H. influenzae on a single benchtop Illumina MiSeq for 
less than £5,000, which would take just 27 hours to run. Additionally, the 
ligation of unique sequence elements to genomic libraries allows several 
isolates to be sequenced in parallel, creating an economy of scale that 
reduces the per genome cost exponentially. 
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These advancements, along with the increased pervasiveness of NGS, 
have greatly improved the ability to rapidly identify and track potential 
disease outbreaks. Using comparative genomic techniques, sequences 
can be mapped against a common reference or ancestor in order to 
identify diverging populations and infer epidemiological source. These 
techniques proved to be of particular importance during an investigation 
of microbiological terrorism. 
 
In 2001, American authorities recovered several envelopes containing 
spores of Bacillus anthracis – the causative agent of anthrax (Rasko et al. 
2011). Forensic genomic investigation revealed a high degree of 
homology between the isolates, suggesting a single common source, and 
also identified three unique single nucleotide polymorphisms, with 
phenotypic eﬀects linked to sporulation. These polymorphisms were not 
present amongst common environmental isolates, but were linked to 
cultures stored in the FBI repository, allowing the source of the threat to 
be traced. As a species, B. anthracis exhibits a high degree of genetic 
homology, and due to the spore-forming nature of the organism long 
periods of genetic dormancy further limit the variation observed (Read et 
al. 2002). However, the successes of comparative genomics aren’t limited 
to the study of genetically invariable organisms. 
 
In 2011, a nosocomial outbreak of carbapenem resistant Klebsiella 
pneumoniae was reported amongst 18 intensive care patients, 11 of which 
died as a result of the infection (Snitkin et al. 2012). Pairwise comparison 
of WGS data from the outbreak isolates revealed three key transmission 
events from a single patient, and identified an average of 12 SNPs 
between each subsequent isolate. The number of polymorphisms were 
typically higher in isolates that were collected later during the course of 
the outbreak, suggesting an accumulation of variants - potentially as a 
result of transmission and pathogenesis. 
 
Also in 2011, two concurrent outbreaks of bloody diarrhoea occurred in 
Europe, caused by the O104:H4 serotype of E. coli. In Germany, roughly 
4000 cases were identified, with a second smaller outbreak of 15 cases 
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occurring in France (Grad et al. 2012). The outbreak was traced to a 
shipment of Fenugreek seeds that was received in Germany during 2009, 
and later distributed to a German sprout farm and French garden stores  
(EFSA 2011b). By conventional molecular characterisation (e.g. MLST, 
serotyping) the isolates appeared to be indistinguishable from the 
ancestral strain. When analysed by mapping genomic reads against the 
ancestral reference, isolates collected from Germany showed very little 
variation (2 SNPs). However, isolates collected from the France outbreak 
showed a much higher level of diversity (19 SNPs). This is hypothesised 
to be due either to a bottleneck in the German isolates resulting in a 
purge of diversity, variation in the mutation rates of the individual E. coli 
populations, or an uneven distribution of population diversity in the 
initial shipment of seeds (EFSA 2011b). The findings from this study 
highlight that variation can be observed in the levels of diversity present 
amongst isolates derived from a single infectious source. 
3.2.1. Comparative genomics of Campylobacter spp. 
The majority of Campylobacter infections are thought to be sporadic in 
nature and therefore do not share a single, commonly identifiable source 
(Cody et al. 2012, Olson et al. 2008). The sheer volume of cases that occur 
make routine genotyping infeasible for clinical and public health 
laboratories, and infections are simply reported nationally at the genus 
level. Very few publications have used whole-genome sequencing to 
identify isolates from a common source-point outbreak, perhaps in part 
due to the diﬃculties surrounding real-time detection of Campylobacter 
outbreaks and the low discriminatory power of routine clinical tests (i.e. 
basic identification of faecal cultures).  
 
The most comprehensive genetic study of campylobacteriosis analysed 
WGS data from 384 Campylobacter spp. isolates, collected from a clinical 
microbiology laboratory over a period of four months (Cody et al. 2013). 
The study aimed to describe a quick and comparable method of 
detecting epidemiologically related cases, that would also be viable for 
use by non-specialised clinicians. Irrespective of knowledge or training, 
several factors impact the viability of comprehensive bacterial genomics 
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in a clinical environment. Both the hands-on and compute-times 
required for large scale analyses are significant barriers, which typically 
require high-end (i.e. expensive) workstations. Additionally, raw 
sequence data has a large digital footprint, with next generation 
sequencing outputting tens of gigabytes of data per run. This makes 
short and long term storage of data, as well as timely analysis in a 
confidential and clinically accountable manner particularly diﬃcult 
(Fricke & Rasko 2013).  
 
The method described within the study – known as whole genome MLST 
(wgMLST) - addresses many of these concerns, relying on the upload and 
analysis of de novo assemblies, which are orders or magnitude smaller 
than raw reads, and are easily obtained via automatable pipelines. 
wgMLST is functionally identical to the MLST methodology described in 
Chapter 1, whereby loci are assigned an arbitrary allele number based on 
iterative diﬀerences in their constituent nucleotide sequences. Query 
sequences are then compared against a central repository containing 
previously identified alleles, providing a whole genome allelic profile of 
identified loci, and allowing pairwise comparison of other isolates 
processed in the same manner.  
 
The study considers isolates to be linked if they diﬀer by ≤20 loci. 
Excluding data from repeat patient sampling, and one instance of likely 
laboratory contamination, no epidemiological case linkage was detected. 
This does not mean that case linkage did not occur, as discussed 
previously, Campylobacter incidence is severely under reported (1 in 9.3 
cases reported nationally), therefore not all cases would be processed by 
the clinical laboratory. Additionally, the cut oﬀ value may not be an 
adequate or finite measure for case linkage. Within the study, repeat 
isolations from a single patient yielded alternative alleles in 3-14 loci, 
whilst repeated sequencing of some isolates showed an average number 
of alternative alleles in 1-7 loci. This reflects one of the main limitations 
of wgMLST, in that the results are purely qualitative, and provide no 
quantitative measure of variation. 
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For example, assume locus X is encoded by three nucleotides: ATG. Upon 
submission to the database, this locus is assigned allele number 1. In 
another isolate, the same locus has a mutation in the first base: TTG, 
which is assigned to allele number 2. In a third isolate, all three bases 
diﬀer from both isolates: GGC, and is assigned to allele number 3. 
Organisms X and Y and Z are then queried against the database, 
returning allele numbers of 1, 2 and 3 respectively. It’s apparent that the 
organisms are diﬀerent, but it’s not clear that organism X and Y are more 
homologous to each other than either are to organism Z. 
 
Additionally, this method only measures variation within CDS that have 
an equivalent definition in the sequence database. Hypothetical proteins 
that are inferred from protein homology, but are not present in the 
current C. jejuni/C. coli repository are not analysed. This is demonstrated 
to aﬀect a dataset from a milk-borne outbreak, during which several 
novel alleles were identified, but could not be analysed using the 
wgMLST approach (Revez et al. 2014).  
 
Intergenic variation is also undetectable using this methodology. This is 
of particular importance in Campylobacter due to the presence of several 
phase-variable genes that are mediated by the length of homopolymeric 
tracts. These tracts contain repeat regions of nucleotides that favour slip-
strand mispairing during DNA replication, generating a significant level 
of diversity both in terms of measurable polymorphisms and subsequent 
gene expression. Whilst many of these tracts are contained within a 
phase-variable gene’s open reading frame, there are instances of 
intergenic tracts. Results from the following chapter, as well as research 
conducted by Revez et al. (2013), demonstrate that variation occurs 
within intergenic poly-G tracts during human infection, which would not 
be quantifiable via wgMLST. 
 
Revez et al. (2014), utilised the same wgMLST methodology described 
above to compare isolates obtained from a milk-borne outbreak of C. 
jejuni. A total of six isolates were compared to the identified source 
sequence, yielding between 4-12 variable loci. This study also 
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investigated the diﬀerences at the sequence level, and found a limited 
number of polymorphisms (15 across the dataset). Whilst this approach is 
favourable, there are still significant limitations due to the use of 
assemblies in place of raw genomic reads.  
 
Assemblies are consensus sequences derived from the statistically 
informed merging of raw sequence reads. For example, short read 
assembler ‘SPAdes’ breaks raw reads into multiple sized k-mers and 
produces a de Bruijn graph to link those k-mers into contiguous 
sequence data (Bankevich et al. 2012, Alkan et al. 2011). Reads may cover 
any given position within a genome multiple times, depending on the 
size and number of genomes sequenced on a platform, as well as the 
number and length of the reads (Detailed in Chapter 2), however that 
coverage is collapsed to 1x during assembly. Read mapping confers a 
significant increase in the number, accuracy and quality of identified 
variants, and as such confers a finer scale of resolution to 
epidemiological investigation (Olson et al. 2015, Inouye et al. 2014). 
 
This study aimed to investigate case linkage between clinical 
Campylobacter isolates across the greater Nottinghamshire area. Whilst 
links have not been previously established in similar Campylobacter 
datasets, the analysis relied on partial genomic comparisons (i.e. 
wgMLST). By utilising alternative whole-genome methodologies (i.e. 
read mapping), additional fine-scale associations may be apparent that 
would be undetectable when relying solely on other methods. This is 
thought to be the first instance in which a read mapping approach has 
been used to infer the genetic epidemiology of Campylobacter spp., and 
aims to evaluate the eﬃcacy and comparability of this technique to  
other methods.  
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3.3. Methods 
Incidence of Campylobacter spp. within the greater Nottinghamshire 
area was defined using a report generated by Queen’s Medical Centre, 
including any isolate with a valid collection date within 2014, and with 
an assigned laboratory number. Entries without a corresponding frozen 
isolate were included in the incidence analysis, but excluded from the 
sampling process. Full details of the sampling and data generation 
processes can be found in Chapter 2.  
 
MLST profiles providing data on CC and constituent sequence types were 
obtained using the PubMLST C. jejuni/C. coli allele database hosted on 
the BigsDB platform (Jolley & Maiden 2010). Whole genome assemblies 
were analysed using Quast (Gurevich et al. 2013) to obtain the N50, total 
assembly length and number of contigs. Assemblies that were deemed to 
be of insuﬃcient quality for downstream analysis due to an extremely 
low N50, notably larger or smaller total genome length, or with an 
unusually high number of contigs were excluded from subsequent 
analysis. 
 
The core genome phylogeny of assemblies with suﬃcient quality was 
reconstructed using the Parsnp tool from the Harvest software suite 
(Treangen et al. 2014). Due to the constraints of the maximal unique 
matches index, C. jejuni and C. coli isolates were processed separately, 
with the datasets comprised of 142 and 11 isolates respectively. The 
resulting newick formatted trees were visualised using the Interactive 
Tree of Life (Letunic & Bork 2016), with colour-bar legends prepared 
manually in post-editing. 
 
The core genome phylogeny was used to infer case linkage. Isolates that 
shared the same clade with zero branch length were treated as 
potentially linked, with additional information such as matching CC and 
sequence type used to qualify further investigation. Due to the overall 
phylogenetic distance within the C. jejuni dataset, additional 
phylogenies were constructed for CC’s displaying potential case linkages.  
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Isolates within the intra-complex phylogenies that appeared to be 
associated were then compared. De novo assemblies were analysed using 
the BigsDB platform to obtain whole genome MLST profiles (Jolley & 
Maiden 2010). A cut oﬀ value of ≤20 variable loci in a pairwise 
comparison was used to indicate linkage. Loci that were unique to an 
isolate’s assembly were discounted from the comparison. 
 
Isolates that were homologous at the core genome levels were also 
compared using Bowtie2 to map genomic reads of one isolate to a de novo 
assembly of another (Langmead & Salzberg 2012). Polymorphisms were 
filtered to only include sites with a base and mapping quality of ≥30, and 
a minimum depth of 8 using SAMtools and vcftools (Li et al. 2009, 
Danecek et al. 2011). 
 	
 67 
3.4. Results 
 
3.4.1. Incidence 
Over the 2014 sampling period, Queen’s Medical Centre processed 771 
stool samples that tested positive for Campylobacter spp. 11 isolates did 
not have an associated date of collection and as such were excluded from 
analysis. A total of 760 eligible isolates were collected in 2014, with the 
greatest incidence occurring in June (n=104). There were two additional 
peaks in incidence in February and September, as shown in Figure 3.1. 
 
  
Figure 3.1 - Monthly incidence of Campylobacteriosis cases identified across 
the Queen's Medical Centre's catchment area during 2014 
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Overall, there was a 9.1% reduction in total observed incidence across 
Nottinghamshire, compared to an average incidence from previous years 
(~836 ± 14). July and August – typically months with a large incidence – 
yielded notably fewer Campylobacter spp. isolates (75 vs ~110 ±6 and 64 
vs ~87 ±0 respectively) as shown in Figure 3.2. 
  
Figure 3.2 - Current vs. historical incidence of Campylobacteriosis. within the 
greater Nottinghamshire area 
Data supplied by Queen’s Medical Centre, with ‘current’ incidence constituting data from 
2014, and historical incidence formulated form an average of two years’ worth of previous 
data from the same health trust site (data supplied in Appendix 9.2). 
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3.4.1.1. February 
Cases of Campylobacter were higher than expected during February, with 
a total of 65 cases compared to a local historic average of 43.5. Two 7-day 
tranches (7th-14th and 21st-28th) accounted for over 73% of all reported 
infections. These tranches were preceded by two events occurring 
roughly a week before the increase in cases was observed. Chinese New 
Year fell on the 31st of January, and Valentine’s Day on the 14th of 
February. Figure 3.3 shows the total daily incidence during February, 
with both events and 7-day tranches highlighted. 
Figure 3.3 - Incidence of campylobacteriosis across Nottinghamshire during 
February, 2014 
Two peaks in incidence occurred following two marked events. Orange bars represent the 
week long tranches of increased incidence. 
 
Incidence data from the United Kingdom was analysed to measure 
isolation rates during February from previous years. Figure 3.4 shows 
monthly Campylobacter spp. incidence ranging from 2008-2011, 
formatted in monthly and daily averages. The latter accounts for the 
deviation of month length in days, with consideration to leap years. Both 
sets are normalised to a percentage of the total dataset to allow 
comparison. When formatted as a daily average, an additional peak in 
February can be observed, reflecting a national distribution of this 
previously undescribed peak. 
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Additional metadata encompassing patient age and sex was available for 
766 isolates. Across 2014, 55.7% of cases were isolated from males. Figure 
3.5 displays the monthly distribution of cases amongst age groups. This 
shows that for the majority of groups, the peak in age-specific incidence 
coincides with the seasonal peak observed in the summer. Certain age 
groups exhibit raised incidence outside of the seasonal peak (e.g. 5-10 
year olds had the highest incidence during April). 
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Figure 3.4 - Percentage of average Campylobacter spp. incidence across the 
United Kingdom, from 2008-2011* 
* - Data obtained from PHE (DEFRA & PHE 2015). 
Normalised to account for the length of the month in days. 
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Figure 3.5 – Monthly distribution of campylobacteriosis cases amongst age 
groups in the greater Nottinghamshire area 
In a similar fashion, Figure 3.6 shows the distribution of constituent age 
groups of campylobacteriosis cases by month (i.e. percentage of cases 
within a given month attributed to a single age group). The majority of 
months follow a typical age distribution, with the bulk of constituent age 
groups lying between the 16-65 marks. February is of particular interest 
as no cases occurred in persons under 15 years, or over 70 years of age. 
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Figure 3.6 - Monthly incidence of campylobacteriosis across the greater 
Nottinghamshire area with abundance of constituent patient age groups 
A total of 664 Campylobacter samples were isolated from patients living 
within the greater Nottinghamshire area. Figure 3.7 provides a heat map 
of Campylobacter infections assigned to each of the postal boundaries 
within Nottinghamshire, based on the incidence of campylobacteriosis 
per 100,000 persons. The highest areas of incidence lie within postal 
boundaries close to the city centre, and reflect a relatively dense and 
largely urbanised environment.
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Figure 3.7 - Distribution of Campylobacteriosis incidence* across Nottinghamshire postcode areas during 2014 
Incidence given in cases per 100,000 people, determined by 2011 population census data (ONS, 2011). 
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3.4.2. Sequencing and Assembly Quality 
A total of 185 clinical Campylobacter spp. isolates were selected for 
whole-genome sequencing. All isolates were collected throughout 2014, 
and represented 24% of the total number of isolates that were processed 
by Queen’s Medical Centre that year. Prior to further analysis, the 
generated sequence data was assessed for quality, with contaminated or 
otherwise inadequate files excluded. 
 
The final curated genomic dataset (n=158) had a mean N50 of 120,954bp 
(95% CI: 96,616bp to 145,291bp), a mean total length of 168,001bp (95% 
CI: 1,666,466bp to 1,693,696bp) and a mean number of contigs of 169 
(95% CI: 129.4 to 208.6). Figure 3.8 shows the distribution of these  
quality metrics.  
 
Figure 3.8 – Distribution of quality metrics amongst the final genomic dataset, 
as reported by Quast 
Horizontal bars represent mean values with 95% confidence intervals.  
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3.4.3. MLST 
A total of 158 draft genomes were produced with suﬃcient quality and 
coverage depth for use in MLST analysis. Of these 158 isolates, 90% 
(n=143) belonged to C. jejuni subsp. jejuni and a further 7.6% (n=12) were 
identified as belonging to C. coli CC ST-828. Three isolates (1-55, 5-65 and 
6-20) yielded novel allele profiles that could not be assigned to an 
existing CC or ST. Their respective allele profiles are displayed in Table 
3.1. 
 
The dataset yielded a total of 29 unique CC’s. The dominant complex 
identified was ST-21, which accounted for 26.5% (n=42) of all isolates. A 
further 6 complexes constituted more than 5% of the dataset – ST-828, 
206, 48, 353, 257 464 and 45. Figure 3.9 shows the distribution of 
identified CC’s. 
Locus 
Isolate 
1-55 5-65 6-20 
aspA 8 2 2 
glnA 2 364 28 
gltA 2 4 29 
glyA 64 38 243 
pgm 238 141 286 
tkt 3 25 267 
uncA 35 35 124 
* - locus allele numbers of seven housekeeping genes, 
as defined by PubMLST scheme for C. jejuni and C. coli. 
 
Table 3.1 - MLST allele profiles for isolates with no identified sequence type 
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Figure 3.9 - Distribution of clonal complexes amongst 158 clinical Campylobacter spp. isolates obtained from Queen’s Medical Centre 
* - C. coli clonal complex. 
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3.4.4. Phylogeny 
Separate core genome phylogenies were constructed for all (n=143) C. 
jejuni subsp. jejuni isolates (Figure 3.10) and C. coli isolates (Figure 3.12). 
 
Figure 3.10 shows the core genome phylogeny of all C. jejuni isolates. 
Branches highlighted in red indicate isolates that share a significant 
genetic homology (i.e. branch length: o) and that were investigated 
further. This included 18 isolates from the dominant CC: ST-21, which 
were reanalysed as a subgroup as shown in Figure 3.11. 
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Figure 3.10 - Core genome phylogeny of 143 clinical C. jejuni isolates 
Annotated with colour bars representing constituent clonal complex, and red lines indicating 
isolates that bear significant genetic homology at the core genome level. Rooted to 
reference sequence 81116. Additional phylogenies are presented below in a clearer fashion. 
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Figure 3.11 - Core genome phylogeny of isolates belonging to clonal complex 
ST-21 with linked isolate pairs and respective number of Single Nucleotide 
Polymorphisms (SNPs) highlighted 
Tree rooted to mid-point with isolate ‘9-40’ used as a reference. Sequence types with more 
than one constituent isolate are annotated with colour bars. In instances where a branch 
length shows as ~0 but is not highlighted, additional analysis revealed diversity outside of 
the called core region discounting case linkage.  
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Figure 3.12 - Core genome phylogeny of clinical C. coli isolates 
Tree rooted to mid-point. Sequence types are annotated with colour bars according to their constituent sequence types
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Isolates that appeared to share a common source based on the core 
genome phylogeny were analysed using wgMLST. Isolates that contained 
fewer than 20 loci in which a variant allele was identified were then 
further analysed using alignment to identify single nucleotide 
polymorphisms (SNPs). A total of 10 isolates were considered to be 
potentially linked by wgMLST methods (Table 3.2).  
Isolates* Clonal Complex 
Sequence 
Type 
Variable 
Loci 
Unique 
Loci SNPs
† 
2-5 → 2-10 ST-21 ST-50 1 0 12 
4-69 → 4-67 ST-21 ST-53 12 51 26 
9-71 → 9-46 ST-354 ST-354 3 6 26 
2-1 → 1-79 ST-21 ST-19 2 30 27 
4-52 → 4-51 ST-21 ST-53 3 159 34 
9-27 → 9-72 ST-464 ST-5136 4 3 47 
1-49 → 5-38 ST-353 ST-5 7 116 61 
1-46 → 6-72 ST-21 ST-21 17 124 92 
4-6 → 9-44 ST-257 ST-257 17 55 142 
2-9 → 2-10 ST-21 ST-50 4 235 166 
* - Reads from isolates in the right hand column were mapped against assemblies of isolates 
in the left hand column, based on the isolate that contained the fewest identified loci.  
† - Number of Single Nucleotide Polymorphisms with a mapping and base quality of ≥30, 
depth of ≥8 and present in more than 90% of reads. 
Variable loci identified using wgMLST, unique loci are defined as genes present in only one 
of the two assemblies. 
Upon further investigation, four of these isolates contained fewer than 
30 SNPs and shared a strong temporal association. The closest relative 
isolates – 2-5 and 2-10 – yielded 12 SNPs, and were collected a day apart 
on the 24th and 25th of February respectively. Upon further investigation, 
it was revealed that these samples were collected from the same patient. 
Isolates 1-79 and 2-1 shared 27 polymorphisms, and were also collected a 
day apart during February from separate patients. The isolate pairs – 
4-69/4-67 and 9-71/9-46 were also verified as originating from diﬀerent 
patients, at 4 and 10 days apart respectively. 
  
Table 3.2 - Homology measured by wgMLST and mapping approaches of 
potentially linked Campylobacter spp. isolates 
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3.4.5. Single Patient Isolates 
Seven of the 12 SNPs detected in the single-patient isolate pair (2-5 and  
2-10) occurred in a single locus – CAMP1252/Cj1335, encoding the 
membrane protein maf4. The remaining polymorphisms were in a single 
stretch of intergenic sequence on a short contig with no identified CDS. 
The point mutation and its eﬀect on the respective amino acid residue is 
provided in Table 3.3. 
 
Table 3.3 - The position, alteration and effect of detected SNPs to their relative 
amino acid of a single-patient isolate pair 
 Codon Amino Acid 
Residue Ref  Alt Ref  Alt 
1644 GGT → GGA Glycine → Glycine 
1644 GGT → GAT Glycine → Aspartic Acid 
1644 GGT → CGT Glycine → Arginine 
1645 CCC → CCT Proline → Proline 
1646 CTA → CTG Leucine → Leucine 
1647 CTA → CTT Leucine → Leucine 
1647 CTA → CGA Leucine → Arginine 
Polymorphisms were contained within a single locus – CAMP1252/Cj1335. 
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3.5. Discussion 
 
This study sought to characterise clinical Campylobacter spp. isolates 
obtained from a single health trust site, within the greater 
Nottinghamshire area. These results reveal that using a read mapping 
approach to comparative genomics, case linkage can be detected, albeit 
with relative infrequency.  
3.5.1.1. Incidence 
A 9.2% reduction in Campylobacter spp. isolation rates was observed 
across Nottinghamshire during 2014, compared to data from previous 
years. At a national scale, the average annual incidence reported to 
Public Health England from 2010-2013 was 70,474, with preliminary data 
from 2014 reporting 70,353 confirmed cases across the UK. This suggests 
that national incidence during 2014 was unchanged and that the 
reduction observed is a local occurrence (DEFRA & PHE 2015). This 
reduction may have several impacting factors, or may simply be a 
natural fluctuation - there is a lack of suﬃcient regional data to draw a 
valid conclusion for the Midlands or Nottinghamshire specifically. 
National data from 2002-2015 reveals a similar reduction in incidence 
across England and Wales collectively in 2013 (-9.2% from 2012). 
Incidence in the years following have not shown any change, and as the 
only example of such a reduction in numbers it is plausible that the 
reduction has an underlying cause. 
 
One aspect that could have aﬀected the number of observed 
campylobacteriosis cases at a local level was the weather. Several studies 
have shown that weather features such as ambient temperature and 
rainfall aﬀect Campylobacter incidence and poultry contamination levels 
(Meldrum et al. 2005, Tam et al. 2006, Bi et al. 2008, Nichols et al. 2012). 
Local meteorological data shows the total amount of sunshine hours in 
2014 were down from 2013 by ~7.2% (Met Oﬃce, 2016). There were also 
more days with rainfall >1mm (Figure 3.13) which, combined with the 
decrease in sunshine hours would likely discourage certain risk factors 
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typically encountered during the summer months. Barbequing has been 
linked to Campylobacter incidence, and has in some instances lead to 
outbreaks (Studahl & Andersson 2000, Allerberger et al. 2003, G. 
Kapperud et al. 1992). In 2014 the UK had an estimated 9.25% reduction 
in barbecue occasions, which would likely have an impact on the number 
of cases usually attributed to this source (Kantar Worldpanel, 2015). 
Additional risk factors such as swimming in natural water sources and 
contact with environmental isolates during outdoor activities would also 
likely have been reduced in the poorer weather conditions (Schönberg-
Norio et al. 2004, Doorduyn et al. 2010).  
Figure 3.13 - The average monthly temperature and rainfall across 
Nottinghamshire from 2012-2014 
 In 2010, the Food Standards Agency (FSA) set a target to reduce total 
Campylobacter prevalence across the food chain, with a particular focus 
on initially reducing the percentage of samples contaminated with the 
highest levels (>1000 CFU/g) of Campylobacter (FSA & DEFRA 2010). As 
result of this initiative, several strategies have been implemented, 
including novel meat processing techniques and large-scale social media 
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campaigns to aid education and awareness. There has also been a high 
degree of retailer participation, with several large super markets and 
vendors participating in the surveillance and reduction strategies. As a 
result of the study, participating retailers now remove the neck skin from 
whole carcasses, which was identified as an area that consistently 
harboured excessive Campylobacter loads.  
 
Preliminary data shows that during 2014, a similar level of 
Campylobacter prevalence was observed amongst samples of retail 
poultry, with 71% of packages found to be colonised. However, there was 
a reduction of ~8% in samples that were found to contain the highest 
Campylobacter loads of over 1,000 CFU/g, which may have prevented 
some incidence of campylobacteriosis (FSA, 2010; 2015). The impact of 
these reductions would likely be more apparent in areas where 
participating retailers have a strong market presence. 
 
This is particularly relevant to Nottinghamshire, where roughly 85% of 
the population reside in urban areas, and over 30% in the main 
Nottingham city area (Oﬃce for National Statistics, 2011). Many studies 
demonstrate that rural areas contribute a higher proportional incidence 
of Campylobacter than urban areas, with fewer cases linked to the 
consumption of poultry meat and instead associated with animal or 
contaminated water contact (Nichols et al. 2012, Schielke et al. 2014, 
Olson et al. 2008).  
 
Given the largely urbanised distribution of cases apparent in Figure 3.7 
(i.e. higher incidence in densely populated postal areas close to the city 
centre), it is plausible that the reduction observed in Nottingham may in 
fact be due to the improvements made in poultry contamination with 
Campylobacter. Further study of the Nottinghamshire area would help to 
delineate this eﬀect, particularly if there are historic records containing 
postcode information. 
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3.5.1.2. Population Structure 
The distribution of CC’s amongst the sequenced isolates was highly 
similar to datasets in other parts of the UK. ST-21 is the major constituent 
CC in the dataset. ST-21 is frequently identified as the main lineage 
associated with clinical infection, and has been isolated from a wide 
range of host sources, with many studies also finding it to be the most 
abundant amongst clinical datasets (Colles et al. 2003, Strachan et al. 
2009, Cody et al. 2012). Clonal complex ST-828 – a  
C. coli grouping - is the second largest complex in the dataset. C. coli is 
often attributed to roughly 5-10% of all campylobacteriosis incidence, 
which is reflected herein by a 7.6% isolation rate (Cody et al. 2012, 
Nichols et al. 2012, Olson et al. 2008). A further 6 complexes constitute 
more than 5% of the total dataset and as such are referred to as ‘major’ 
complexes, consisting of: ST-206, 48, 353, 257 464 and 45. The 
distribution of identified major CC’s is identical to that of a larger 
published dataset encompassing isolates from Oxfordshire, Scotland and 
Northwest England (Cody et al. 2013), indicating that the Campylobacter 
population in Nottingham is representative of and comparable to the UK 
as a whole. 
 
There were an additional 17 complexes considered to be minor due to a 
relatively low abundance amongst the dataset. Minor variations in 
isolation frequency were observed when compared to similar datasets 
(Cody et al. 2012, Cody et al. 2013, Dingle et al. 2002). Given the wide 
dissemination of Campylobacter spp. across a vast host and 
environmental range, variance in abundance of these minor complexes 
is perhaps inevitable, and may be resolved (or indeed exacerbated) with a 
greater sample size. These minor complexes are also found in low 
abundance in other clinical studies (Cody et al. 2012, Dingle et al. 2001), 
perhaps indicating a relatively infrequent exposure to their infectious 
source. Many of these complexes have been isolated from agricultural 
samples (Sheppard et al. 2014), which would indicate that these isolates 
are perhaps more adapted to a particular host niche.  
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Three C. jejuni isolates (1-55, 5-65 and 6-20) were identified as novel 
sequence types. These isolates yielded full, unique allele profiles that did 
not belong to any assigned sequence type in the Campylobacter 
PubMLST database at the time of query. These isolates are contained 
within a sub-clade in the core-genome C. jejuni phylogeny, with isolates 
5-65 and 6-20 forming an additional subclade indicating a greater level of 
homology at the core genome level. The novel ST sub-clade branches 
from two isolates belonging to CC ST-573, which has been strongly 
associated with poultry sources, providing a potential infectious source 
of these novel sequence types (Sheppard et al. 2014).  
3.5.1.3. Case linkage 
This study presents the first examples of genetic homology amongst 
confirmed cases of clinical campylobacteriosis. Four isolates were found 
to contain fewer than 30 SNPs when analysed via read mapping, with 
one pair of isolates diﬀering by just 12 SNPs. Of these pairings, 3 belonged 
to CC ST-21, and a single pair to CC ST-354. Whilst these results are in 
concordance with the notion that the majority of Campylobacter 
infections are sporadic, it demonstrates that case linkage can be 
observed at relatively minor levels.  
 
As discussed in the introduction to this chapter, previous studies have 
relied on incomplete genomic analyses that only assess linkage in CDS in 
a qualitative manner (Cody et al. 2013, Revez et al. 2014). The strength of 
wgMLST as a comparative tool lies in its originally described context (i.e. 
speed, simplicity) and is a strong method of first pass analysis, however 
these results present the importance of additional analysis to delineate 
false positive associations.  
 
Using the wgMLST criteria alone, six additional isolate-pairs were 
considered to be linked. These isolates were later discounted on the basis 
of excess genetic heterogeneity when measured using a read mapping 
approach. Additional sample metadata may have been able to eliminate 
the false negative associations implicated by wgMLST. Temporal 
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association alone discounts 5 of the 6 spurious isolate pairs. However, 
the final pair (2-9/2-10) were collected on the same day, and vary at just 4 
loci – it’s only when these isolates are analysed at the read level that their 
heterogeneity (126 SNPs) is apparent. 
 
The availability of sample metadata such as sample collection date can 
vary between and even within datasets. Furthermore, relying on 
temporal association to eliminate false positives would also obfuscate 
any single-source infections that occur outside of the timeframe 
considered (e.g. frozen reservoir). Read mapping provides an objective 
measure of pairwise homology to infer case linkage, which is 
strengthened rather than qualified by additional sample metadata.  
 
There was a disparity between the number of variable loci identified via 
wgMLST and number of SNPs identified during alignment. One isolate 
pair exhibited 7 variable loci, suggesting an initial potential linkage. 
However, these isolates were later found to diﬀer by 67 SNPs. This is in 
contrast to another pair with 12 variable loci containing only 26 
polymorphisms. This reiterates the limitations of the qualitative nature 
of wgMLST, and suggests that the ≤20 loci criteria is perhaps a weak 
measure of true case linkage. Additionally, several loci were found to be 
unique to an individual assembly (i.e. only present in one of the 
assembly pairs). Diﬀerences in coverage and per-base quality at any 
given locus position will aﬀect the de novo assembly process, and may 
result in variable inclusion of a particular sequence region. These regions 
were excluded from analysis by utilising the assembly with fewer loci as 
a reference to which reads were mapped. Comparison in these regions 
could be achieved via resequencing of the isolate pairs. 
 
The isolate pair displaying the greatest genetic homology (2-5/2-10) were 
collected from the same patient, with samples taken a single day apart. 
wgMLST analysis revealed just a single variable locus and read mapping 
yielding 12 SNPs. As patient metadata was provided after the genomic 
analysis had taken place, the detection of this linkage acts as a validation 
of the methodology. No other samples within the sequencing data set 
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were obtained from the same patient, making this instance unique in its 
circumstance. It is reasonable to assume that a single patient sample 
would contain the fewest number of polymorphisms, which is in 
accordance with our results. 
 
On further investigation, 7 of the 12 SNPs were located within the 
CAMP1252/Cj1335 locus, which encodes motility accessory factor 4. This 
locus is one of several phase-variable genes within the Campylobacter 
genome and has been shown to come under variation within same-
patient samples in other genomic studies (Gundogdu et al. 2007, Cody et 
al. 2013). Three of the seven polymorphisms resulted in a non-
synonymous alteration, which would ultimately alter protein function 
and may reflect an ongoing adaptation to the host environment. As the 
samples were collected a day apart, the variation observed may be a 
result of sampling an infectious population at diﬀerent stages or 
progressions of the disease. 
 
This level of diversity amongst this isolate pair is similar to the that 
observed amongst C. jejuni 11168 isolates following human and mice 
passage (Jerome et al. 2011, Revez et al. 2013). It is also comparable to 
studies investigating epidemiologically related Klebsiella pneumoniae 
isolates, which also yielded an average of 12 SNPs between patient 
samples from a commonly identified infectious source (Snitkin et al. 
2012). K. pneumoniae is a genetically diverse species (Holt et al. 2015), 
with a weakly clonal population structure similar to that observed in 
Campylobacter (Wang et al. 2013). 
 
Whilst considering the cut oﬀ value for defining case linkage in terms of 
number of SNPs, it was important to consider several factors. Revez et al. 
(2013), measured the level of genetic heterogeneity amongst C. jejuni 
NCTC 11168 following an accidental human infection. A total of 7 SNPs 
were identified in the passaged isolate when mapping against the 
completed reference genome.  
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Similarly, genetic comparisons of 11168 passaged in mouse models 
yielded 23 instances of variation, suggesting that an increase in diversity 
may be observed during novel host-colonisation (Jerome et al. 2011). 
NCTC 11168 belongs to the dominant and host-generalist clonal lineage 
ST-21 and has been isolated from a wide range of sources, both clinical 
and environmental in nature (Cody et al. 2013, Sheppard et al. 2014). As 
such, clinical isolates within this complex may exhibit more or less 
diversity than the previous studies would indicate, based on the source 
of the aetiological isolate. Similarly, the diversity present in isolates from 
other CC’s that are associated with a particular host niche is not 
necessarily directly comparable to the 11168 results. In both 11168 studies, 
a completed reference genome was available to use for comparison. The 
necessary reliance on draft genomes within this study may also have an 
impact on the measurable diversity depending on aspects such as 
sequence quality and total-genome coverage.  
 
During the routine sampling process, approximately 20% of reported 
cases were sequenced from a mixture of temporally related and 
unrelated isolates. It was deemed necessary to test whether an increase 
in sample coverage would reveal any additional linkage that may be 
undetectable at a 20% coverage. Following a spate of unusual incidence 
in February, all samples from a 7-day tranche were sequenced. Due to the 
fact samples were produced from faecal cultures, some isolates 
contained an excess of contaminants that were not excluded by selective 
culture. This, combined with some drop out in the sequencing process 
resulted in a final sample that represented 75% of the tranche.  
 
Two of the four identified linkages occurred during this period. This was 
proportionate to a 12% case linkage rate during the week long period, vs 
2% for the dataset as a whole. It’s not clear whether the increase in 
observed linkage was as a result of the increased proportional sampling 
of these isolates, or simply an increase in case linkage during this 
abnormal period of incidence. To address this, an additional dataset 
covering a comparable proportion of isolates would need to be sampled, 
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during a time in which no abnormalities (i.e. no increased/decreased 
incidence) are observed. 
 
Several isolates were later re-sequenced to a greater depth for additional 
analysis in Chapters 4 and 5. When comparing the reads generated from 
the deep-sequence dataset to the de novo assemblies generated herein, 
the pipeline employed did not identify any SNPs. Analysis of the 
resulting assemblies via wgMLST did not identify any variable loci, 
however, several unique loci were identified in all analysed pairs. The 
lack of SNPs amongst re-sequenced isolates validates that variation is not 
falsely introduced as an unintended result of the culture, library 
generation, sequencing or analysis processes. 
 
The case linkage results are met with the same limitations faced by many 
genetic epidemiology studies, in that it does not provide a complete 
overview of the disease. Only one in nine cases of campylobacteriosis 
will be reported at a national level as a result of a confirmed laboratory 
analysis (Tam et al. 2012), indicating that the total number of 
Campylobacter cases across Nottingham during 2014 would be 
approximately ~7,200. The severity of campylobacteriosis symptoms is 
often highly variable, driven by factors such as strain pathogenicity and 
infectious dose (Butzler 2004), with milder manifestations of the disease 
contributing to the under reported nature of the illness. Even the most 
comprehensive clinical study would only be able to sample isolates that 
produced an illness severe enough for a patient to seek medical aid, 
which may not reflect the degree to which single-source infections occur 
in the wider environment. Whilst there is no way to mitigate this, it 
would be particularly interesting to investigate whether any of the 
reporting patients’ friends and family experienced similar symptoms 
during the course of their illness, potentially indicating a transient 
infection that did not lead to a formal diagnosis.  
3.5.1.4. February 
During the sampling process, an unusually high rate of incidence was 
observed during February, 2014. Two 7-day tranches of incidence were 
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found to account for 73% of all samples that were isolated that month. 
Following infection with Campylobacter spp., there is a mean incubation 
period of 3.2 days, though this can vary with some reports of periods in 
excess of 7 days (Silva et al. 2011, Janssen et al. 2008). In 30% of cases, 
patients experience a prodromal phase that precedes the onset of 
diarrhoeal symptoms by approximately 24 hours. It’s therefore likely that 
from the point of sample collection, 3-8 days may have passed since the 
initial infection occurred. Additionally, it’s unlikely that patients will 
seek medical help immediately after developing diarrhoeal symptoms, 
which may introduce an additional lag between infection and 
presentation at a primary health site.  
 
When looking at the dates in which incidence had increased, two 
antecedent events were identified 7 days prior to the initial increase in 
cases: Chinese New Year and Valentine’s day. These events are widely 
observed in the United Kingdom, and may see an increase in certain risk-
related behaviours. For example, people may be more inclined to eat at 
restaurants, which during popular celebrations and social observances 
often oﬀer a reduced set menu. An increase in number of patrons, as well 
as a reduced variety of dishes eaten may increase the likelihood of 
multiple single-source infections. Additionally, it may also be assumed 
that a greater number of celebratory meals are prepared at home, where 
experience with hygiene and culinary methods may vary.  
 
Additional samples were taken from the peak in incidence following 
Valentine’s day, which provided sequence data for 75% of all isolates 
occurring within this tranche. Pairwise comparison of isolates with a 
strong core genome homology revealed two instances of suspected case 
linkage, representing 12% of the total dataset. It is not possible to 
definitively conclude whether these links were discovered due either to 
an increase in the relative proportion of single-source infections, or the 
enhanced sequencing coverage of this period. However, the fact that the 
larger dataset excluding these results only identified 2 instances across a 
period of 12 months (even at a lower 20% coverage) would suggest that at 
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least a partial increase in case linkage was apparent during the post-
Valentine’s day tranche. 
 
When considering the demographics of patients presenting with 
campylobacteriosis, February is unique in that almost all of the 
constituent age groups were between 16 and 70 years old (Figure 3.6). It is 
reasonable to assume that these age groups are perhaps more likely to be 
courting or married, and may as a result be exposed to risk factors 
associated with Valentine’s Day. February represented the 16-20 and 66-
70 year age groups’ highest monthly incidence (Figure 3.5). These are the 
only examples of an age groups highest monthly incidence falling 
outside of the previously defined summer peak in incidence. 
 
February contains the fewest number of days, with 28 during regular 
years and 29 during leap years. Datasets that report incidence in a 
monthly format do not adequately reflect this diﬀerence, or indeed the 
lesser diﬀerences in other month lengths. Given that Valentine’s Day 
occurs on the 14th of February every year, and Chinese New Year often 
falls within a similar time frame, any peak in incidence due to these 
occasions – or other variables unique to February, but not unique to 
Nottinghamshire - would be observable across multiple years at a 
national level. When standardising national incidence data from 2008-
2011, accounting for the month length in days, a third previously 
undescribed peak is apparent during February. This would suggest that 
there is in fact a nationally observed factor that is driving an increase in 
incidence during this month (Figure 3.4). Additional data combining 
enhanced genetic surveillance with classical epidemiology (e.g. patient 
questionnaires, point-source investigation) would be of particular use in 
delineating potential causes of the increase in incidence, and provides an 
opportunity for future work. It would also be of interest to study the 
incidence of other food-borne pathogens to distinguish whether the 
increase is specific to Campylobacter, or perhaps observable in many 
food related illnesses. 
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4. Chapter Four: Intrapopulation diversity 
amongst clinical C. jejuni isolates
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4.1. Abstract 
In conditions such as cystic fibrosis, bacterial evolution has been 
demonstrated to occur within a single patient throughout the course of 
their disease (Workentine et al. 2013, Lieberman et al. 2013). Comparative 
studies have also shown that these infections are comprised of 
genetically diverse communities, rather than a clonal population of 
isolates that share a single common haplotype (Lieberman et al. 2013). 
Campylobacter spp. is the leading cause of bacterial enteritis worldwide. 
It exhibits a vast amount of genomic diversity, and is found across 
numerous hosts and environmental sources. Existing research has 
revealed a large degree of genetic heterogeneity amongst clinical 
Campylobacter isolates, and there is limited evidence for within-host 
diversity during repeat sampling. However, due to the technical 
limitations of existing studies it is unclear as to whether a typical 
infectious population of Campylobacter spp. exhibits genomic diversity, 
or indeed how diverse a clinical population may be.  
 
This is the first study to use deep sequencing and novel read mapping 
approaches to detect and quantify intra-population diversity in clinical 
Campylobacter spp., with findings revealing genetic heterogeneity in the 
majority of tested samples. 17 clinical ST-21 C. jejuni isolates were 
sequenced to an average depth of 144X, with read mapping revealing 36 
instances of minor allele variation, and several cases of repeat variation 
at the same amino acid residue. 
 
Four polymorphisms were detected within the homopolymeric tract 
mediating Cj1321 (encoding a putative transferase), with the same tract-
position undergoing a G>C substitution and switching oﬀ the expression 
of the Cj1321 locus. The remaining variants were distributed across 12 
loci, with the major functional group encoding chemotaxis related genes. 
Several isolates exhibited minor allele variation in the chemotaxis gene 
ccmL, with two genomic positions undergoing the same nucleotide 
substitutions. Variations in the ccmL locus, as well as other chemotaxis 
genes were found to lie within methyl-accepting signalling domains 
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which may produce a phenotype in which transduction in response to 
specific ligands is modulated. Variation was also detected in two surface 
exposed outer membrane proteins, which may reflect epitope 
polymorphism in response to the host-immune response or adhesion.  
 
These results clearly show that clinical populations of Campylobacter 
jejuni ST-21 are genetically heterogeneous entities. However, it is unclear 
as to whether the observed diversity is a result of human passage, is 
unique to ST-21, or whether that diversity is apparent prior to clinical 
infection.  
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4.2. Introduction 
4.2.1. Bacterial evolution 
Bacterial evolution is ultimately mediated via alterations to genomic 
DNA. These changes include gene modification, gene gain and gene loss. 
Genomic study of bacterial evolution typically involves comparing the 
whole genome sequence of an ancestral isolate to its progeny (or other 
suitable reference to a query sequence). The smallest measure of 
variation is at the per-base nucleotide sequence level – computational 
analysis can reveal singular changes to genomic base-pair positions 
known as fixed variants, or single nucleotide polymorphisms (SNPs) 
(Pallen & Wren 2007). The process of detecting these variant sites is also 
referred to as SNP calling, SNP analysis and variant calling (Altmann et 
al. 2012). The first instance of SNP analysis was used to sub-type 
populations of the genetically monomorphic bacteria Mycobacterium 
tuberculosis (M Cristina et al. 2005). Historically, measure of this sort of 
mutation was conducted by analysing variation in protein isoforms, and 
took considerable time and eﬀort to investigate (Ketley & Konkel 2005). 
Using next-generation sequence data, it is now possible to infer 
phylogeny with exponentially greater haste and accuracy. 
 
Variant calling techniques have been used in a variety of applications, 
such as the forensic investigation into acts of terrorism involving B. 
anthracis described in Chapter 3 (Rasko et al. 2011). These techniques are 
also useful to track the genetic basis for a phenotypic change, and have 
been used to track in vitro evolution on much smaller time scales. 
Herring et al. (2006), noted that the growth of particular  
E. coli strains on glycerol-containing medium accelerated after several 
rounds of subculture. The researchers subjected 5 strains of E. coli to a 
44-day ‘adaptation period’ of repeated growth on glycerol-containing 
medium and used microarray sequencing to compare the ancestral and 
progeny populations. 18 PCR-verified SNPs were detected across the five 
diﬀerent strains, in addition to a higher observed rate of growth (Herring 
et al. 2006). SNP calling has also been used to observe genetic variation 
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amongst outbreak isolates of bacterial pathogens. As discussed in 
Chapter 3, comparative genomic techniques have been used to 
successfully track outbreaks of organisms such as K. pneumoniae and E. 
coli by analysing the distribution of shared polymorphisms amongst 
isolates (Snitkin et al. 2012, Grad et al. 2012). 
 
Some species of bacteria form genetically uniform lineages, with very 
little variation between isolates. B. anthracis is a notable example, with 
distinct isolates typically sharing >99% nucleotide sequence identity 
(Read et al. 2002). Other species however can contain a far greater 
genomic variability between strains. Comparison of E. coli K-12 and 
enterohemorrhagic strain O157:H7 revealed 1.4-Mb of sequence that was 
unique to O157, which represents approximately 25% of the total genome 
length (Hayashi 2001). The degree of genomic uniformity amongst any 
given species is a result of the combination of mechanisms by which 
genetic variation occurs (i.e. lateral genetic exchange, homologous 
recombination and spontaneous mutation). The cumulative eﬀect of 
these mechanisms can be defined collectively as a total mutation rate. 
The total mutation rate of bacterial pathogens varies greatly, with WGS 
revealing a range of 0.1 mutations per Mb per year in the genetically 
monomorphic species M. tuberculosis to as much as 19 mutations per Mb 
per year in the highly diverse H. pylori (Kennemann et al. 2011, Ford et 
al. 2011). The mutation rate for Campylobacter however has not been 
robustly defined. 
 
4.2.2. Within-host variation 
Many studies have demonstrated that infectious populations of common 
pathogens are genetically diverse entities, and undergo genomic 
variation during the course of a typical infection (Young et al. 2012, 
Kennemann et al. 2011, Mwangi et al. 2007, Nguyen & Singh 2006, Ford 
et al. 2011). Bacterial pathogens with a high rate of genomic variation, 
and that produce a chronic pathology can logically be observed to 
undergo adaptation within a single host.  
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Cystic fibrosis is a genetic disorder that causes impaired immune 
function and reduced mucus clearance, which ultimately leads to 
bacterial colonisation of the lower respiratory tract. Whilst the lungs 
have an abundance of organic compounds suitable for microbial growth, 
bacteria must continually adapt to changes in specific nutrient 
deficiencies, as well as the routine, prolonged exposure to antimicrobial 
therapy (Nguyen & Singh 2006). Pseudomonas aeruginosa is found in up 
to 85% of cystic fibrosis suﬀerers by the time they reach adolescence, and 
is a significant cause of mortality (Davies 2002). Phenotypic study of  
P. aeruginosa populations isolated from the sputum of cystic fibrosis 
patients reveals a large degree of heterogeneity, with a range of colony 
morphologies and antibiotic resistance profiles (Oliver et al. 2000). 
Genomic comparison of P. aeruginosa collected from a single patient at 
diﬀerent time points also indicates an on-going pattern of genome-wide 
adaptation, with 68 SNPs detected in a single clone across a 96 month 
period (Smith et al. 2006). 
 
Within-host diversity has also been demonstrated in gastrointestinal 
disease. H. pylori infects as much as half of the global population 
(Kusters et al. 2006). Carriage of H. pylori is chronic in nature, and whilst 
carriage is not in itself a disease, it has been implicated in a number of 
pathologies ranging from peptic ulcers to gastric cancer (Kusters et al. 
2006). Kenneman et al. (2011), compared H. pylori isolates collected from 
the same patients at varying time points, with intervals ranging from 3 to 
16 years. The genomes revealed 27-232 SNPs between isolate pairs, with 
additional diversity present in areas of apparent recombination 
(Kennemann et al. 2011). 
 
In both examples, collection and subsequent analysis of a single 
infectious population has occurred in the magnitude of months apart. It 
is clear that variation at this time scale does indeed occur. The 
methodologies employed by these studies (i.e. comparison of de novo 
assemblies) are only sensitive to mutations that have become (or are 
close to becoming) fixed within a population, and as such do not provide 
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an insight into developing mutations, as there is no data concerning the 
frequency of these alleles. 
 
4.2.3. Limitations of assembly based genomics 
Under strong selective pressure, a mutation will move towards fixation 
amongst a population. This is seen in positive selection, whereby an 
advantageous mutation leads to an increase in fitness and an eventual 
dominance of clones that share that mutation ensues. The reverse is also 
true in negative or purifying selection, wherein a disadvantageous 
mutation leads to a decrease in fitness, causing a deleterious eﬀect 
(Pallen & Wren 2007). Measuring bacterial mutations that have swept to 
fixation is logically (and computationally) simple, and requires just a 
single read of a reference and query sequence. This can therefore be 
achieved at the whole genome level using de novo assemblies, which 
represent a consensus contiguous sequence generated from multiple 
sequencing reads.  
 
Relying on de novo assemblies for comparative genomics has its 
advantages. The files are smaller in size compared to raw sequencing 
reads, which in turn requires less processing power and memory to 
analyse, and far less hard drive space to maintain. However, it also limits 
the sensitivity of computational analyses. Due to the nature of the 
assembly process, any analysis using de novo assemblies alone assumes 
that the sequenced population shares a single common haplotype. 
Genetic mutations that occur in the majority of a sampled population 
will by extension occur in the majority of sequencing reads. These 
mutations will therefore be represented in the final assembly as either a 
break in sequence (i.e. a new contig) where the number of variations is 
suﬃcient (e.g. large insertion/deletion or sequencing error events), or a 
consensus base call that supports the majority of reads at a variable site.  
 
A break in contiguous sequence would obviously prevent comparison at 
any omitted bases, which may only be avoided by utilising closed, 
complete genome sequences, which are labour and cost intensive to 
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produce. In instances where a consensus base call is produced, there is 
no distinction between a mutation that has become fixed in a population, 
and a single nucleotide polymorphism that is present in a suﬃcient 
percentage of the sequencing reads to produce a consensus base call. 
 
4.2.4. Measuring intra-population diversity 
Lieberman et al. (2013), reason that there are two conflicting models of 
within-host bacterial diversity. The ‘dominant lineage’ model, which 
suggests that over time, beneficial mutations that confer a greater fitness 
will drive clones sharing that mutation to fixation. The ‘diverse 
community’ model however, suggests that genomic variation is in a 
constant state of flux, with many lineages rising to intermediate 
frequencies concurrently. Irrespective of how diversity progresses, prior 
to fixation in a population, any given mutation must occur at an 
intermediate or minor frequency. In order to correctly measure intra-
populational diversity, the choice of genetic analysis must be sensitive to 
alleles that are present at these frequencies.  
 
A suitable method for detecting minor frequency alleles is single colony 
sequencing (Köser et al. 2014). In conventional sequencing protocols, 
DNA is isolated and sequenced from a single isolate treated as a group 
(e.g. whole plate sweep, liquid culture). Single colony sequencing – as its 
name implies – relies on isolating DNA from multiple individual 
colonies, and treating each as a separate entity thereafter. By mapping de 
novo assemblies produced from individual colonies to a common 
reference, polymorphic sites can be identified, and the percentage of 
colonies in which that polymorphism appears provides the minor allele 
frequency (maf). This is an indication of the percentage of a population 
that shares a haplotype, and can be used to distinguish fixed and 
polymorphic sites. Single colony sequencing is perhaps most useful in 
instances where there is a measurable phenotype to distinguish variant 
colonies (e.g. antimicrobial susceptibility). In the absence of a distinctive 
phenotype a large sample size would be necessary to reduce sampling 
bias, which is both labour and cost intensive (Lieberman et al. 2013). The 
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utility of single colony sequencing is also severely hampered by highly 
motile organisms that exhibit swarming on solid media, making 
individual colony isolation diﬃcult. 
 
Another method for assessing intra-populational diversity is referred to 
as ‘deep sequencing’. For most purposes, sequencing an isolate to 20-30x 
coverage (i.e. each position in the genome is sequenced 20-30 times) is 
suﬃcient. This level of coverage will typically produce a useable draft 
genome, and allow basic SNP calling. Deep sequencing uses the same 
principal, but greatly increases the coverage (100X+) at which the isolate 
is sequenced. The genomic reads are then mapped against an assembled 
reference sequence. This approach significantly increases the number of 
alleles that are compared to the reference sequence. As the technique 
uses a read mapping approach, each sequenced base is queried an equal 
number of times to the positional depth. This approach treats the 
number of reads at a polymorphic site as the total population size, and 
uses the percentage of reads at that site which support a given allele to 
infer the frequency at which it occurs. The single colony and deep 
sequencing methodologies were compared in their ability to discern 
minor allele variation. Deep sequencing was able to detect alleles that are 
present in >3% of the population, and is far less cost and labour intensive 
than the single colony approach (Lieberman et al. 2013). 
 
The seminal work by Lieberman et al. (2013) provides key insights into 
within-host bacterial evolution, and addresses many of the questions 
presented by the previously discussed studies (Kennemann et al. 2011, 
Smith et al. 2006). Sputum samples from five cystic fibrosis patients were 
used to characterise single populations of infective Burkholderia dolosa 
isolates. Using the previously described deep sequencing technique, 
Lieberman et al. discovered a vast amount of diversity in each patient 
sample. The majority of mutations that were detected did not sweep to 
fixation. Rather, multiple haplotypes were detected concurrently as 
described in the diverse community model of within host-diversity.  
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The concurrent existence of multiple clonal lineages demonstrates that 
even at a single time point multiple haplotypes can be detected. This 
raises questions regarding other pathogens and their related pathologies. 
For example, whether other genera exhibit similar intra-populational 
diversity, or if the observed diversity is unique to chronic disease types.  
 
4.2.5. The Diversity of Campylobacter spp. 
As discussed in previous chapters, Campylobacter is the leading cause of 
bacterial enteritis in the developed world. It is also highly genetically 
diverse, with a weakly clonal population structure that is distributed 
across a vast range of hosts (Schielke et al. 2014, Garénaux 2008, 
Waldenström et al. 2002, Baker et al. 1999, Dearlove et al. 2015). Many  
C. jejuni isolates are naturally competent, and have been demonstrated 
to undergo a significant amount of recombination, as well as exhibiting a 
high mutation rate (Wang & Taylor 1990; Suerbaum et al. 2001; 
Fearnhead et al. 2005).  
 
There are a limited number of comprehensive genomic studies into 
Campylobacter diversity, however initial results suggest that 
Campylobacter does exhibit intra-populational variation. Cody et al. 
(2012), identified several variable loci when analysing repeated samples 
from patients infected with Campylobacter spp. Repeat samples were 
found to vary at 3-14 loci, however information on the variant bases or 
allele frequency is not available due to the restrictive methodology 
employed.  
 
There is also a singular study investigating genetic heterogeneity of a 
human infection with C. jejuni. Following an accidental passage of C. 
jejuni isolate NCTC11168, a total of 7 SNPs were detected in the passaged 
isolate (Revez et al. 2013). This represents far fewer variants than 
previous research investigating passage of 11168 in mice, which yielded 
23 instances of variation (Jerome et al. 2011). All variants identified in the 
human passage were located within hypervariable homopolymeric 
tracts, and no information regarding the allele frequency is provided. 
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The researchers suggest that human passage – at least of this laboratory 
strain – does not result in a significant amount of genetic heterogeneity, 
particularly in comparison to the results from the mice passage.  
 
Whilst this is certainly an interesting case study, it is not possible to 
extrapolate the findings to real-world manifestations of 
campylobacteriosis. The infection occurred as a result of an undisclosed 
accident involving the reference strain NCTC 11168. This frozen stock was 
provided by the Centre for Disease Control, and is intentionally clonal in 
nature. Typical clinical infections are unlikely to come from such 
pristine sources. Using contaminated poultry as an example, any 
colonising population of Campylobacter will have been exposed to 
multiple selective pressures throughout the slaughter to consumption 
food chain. Any diversity present at this stage may impact subsequent 
variation during passage, or in the case of a purified surviving clone, 
some adaptation would be expected to move from survival through the 
poultry food chain and entry to the human host. Additionally, the 
infected person was aware of the accident, and accordingly expected to 
develop symptoms. This likely altered the typical clinical management of 
the disease, with intervention and sample collection occurring far sooner 
than in community based infections. 
 
In this study, we aimed to assess the degree of genetic heterogeneity 
amongst clinical Campylobacter spp. populations. Given that CC ST-21 is 
the most commonly isolated lineage in human gastrointestinal disease 
(Cody et al. 2012), the study will focus on this grouping as an indication 
of a successfully pathogenic genotype. This is the largest study utilising a 
deep sequencing methodology to investigate Campylobacter diversity in 
the context of a single clinical infection, and the first to focus on 
naturally occurring disease. 
  
 105 
4.3. Methods 
4.3.1. Sequencing 
Isolates belonging to CC ST-21 were selected from the genomic dataset 
produced in Chapter 3. Supplementary data detailing the patient 
demographics of analysed samples later revealed that all isolates were 
obtained from separate patients.  
 
Fresh genomic DNA was extracted from whole plate growth, and 
sequenced as previously described in Chapter 2. Two alterations were 
made to the sequencing process in order to increase the coverage depth 
and quality of the resulting sequence data.  
 
First, a reduction to the total number of samples (N=24) multiplexed on a 
single flow cell was used. This increases the depth of sequencing 
coverage at a given position and allows finer resolution of minor allele 
variation. The number of multiplexed samples was set at the maximum 
number of isolates that would produce a target coverage of >150 using the 
MiSeq V3 chemistry, as demonstrated below.  
 !"#$%	'3	)ℎ$+",-./:	 250	×	25, 000, 0001, 628, 115	×	96 	= 159.95 
 	 <$=>	?$@A-ℎ	×	B=-=	CD-ED-#=+E?$	A$@C+$	?$@A-ℎ	×	FC. ,=+E?$, 	= )CG$.=A$	B$E-ℎ	
 
Additionally, due to a declining per-base quality towards the tail end 
(>250bp) of the MiSeq V3 reagent kit’s fourth read, the sequencing run 
was configured to only utilise 250 (of 300 maximum) cycles. Whilst this 
decreased the overall data output and thus coverage of the run, it served 
to produce a greater overall number of reads passing the minimum 
quality filter (Q≥30) and therefore an enhanced degree of accuracy during 
read mapping. Sequence data was assembled and annotated as 
previously described in chapter two, using SPAdes and Prokka 
respectively (Bankevich et al. 2012, Seemann 2014).  
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4.3.2. Read Mapping 
Genomic reads were initially processed using the sliding window quality 
trimmer, Sickle (Joshi & Fass 2011). Sickle was configured to discard 
reads that were less than the configured sequencing run length (i.e. 
250bp), and trim reads in which the quality within the sliding 25bp 
window falls below 20. This sought to maintain only high quality, full 
length reads for robust variant calling.  
 
The filtered reads were then aligned to their respective de novo assembly 
using Bowtie2 (Langmead & Salzberg 2012). The maximum insert size 
was raised from the default 500 to 2000 to permit larger paired-end 
fragment length alignments. Only alignments containing less than 1% of 
ambiguous characters were included in the output BAM file.  
 
The resulting alignment was processed using the SAMTools suite of tools 
(Li et al. 2009). The final VCF output was configured to only include 
variants with a mapping and base quality of >30 (i.e. >99.99% accuracy), 
and a minimum depth of 30 reads. 
 
Due to the process of de novo assembly, several variants were identified 
at the breaking points of contigs, any variants that occupied positions 
close to the start or end of contigs were discarded. Some variants failed to 
produce the relevant ‘INFO’ fields necessary for further analysis, which 
were also discarded. 
 
The curated VCF was visualised against the read-distribution in Artemis 
(Rutherford et al. 2000). This sought to assess the position of variants in 
respect to the read. Due to the relatively high error rates observed at start 
and end positions in Illumina sequence reads, any variants that occurred 
in the majority at such positions were excluded from analysis. 
 
Figure 4.1 provides a summary workflow of the deep-sequencing read 
mapping approach.  
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Figure 4.1 - Curation and mapping pipeline for the ST-21 deep sequencing 
dataset 
Software names highlighted within red boxes in bold, with key optional changes to default 
parameters listed below. 
4.3.3. Variant Calls 
Annotated assemblies were cross referenced with the genomic positions 
of called variants to identify potential genes. In instances where 
variation occurred within CDS, the amino acid residue was used as a 
reference point rather than raw genomic position, to allow comparison 
between isolates. Protein sequences were aligned to the Pfam database to 
identify conserved domains (Finn et al. 2016), and - where possible - 
variants were assigned to a specific functional domain of the protein. 
Loci are listed primarily by their designation in the PubMLST 
Campylobacter jejuni and coli database to allow ease of comparison, and 
where possible include common aliases thereafter. 
 
The variant call format that provides the final curated list of polymorphic 
bases includes information on the number of reads that support a given 
allele, denoted by the tag ‘DP4’. There are four fields that comprise DP4: 
Forward reference (FR) allele, reverse reference allele (RR), forward 
alternative allele (FA) and reverse alternative allele (RA). This can be 
used to infer the relative frequency of a minor allele amongst a 
population of reads using the following equation: 
 
 !"@C.	H??$?$	I.$%D$@J/ = 	 IH + <HI< + << + IH + <H 
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4.3.4. Statistical Analysis of Assembly Metrics 
As query genomic reads were mapped against a de novo assembly of the 
same reads, it was necessary to discern whether various assembly 
metrics had any impact on the number of minor allele variants detected.  
 
Sequencing coverage depth, assembly N50, and the total number of 
contigs present in the final assembly were all considered. A linear 
regression analysis was performed using GraphPad Prism 7, with a 
significance threshold set at P>0.05.  
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4.4. Results 
4.4.1. Isolates, sequencing and assembly. 
A total of 17 ST-21 isolates were sequenced to an average depth of 144X. 
All isolates were found to belong to separate patients, based on age, sex 
(Table 4.1) and post code (data not shown).  
Table 4.1 - Patient demographics of samples belonging to the deep 
sequencing dataset 
Isolate Collection Month 
Patient 
Sex 
Patient 
Age 
Coverage 
Depth 
D1-81 September M 86 114 
D2-11 February F 79 184 
D2-23 February F 30 103 
D2-32 March F 69 162 
D2-36 March M 57 158 
D2-9 March M 44 146 
D3-22 April F 1 113 
D4-24 April M 23 92 
D4-67 April M 25 182 
D4-69 June M 61 140 
D4-7 June M 47 158 
D5-69 June F 33 169 
D5-80 June M 15 196 
D6-57 July M 63 85 
D7-57 September M 23 160 
D7-62 September M 55 130 
D9-10 October M 21 165 
Samples were screened to check whether they were obtained from separate patients. In 
instances where this was not clear by the provided demographics, geographic data was 
used for exclusion (data not shown). 
 
The deep sequencing dataset had an average N50 of 384,793bp (95% C.I: 
165,003bp to 604,584bp), a mean total length of 1,708,840bp (95% C.I: 
1,664,273bp to 1,753,407bp) and a mean number of contigs of 47.12 (95% 
C.I: 9.345 to 84.89). The distribution of these quality metrics is displayed 
in Figure 4.2. 
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Linear regression was used to assess whether the sequencing coverage 
depth, assembly N50 or number of contigs had an impact on the number 
of loci in which minor allele variation was detected (Figure 4.3). These 
analyses revealed no statistical significance (P = 0.6117, 0.2985 and  
0.7322 respectively). 
 
 
Figure 4.3 - The statistical impact of sequencing and assembly metrics on the 
number of loci in which minor allele variation was detected 
Slopes calculated via linear regression analysis, results were not statistically significant in all 
instances (P > 0.5). 
  
Figure 4.2 - Quality metrics of draft de novo assemblies  
Mean inclusive of upper and lower confidence intervals highlighted in orange. 
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4.4.2. Minor allele variation 
A total of 36 minor allele variants were detected within the dataset with 
suﬃcient depth and quality to qualify further analysis. Of the 17 analysed 
isolates, 35% (n=6) did not produce any minor allele variants that met the 
strict quality filtering thresholds.  
 
The majority of variants (n=28) were contained within identified loci. 
Four variants were located within a homopolymeric tract, and a further 
four variants were present at intergenic positions. These are discussed in 
greater detail below. 
 
The loci in which minor allele variation was detected were grouped 
according to the gene product function. Table 4.2 shows the number of 
isolates (n.b. not the number of variants) that contained minor allele 
variation in these functional groups.  
Table 4.2 - Genes in which minor allele variation was detected, grouped 
according to putative function 
Gene Function Instances of Variation* 
Chemotaxis 5 
Homopolymeric Tract 4 
Intergenic 3 
Flagellar 2 
Membrane 2 
* - i.e. number of functionally grouped loci that contained variants in separate isolates. Loci 
containing multiple variants in a single isolate are counted as one instance. Loci that contain 
variants in multiple isolates are counted individually. 
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4.4.3. Chemotaxis 
 
Four isolates yielded variation within chemotaxis related genes. Three of 
these isolates contained variants within the same gene – CAMP1460 – 
which is detailed below. The final isolate, D5-69 yielded two minor allele 
variations in two separate loci (Table 4.3). 
 113 
Table 4.3 - Minor allele variants detected within loci encoding chemotaxis related proteins 
Isolate Locus Residue Codon 
Amino Acid Mapping 
Quality* 
Coverage 
Depth MAF† Ref  Alt Ref  Alt 
D5-69 CAMP1031 343 GGG → GAG Glycine → Glutamic Acid 225 428 0.58 
D5-69 CAMP1109 275 GCT → GTT Alanine → Valine 46 548 0.2 
D3-22 CAMP1460 461 GAT → AAT Aspartic Acid → Asparagine 225 589 0.53 
D2-36 CAMP1460 477 TTA → CTA Leucine → Leucine 164 1788 0.28 
D2-36 CAMP1460 516 ATG → ACG Methionine → Threonine 157 1840 0.52 
D4-69 CAMP1460 523 ACT → GCT Threonine → Alanine 122 763 0.28 
D2-36 CAMP1460 523 ACT → CCT Threonine → Proline 225 1838 0.53 
D4-69 CAMP1460 550 CTA → CCA Leucine → Proline 225 966 0.30 
D2-36 CAMP1460 550 CTA → CCA Leucine → Proline 225 1682 0.52 
D2-36 CAMP1460 568 TTT → CTT Phenylalanine → Leucine 225 1476 0.52 
D4-69 CAMP1460 615 CAT → CAC Histidine → Histidine 198 691 0.28 
D4-69 CAMP1460 621 ACT → GCT Threonine → Alanine 225 612 0.27 
* - Provided as a PHRED score 
† – Minor allele frequency (i.e. indicative of percentage of reads that support the minor allele). 
Colours represent sequence type.  
Legend: ST-53 ST-44 ST-21 
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CAMP1031, also referred to as Cj110c, encodes transducer like protein (Tlp) 8, 
CetZ. Residue number 343 contained a minor frequency variant in the second 
codon position, causing a non-synonymous mutation from glycine to glutamic 
acid. This residue is located within the methyl-accepting signalling domain of 
the protein, as shown in Figure 4.4. 
 
 
 
Figure 4.4 - Topology of Tlp8 (CetZ) encoded by the CAMP1031/Cj1110c locus 
Residue numbers provided below domains show regions of Pfam alignment. Residue 343 yielded 
variation at its second base position. 
Per-ARNT-Sim (PAS). 
 
The locus CAMP1109 (Cj1190c) encodes Tlp9 (CetA), and again contained a 
minor variant within the methyl-acepting signalling domain located within this 
protein. Figure 4.5 shows the topology of the cetA locus and the position of the 
variant amino acid residue. 
 
 
 
Figure 4.5 - Topology of CetA encoded by the CAMP1109/Cj1190c locus 
Residue numbers provided below domains show regions of Pfam alignment. Residue 275 yielded 
variation at its second base position. 
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CAMP1460 – also referred to as Cj1564 or ccmL – encodes transducer like protein 
3 (Tlp3). The majority minor allele variants were contained within the methyl-
accepting signalling domain, as shown in Figure 4.6. Residue 523 underwent 
non-synonymous mutations in two isolates, from the polar amino acid 
threonine to separate non-polar residues (proline and alanine). Additionally, 
residue 550 underwent an identical non-synonymous mutation in two isolates, 
substituting leucine with proline. 
 
Figure 4.6- Topology of CAMP1460 (CcmL) highlighted with positions of variable 
residues. 
TM1 and 2 = transmembrane helixes.  
HAMP1 and 2 = histidine kinases, adenylyl cyclases, MCPs and phosphatases. 
Residue positions provided in bold italicised font adjacent to red lines correspond to minor allele 
variations detected and listed in Table 4.3. Topology adapted from Liu et al. (2015), and Pfam 
alignment (Finn et al. 2016). 
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4.4.4. Flagellar and Membrane 
Four isolates yielded variation within flagellar and membrane related genes, as 
detailed in Table 4.4. 
 
Isolate D2-36 exhibited five instances of minor allele variation within locus 
CAMP0586. This locus – also referred to as Cj0628, yielded no alignments to the 
Pfam database. Cj0628 functions as a membrane bound autotransporter. 
 
A single instance of minor allele variation was detected within the CAMP1178 
locus, which encodes the major outer membrane protein, PorA.  
 
Two isolates yielded variants within the CAMP1257 locus, which is responsible 
for flagellar glycosylation. Isolates D2-9 and D2-11 contained 4 and 5 instances of 
minor allele variation at this locus respectively. All substitutions in isolate D2-11 
were transitional, whereas isolate D2-9 displayed two instances of synonymous 
substitutions. Residue 251 exhibited variation in both isolates, with both cases 
introducing a change to the amino acid sequence. All variants within this locus 
occurred at a relatively low frequency (0.14-0.28). 
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Table 4.4 - Minor allele variants detected within loci encoding flagellar and membrane related proteins 
	
Isolate Locus Residue 
Codon Amino Acid Mapping 
Quality* 
Coverage 
Depth MAF
† 
Ref  Alt Ref  Alt 
D2-36 CAMP0586 84 TTT → GTT Phenylalanine → Valine 225 766 0.47 
D2-36 CAMP0586 98 ACC → AAC Threonine → Asparagine 225 822 0.47 
D2-36 CAMP0586 98 ACC → ACA Threonine → Threonine 225 815 0.46 
D2-36 CAMP0586 99 ATA → GTA Isoleucine → Valine 225 816 0.47 
D2-36 CAMP0586 100 AAA → GAA Lysine → Glutamic Acid 225 809 0.47 
D4-7 CAMP1178 180 GGA → GAA Glycine → Glutamic Acid 225 576 0.26 
D2-9 CAMP1257 223 AGC → AGT Serine → Serine 225 192 0.20 
D2-9 CAMP1257 224 CAA → GAA Asparagine → Glutamic Acid 225 190 0.20 
D2-9 CAMP1257 229 TTT → TTC Phenylalanine → Phenylalanine 225 190 0.20 
D2-11 CAMP1257 251 TAT → CAT Tyrosine → Histidine 182 142 0.14 
D2-9 CAMP1257 251 TAT → TGT Tyrosine → Cysteine 225 164 0.28 
D2-11 CAMP1257 265 CGA → CAA Serine → Asparagine 222 84 0.22 
D2-11 CAMP1257 271 GGC → GAC Glycine → Aspartic Acid 225 69 0.26 
D2-11 CAMP1257 273 ATA → ACA Isoleucine → Threonine 178 58 0.26 
D2-11 CAMP1257 274 ATA → ACA Isoleucine → Threonine 209 63 0.27 
* - Provided as a PHRED score 
† – Minor allele frequency (i.e. indicative of percentage of reads that support the minor allele). 
Colours represent sequence type. Legend: ST-50 ST-44 ST-21 
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4.4.5. Homopolymeric Tract 
Four isolates contained minor allele variants within the intergenic 
homopolymeric tract that mediates the CAMP1239 (Cj1321) locus, which 
encodes the protein Maf6. In all instances a C>G substitution occurred, 
converting a G10 tract to a G13 (Table 4.5), resulting in ‘Oﬀ’ expression. 
 
Table 4.5 - Minor allele variation detected amongst multiple isolates in the 
Cj1321 homopolymeric tract 
Isolate 
Homopolymeric Tract Sequence Mapping 
Quality* 
Coverage 
Depth MAF
† 
Ref  Alt 
D2-32 GGCGGGGGGGGGG → GGGGGGGGGGGGG 35 111 0.2 
D2-36 GGCGGGGGGGGGG → GGGGGGGGGGGGG 44 100 0.21 
D4-24 GGCGGGGGGGGGG → GGGGGGGGGGGGG 73 67 0.28 
D5-69 GGCGGGGGGGGGG → GGGGGGGGGGGGG 58 32 0.25 
* - Provided as a PHRED score 
† – Minor allele frequency (i.e. indicative of percentage of reads that support the minor 
allele). 
 
4.4.6.  Intergenic 
Four instances of intergenic variation were detected, distributed across 
three isolates. All substitutions were transversions (Table 4.6). 
 
Table 4.6 - Minor allele variation present at intergenic positions 
Isolate 
Nucleotide Mapping 
Quality* 
Coverage 
Depth MAF
† Position 
Ref  Alt 
D2-36 G → A 205 819 0.45 Node_70 572 
D3-22 A → G 208 347 0.43 Node_13 286 
D3-22 A → G 225 372 0.53 Node_13 287 
D5-80 T → C 118 258 0.34 Node_45 97 
* - Provided as a PHRED score 
†– Minor allele frequency (i.e. indicative of percentage of reads that support the minor allele). 
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4.4.7. Hypervariable Loci 
 
The PubMLST Campylobacter database was interrogated for isolates 
containing whole-genome sequence data, and a confirmed presence of 
each variable loci identified in the deep sequencing dataset. A total of 56 
isolates were returned and used for further analysis. 
 
The dataset was broken down by reported allele number under the 1643 
Gundogdu loci scheme (Gundogdu et al. 2007). Table 4.7 provides the ten 
most variable loci, as defined by the percentage of isolates exhibiting a 
unique allele.  
 
Table 4.7 - Loci in which the greatest frequency of unique alleles was 
observed amongst a group of isolates from the PubMLST database 
PubMLST 
Locus Locus Aliases 
Isolates With 
Unique Allele 
CAMP1460 Cj1564, CcmL 71% 
CAMP1257 Cj1341c, maf6 68% 
CAMP1256 Cj1340c 63% 
CAMP0035 Cj0036 50% 
CAMP0038 Cj0039c, typA 50% 
CAMP1178 Cj1259, porA 50% 
CAMP0034 Cj0035c 48% 
CAMP0124 Cj0136, infB 48% 
CAMP0001 Cj001, dnaA 46% 
CAMP0002 Cj002, dnaN 46% 
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4.4.8. Loci in relation to NCTC11168 
In order to provide a common reference point, loci exhibiting minor 
allele variation were mapped against the common reference assembly of 
C. jejuni strain NCTC11168. The positions of these loci relative to 
NCTC11168 is provided in Figure 4.7.  
 
 
 
Figure 4.7 - Circular chromosome of NCTC111168 with annotated CDS* 
CDS as annotated in the updated re-annotation of the complete NCTC111168 genome 
sequence (Gundogdu et al. 2007). Highlighted CDS were found to contain minor allele 
variation at one or more amino acid residues.  
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4.5. Discussion 
The findings from this study demonstrate that single clinical populations 
of Campylobacter jejuni exhibit some degree of intra-populational 
diversity. A total of 17 isolates were analysed, yielding an average of ~2.1 
polymorphisms per isolate. Whilst this is not as high as similar studies – 
for example studies of pathogens in Cystic Fibrosis patients (Lieberman 
et al. 2013, Smith et al. 2006, Workentine et al. 2013) – it is important to 
take the typical disease manifestation into account.  
 
As discussed in the first chapter, the symptomatic phase of the disease 
lasts between 2 and 7 days (Blaser 1997). Even when considering extreme 
instances of incubation time, and the delay in which patients will 
typically report to clinicians, the length of time in which Campylobacter 
would have colonised the patient is in the order of weeks, compared to 
months and years in chronic conditions. Additionally, these isolates 
were prepared from a single stool sample. Patients pass between 8-10 
stools per day (Blaser et al. 1983), meaning any one stool may 
conceivably not be completely reflective of the total diversity present 
within the host.  
 
A previous study analysing the genetic heterogeneity of a human 
passaged C. jejuni NCTC11168 isolate only detected variation within 
homopolymeric tracts. Whilst this study also identified variation within 
one of these tracts, diversity was also apparent within several loci. This 
disparity in variation may be reflective of the clonality of the infecting 
population, or perhaps indicative of mechanisms by which variation is 
generated within the human host.  
 
Many of the identified variants were found to occur at minor allele 
frequencies, supporting the diverse community model for intra-
populational diversity (Lieberman et al. 2013). However, the 
methodology used within this study is not sensitive to fixed mutations. 
Previous use of the deep sequencing methodology involved mapping 
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genomic reads to a completed reference genome sequence (Lieberman et 
al. 2013).  
 
In this study however, genomic reads were mapped against an assembly 
constructed using the same querying reads, and as such the existence of 
a fixed polymorphism is impossible to discern. Using a self-mapping 
approach is of great advantage when studying pathogens that cause 
acute pathologies, as sampling opportunities are limited by the clinical 
management of the disease. Campylobacter spp. also exhibit a large 
amount of genetic diversity, even between members of the same clonal 
lineage (Colles et al. 2003, Cody et al. 2013). This causes issues when 
selecting a suﬃciently homologous reference sequence to query reads 
against. In chronic conditions, or in instances where repeat patient 
samples from a suitable time course are available, using a historic 
sequence of the same isolate as a reference would be preferable. 
4.5.1. Chemotaxis Genes 
The majority of identified variants were contained within genes related 
to chemotaxis. As discussed in Chapter 1, chemotaxis is an essential 
prerequisite for colonisation of the human gastrointestinal tract. 
Mutagenesis studies in mice, chickens, and human cell lines have all 
shown a reduced infection potential when key chemotaxis related genes 
are knocked-out (Rahman et al. 2014, Li et al. 2014, Hendrixson & DiRita 
2004). 
 
In Campylobacter spp., chemotaxis related sensing is mediated by 
transducer-like proteins (Tlps) which bear a strong homology to the well 
documented Methyl-accepting chemotaxis proteins found in E. coli 
(Lertsethtakarn et al. 2011). These transducer-like proteins encode a 
variety of receptors that feed into the CheA-CheW-CheY signal 
transduction pathway, which ultimately leads to a change in the 
directional rotation of the flagellar motor (Korolik et al. 2008). A total of 
ten transducer-like proteins have been identified via genomic study 
(Marchant et al. 2002). 
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The high degree of genetic diversity present amongst chemotaxis related 
loci may be indicative of changes in selective pressure. As the disease 
progresses, fluid accumulates in the intestinal lumen and intestinal cells 
become damaged (Young et al. 2007, Wassenaar & Blaser 1999). This 
would likely alter the availability of certain nutrients and growth factors, 
as well as introduce an increased contact with immune-responsive cells. 
 
4.5.1.1. CAMP1031 
CAMP1031 – also referred to as Cj1110c – encodes transducer like protein 
8 (Tlp8), CetZ. Tlp8 belongs (along with Tlp5 and Tlp6), to the group C 
transducer like proteins, which are unfortunately less well characterised 
than other Tlp groups (Korolik et al. 2008).  
 
Predictive models of Tlp8 do not identify any transmembrane regions or 
signals of periplasmic export, which suggests this receptor is located in 
the cytoplasm (Reuter & van Vliet 2013). The CetZ protein contains two 
PAS-domains and a single methyl-accepting signalling domain. PAS-
domains, named after the first genes in which these regions were 
identified (Per-Arnt-Sim), are responsible for sensing changes in 
cytosolic redox potential (Key et al. 2007). 
 
This locus exhibited a single transversion from adenosine to guanine 
within amino acid residue 343. This leads to a non-conservative change 
in amino acid at this residue from the non-polar glycine to acidic residue 
glutamic acid. At this intragenic position, the most common allele 
represented in the PubMLST database (i.e. CAMP1031:1) expresses a 
glutamic acid residue. The substitution observed therefore may be a 
divergent haplotype that is either reverting to the most common allele, 
or a common haplotype undergoing variation in response to selective 
pressure. 
 
This locus was also shown to undergo polymorphic change in other 
studies. Genomic investigation of a milk-borne outbreak amongst six 
patients revealed numerous polymorphic loci, with CAMP1031 displaying 
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allelic diversity between the original source and subsequent patient 
isolates (Revez et al. 2014). Similarly, in accidental repeated sampling of 
17 patients, Cody et al. (2013), reported allelic variation in two patients. 
Comparison in these studies was performed using wgMLST, and as such 
the exact genotypic change and position is unknown. However, as 
wgMLST is assembly based, it suggests that the disparate alleles were 
present at a majority frequency that permitted inclusion in the final 
assembly. There may in fact have been a far greater diversity present in 
these samples at minor allele frequencies which would be important to 
consider in future studies.  
 
Variation within this locus may occur as the result of changing metabolic 
health within Campylobacter cells. The internal physiological state of the 
cell may be a driving factor in the modulation of other chemotaxis 
pathways. Reuter et al. (2013), propose that CetZ is responsible for redox 
sensing, and may interact with a redox metabolite such as FAD, which is 
seen in other proteins containing PAS domains (Key et al. 2007). The 
polymorphic base was located within the methyl-accepting signalling 
(MA) domain, which is responsible for signal transduction in the 
chemotaxis pathway. The lack of variation within the PAS domain 
indicates that the ligand recognition site is conserved. Variation within 
the MA-signalling domain suggests that a haplotype is present in the 
population that may exhibit modulated transduction of the ligand-
binding signal. This could for example alter the priority of the signal 
transduction pathway and alter ligand-specific motor switching by 
increasing, deleting, or reducing the signal transduction potential of the 
CAMP1031 locus.  
 
The polymorphism detected within this locus falsely appears to occur in 
the majority of reads (MAF 0.58), however it’s important to note that the 
way in which MAF is calculated only considers bases sequenced with a Q-
score greater than 30 (i.e. 99.99% accuracy). Reads were processed using 
a sliding window quality trimmer, which was configured to trim 25-bp 
regions that fell below an average Q score of 20 (i.e. 99.9% accurate), and 
whilst the mapping process further qualifies bases at Q30, the assembler 
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does not. It is likely that the two divergent alleles are present at an 
intermediate frequency, leading to ambiguity in the final assembly. This 
highlights the limitations of assembly based comparisons – in the 
absence of the allele frequency, it would appear that this variant was 
fixed amongst the population, however in reality these alleles are 
coexistent. 
4.5.1.2. CAMP1109 
CAMP1109 encodes Tlp9, and is the lone member of group B transducer 
like proteins. It is also referred to as CetA, for Campylobacter energy taxis 
protein A (Korolik et al. 2008). The structure of CetA suggests it is a 
cytoplasmic protein, and is anchored to the membrane via a trans-
membranous N-terminal region (Marchant et al. 2002, Korolik et al. 
2008). A single minor allele variant was detected within this locus, with 
residue 275 exhibiting a conservative mutation between the polar 
residues alanine and valine.  
 
The cetA locus is essential for eﬃcient energy taxis, with knock out 
studies revealing reduced taxis towards sodium pyruvate and fumarate 
(Reuter & van Vliet 2013). The overall mechanisms controlling energy 
taxis are also mediated by CetA. Research suggests that eﬃcient energy 
taxis occurs due to a balance of activity between the cetA, cetB, cetC and 
cetZ loci, with the combination of signals from these genes conferring 
appropriate taxis towards favourable energy generation conditions and 
away from hazardous redox potentials (Reuter & van Vliet 2013). Both the 
cetA and cetZ loci yielded variation within the same isolate, which would 
support the hypothesis presented by Reuter and Van Vliet (2013).  
4.5.1.3. CAMP1460 
The locus CAMP1460 – also referred to as Cj1564 or ccmL – yielded minor 
allele variation across multiple ST-21 isolates. This locus encodes Tlp3, a 
group A chemoreceptor responsible for ligand binding in the 
chemotactic sensory pathway. Group A Tlps share a structural homology 
with the methyl-accepting proteins found in E. coli and contain both 
transmembrane and periplasmic domains, suggesting that they may 
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sense ligands that are external to the cell (Marchant et al. 2002). Tlp3 is 
also known as ccmL or Campylobacter chemoreceptor for multiple 
ligands, and interacts with several chemoattractants (e.g. isoleucine, 
purine, malic acid) and chemorepellents (e.g. lysine, arginine, 
glucosamine). In vitro analysis demonstrates that the receptor is able to 
bind multiple ligands simultaneously (Rahman et al. 2014). 
 
The positions at which variable amino acid residues occur reside within 
the intracellular MA-signal transduction domain, as observed in the 
other chemotaxis loci. Again, this may result in modulation of the 
strength of a chemotaxis response to a particular ligand. For example, a 
phenotype that has a reduced ability to transduce chemotactic signals for 
a ligand that is found in abundance may lead to other loci taking priority 
over the flagellar switching mechanism. This in turn would lead to a 
greater chemotaxis towards less common ligands, and a modulated 
growth potential. 
 
Two amino acid residues underwent repeat variation in separate isolates. 
Residue 523 exhibited separate base substitutions in the first codon 
position, resulting in a non-conservative change from threonine to non-
polar residues alanine and proline. Similarly, at residue 550 the second 
codon position underwent an identical base change, resulting in a 
conservative substitution between polar residues leucine and proline. 
Repeat variation – particularly with the same amino acid substitution – 
in independent isolates suggests that this locus may be encountering 
(and adapting) to a specific selective pressure.  
 
The frequency of alleles at these common residues varies, with isolate 
D4-69 yielding a MAF of ~0.3, vs ~0.5 in isolate D2-69. This may be 
indicative a beneficial mutation sweeping to fixation, with sampling of 
the two isolates occurring at diﬀerent stages of the disease progression. 
The CAMP1460 locus appears to be highly variable in general - it was the 
most variable locus identified amongst WGS isolates submitted to the 
PubMLST Campylobacter database, with 71% of isolates containing a 
unique allele – this supports the notion that variation within this locus 
 127 
typically moves to fixation. Additional sampling of a single patient at 
multiple time points would aid in delineating whether this is the case, or 
whether perhaps these alleles would continue to exist at an intermediate 
frequency under the diverse community model of variation (Lieberman 
et al. 2013). Given that the frequency of several alleles detected within 
this locus are actually present in the majority of high-quality reads, the 
diversity observed in the PubMLST may be a consequence of the de novo 
assembly process, as discussed in regards to CAMP1031. 
 
In a mutagenesis study, knock out of the CcmL locus created a phenotype 
with altered cellular shape and reduced chemotactic ability. The CcmL 
mutant also displayed a greater aﬃnity for autoagglutination, and 
increased biofilm formation (Rahman et al. 2014). Campylobacter is 
pleomorphic, and is known to lose its helical shape in times of metabolic 
stress. This conformational change is also associated with an increase in 
biofilm formation (Ikeda & Karlyshev 2012, Walker et al. 1986). It’s 
possible that the variation observed within the ccmL locus had some role 
in shifting the conformational state of the bacteria. 
 
4.5.2. Membrane and Flagella 
Three loci were found to contain minor alleles with functions pertaining 
to the membrane or flagella: CAMP1178, CAMP0586 and CAMP1257. 
4.5.2.1. CAMP1178 
The CAMP1178 locus encodes the major outer membrane protein 
(MOMP), PorA, which regulates membrane permeability to small 
molecules (Cody et al. 2009). Porins are composed of several α-strands 
which form β -barrels. The bottom of these β-barrels exhibit short turns 
which face towards the periplasmic space, and at their top side express 
long loops that are external to the cell surface membrane (Stathopoulos 
1999).  
 
Variation was observed at amino acid residue 180. This residue 
underwent a non-conservative substitution of glycine with glutamic acid 
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as result of a G>A transition in the second codon position. Residue 180 is 
located within the putative surface exposed loop 7 (Cody et al. 2009, 
Zhang et al. 2000). Research shows that the porA locus undergoes 
variation during prolonged infection with Campylobacter jejuni (Cody et 
al. 2009). A single patient provided stool samples that were collected 16 
days apart, with NGS analysis revealing a fixed variation at residue 170. 
This residue also exhibited a G to A transition in the second codon 
position, causing glycine substitution with aspartic acid.  
 
Both the variable residues in this study, and the work from Cody et al. 
(2009), were located within the surface exposed loop 7, and in both 
instances variation induced a G>A transition at the second position of a 
glycine codon. Glycine is a hydrophobic aliphatic residue, and is 
demonstrated to be important in the packing of α-helices (Senes et al. 
2000). In both instances of variation, glycine was replaced with the 
negatively charged residues glutamate and aspartate, which may lead to 
conformational change to the loop structure. The immune response to 
Campylobacter spp. is largely reliant on the recognition of surface-
exposed conformational epitopes (Huang et al. 2007). The variation 
within the surface exposed loops may be a result of immune exposure, 
with conformational change potentially modulating immune recognition 
of Campylobacter cells.  
 
The polymorphic base in this study was detected at a frequency of 0.26 – 
in the prolonged infection a similar variant was found to sweep to 
fixation. This may suggest that sustained exposure to host-immunity 
exerts purifying selective pressure, driving antigenic variation within the 
loop 7 structure. It would be interesting to apply the deep sequencing 
methodology in a case of prolonged exposure, with samples collected at 
multiple points during the symptomatic phase of the disease. This would 
allow tracking of the frequency at which any variation occurs, and 
delineate variants undergoing positive and negative selection by 
revealing alleles that move from minor to major frequencies. 
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4.5.2.2. CAMP0586  
The CAMP0586 locus (also referred to as Cj0628), encodes an 
autotransporter protein known as CapA. In Gram-negative bacteria, 
autotransporter proteins are ubiquitous, and are responsible for several 
virulence mechanisms, including adhesion and toxigenicity (Henderson 
et al. 2004). CapA is a surface exposed lipoprotein, located on the outer 
cellular membrane (Ashgar et al. 2007). The CapA lipoprotein has been 
shown to mediate infection of human epithelial cells, with knock-out 
mutants expressing decreased adhesion in Caco-2 cell lines (Ashgar et al. 
2007). A similar result was observed in chicken colonization, with capA 
mutants exhibiting a 75% reduction in whole-flock positivity (Ashgar et 
al. 2007). 
 
Five instances of polymorphic alleles were detected in a single deep-
sequenced isolate. One of these variants at residue position 98 resulted in 
a synonymous substitution, with the remaining variants causing non-
synonymous mutations. The 98th residue yielded a second polymorphic 
base with a similar allele frequency to the first (0.47 and 0.46 
respectively). Considered individually, this would have led to a 
conservative substitution of polar residues threonine to asparagine. The 
intermediate minor allele frequency indicates that there may be two 
concurrent lineages in circulation, and as such it is also possible that 
both bases were polymorphic as part of a single haplotype. This would 
lead to the codon of residue 98 shifting from ACC to AAA, causing a non-
conservative substitution of threonine to lysine. This, along with the 
non-conservative substitution of lysine with glutamate at residue 100 
may have produced a conformational change. 
 
This locus is the second surface-exposed membrane protein exhibiting 
variation, which as discussed regarding porA, may be a result of exposure 
to host immunity. PorA has been shown to contain multiple putative 
epitopes based on protein sequence analysis (Ingale & Goto 2013), which 
suggests this protein is of antigenic importance. The variation within this 
locus may again be an example of epitope polymorphism. 
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4.5.2.3. CAMP1257 
CAMP1257 – also referred to as Cj1341c – encodes an unknown protein 
referred to as motility accessory factor 6 (maf6). Maf6 is part of the maf 
gene family, and is located adjacent to the flaA flagellin gene. Other maf 
family members modulate flagellin variation via glycosylation, or slip 
strand mispairing as a result of repeat homopolymeric tracts, however 
the function of maf6 has not been elucidated (Wassenaar et al. 1995, 
Szymanski et al. 2003). 
 
This locus exhibited variation across two isolates, with a single residue 
(251) undergoing repeat variation in both. All variants were in a 150bp 
region of CDS (covering amino acid residues 223 to 274), though no 
conserved domains were identified via Pfam alignment. The variation 
present in this locus, and the paucity of data on its function makes it an 
interesting target for future study. 
 
4.5.3. Homopolymeric Tracts 
Campylobacter spp., as well as other organisms such as Neisseria, are 
shown to mediate the expression of phase variable genes via the 
alteration of repetitive DNA sequences (J. Parkhill et al. 2000). These 
tranches of repeat bases are referred to as homopolymeric tracts, and 
induce slip strand mispairing during DNA replication, which ultimately 
leads to a shift in reading frame and diﬀerential expression of the 
aﬀected gene (Henderson et al. 1999). The 11168 Campylobacter genome 
for example, contains 28 phase variable genes that are mediated by a 
range of poly-G tract lengths (Lango-Scholey et al. 2016). 
 
The deep sequencing dataset revealed four isolates exhibiting minor 
allele variation within a single homopolymeric tract, that mediates 
expression of the CAMP1239 (Cj1321) locus. This tract is one of three 
intergenic poly-G tracts that have been identified as mediating the 
expression of phase-variable genes within Campylobacter spp. (Aidley & 
Bayliss 2014).  
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The Cj1321 homopolymeric tract confers ‘on’ expression when the G-tract 
length covers 10 base-pairs. In all four instances, a minor allele variant of 
the poly-G tract identified a G-10 to G-13, on-to-oﬀ alteration. This 
change in expression was conferred via a C > G substitution of the same 
base pair in positional relation to the G-10 tract.  
 
The Cj1321 locus encodes an acetyltransferase which is located within the 
O-linked flagellar glycosylation locus, and has been shown to modulate 
the flagellin protein via pseudaminic acid modification (Champion 2005, 
Kim et al. 2012). The diﬀerential expression of the Cj1321 locus conferred 
by the minor allele may be related to biofilm formation. In mutagenesis 
studies, knock out of the O-linked flagellar glycosylation locus resulted in 
decreased biofilm formation and chick colonisation, however it did not 
aﬀect motility (Howard et al. 2009).  
 
Homopolymeric tracts are found to be hypervariable, and are often 
identified as undergoing variation in a variety of sources (J Parkhill et al. 
2000, Bayliss et al. 2012, Revez et al. 2013, Cody et al. 2013, Cody et al. 
2009). It is perhaps strange that only a single tract was found to undergo 
variation, but this may be explained by limitations of the deep-
sequencing methodology. Whilst still above the Q30 quality threshold 
(i.e. 99.99% accuracy), the mapping quality of the Cj1321 tract variants 
was lower than variants discovered in other loci. This is likely as a result 
of decreased statistical confidence in stretches of single base repeat 
sequence. Additional instances of minor allele variation may have 
occurred within other poly-N tracts, but did not present with suﬃcient 
quality to be detected by the deep-sequence pipeline.  
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4.5.4. Future work 
This study provides novel insights into the intra-population diversity of 
clinical Campylobacter infection. However, the study only includes a 
single CC – ST-21. As the most commonly represented lineage in human 
infection, it is unclear as to whether these isolates would undergo less 
variation – as they may already have a level of adaptation to human 
passage – or whether they are successful due to their ability to generate 
variation. To investigate this, expanding the dataset to include other 
sequence types that are less common would provide a more 
comprehensive overview of Campylobacter diversity. 
 
Additionally, this study does not investigate whether the observed 
diversity is present amongst the population before clinical infection. For 
example, the degree of variation reported may be sustained from the 
chicken host through to consumption and propagation of human 
disease. Applying the deep sequencing methodology to an infectious 
population before and after human passage would aid in delineating the 
origin of diversity. 
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5. Chapter Five: Genetic heterogeneity of 
Campylobacter spp. 
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5.1. Abstract 
In the previous chapter, clinical isolates from the dominant clonal 
lineage of C. jejuni (ST-21) were demonstrated to exhibit intra-population 
diversity at a number of key loci. This presented questions as to whether 
diversity could also be detected in other CC’s, or whether it was specific 
to - and perhaps responsible for the abundance of - ST-21. It was also 
unclear as to whether the diversity observed was generated during the 
course of human disease, or perhaps maintained from a genetically 
diverse infectious population. 
 
To address these issues, this chapter expands on the ST-21 dataset by 
sequencing clinical isolates from a further five CC’s, including the C. coli 
lineage, ST-828. Additionally, we provide an insight into the diversity of 
Campylobacter populations prior to human infection, by sequencing 
populations obtained from the largest single source of human 
campylobacteriosis: fresh retail chicken. 
 
Sequencing of the additional CC’s revealed several loci undergoing minor 
allele variation that are exclusive to non ST-21 lineages. The major 
functional group of variable loci in both ST-21 and non ST-21 lineages was 
comprised of chemotaxis genes. Furthermore, two chemotaxis loci 
encoding transducer like proteins (Tlp) 3 and 8 yielded minor allele 
variation in both ST-21 and non ST-21 complexes. Tlp3 in particular 
contained minor allele variants in ST-21, ST-48, and ST-828 isolates, 
making it the only locus to be repeatedly identified in both multiple 
lineages and in multiple species. The overall dominance of the 
chemotaxis loci amongst the clinical datasets suggests that they are 
coming under strong selective pressure within the gastrointestinal 
environment, and as shown in Tlp3, may exhibit variation that is 
exclusive to the human host.  
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In contrast to the clinical datasets, the poultry isolates did not contain 
any variation within chemotaxis loci. Less variation was detected overall, 
and loci that were found to contain variation were linked to membrane 
and flagellar functions. This likely reflects the harsh ecological niche of 
retail poultry meat, and may be a result of significant selective 
bottlenecks during the slaughter and retail environments.  
 
These results suggest that poultry related campylobacteriosis likely 
occurs via relatively homogenous populations, and that the diversity 
observed amongst clinical isolates may in fact be generated during or in 
response to human infection. Additional sequencing of non-clinical 
Campylobacter spp. would be an important direction for future work to 
determine the validity of this hypothesis. 
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5.2. Introduction 
Clinical cases of campylobacteriosis are largely dominated by the ST-21 
complex of C. jejuni ( Cody et al. 2012; Kovanen et al. 2014; Schielke et al. 
2014; Sheppard et al. 2009). In Chapter 3, we found that this was also true 
of isolates obtained from the greater Nottinghamshire area, with ST-21 
forming the largest constituent complex.  
 
In Chapter 4, we demonstrated that clinical ST-21 isolates were 
composed of genotypically diverse populations. This represents the first 
description of intra-population diversity amongst routine clinical 
isolates, and identified a number of loci relating to chemotaxis, 
membrane and flagellar proteins that were found to contain minor allele 
variation. Due to the novelty of this finding, there is no comparable data 
from isolates belonging to other CC’s, and as such it is unclear as to 
whether the observed diversity is unique to ST-21 isolates.  
 
Additionally, there is no comparable data for Campylobacter coli isolates. 
Campylobacter coli is responsible for approximately 7-12% of all clinical 
campylobacteriosis (Chen et al. 2011, Gillespie et al. 2002, Olson et al. 
2008), which represents a significant number of illnesses. The C. coli CC 
ST-828 was found to be the second most common amongst the clinical 
dataset presented in Chapter 3, and is found in similar abundance in 
other epidemiological datasets (Cody et al. 2012). 
 
In order to address these issues, we sought to apply the deep sequencing 
methodology to additional isolates from non ST-21 clonal lineages. 
Samples were selected from the genetic epidemiology work presented in 
Chapter 3, with representative isolates from several CC’s found to occur 
in more than 5% of the dataset. This included several isolates belonging 
to the C. coli  ST-828 complex.  
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5.2.1. Campylobacteriosis and Poultry 
Poultry meat is the greatest single source of campylobacteriosis, largely 
arising from the high prevalence of retail packages found to be 
contaminated with Campylobacter spp., and the significant volumes of 
meat consumed by the British public (Wilson et al. 2008, Corry & Atabay 
2001, Key Note 2015). Chicken meat accounts for approximately 70-80% 
of poultry production, and the chicken reservoir alone is thought to 
account for between 50-80% of human Campylobacter spp. infections 
(Skarp et al. 2016).  
 
Poultry manufacturers go to extensive lengths to try and reduce the level 
of Campylobacter spp. contamination present on the final retail product. 
At the farm level, several biosecurity measures (e.g. coop 
decontamination, worker hygiene) are employed with varying degrees of 
eﬃcacy (Newell et al. 2011, Gibbens et al. 2001). However, despite these 
eﬀorts Campylobacter spp. is found to routinely colonise approximately 
75-90% of British commercial flocks (Humphrey et al. 1993, Evans & 
Sayers 2000, Stern et al. 2001). This contamination persists during the 
slaughtering process, which ultimately results in approximately 71% of 
retail chicken found to be colonised with Campylobacter spp. (Food 
Standards Agency 2016). 
 
In the previous chapter, clinical isolates of the dominant clonal lineage - 
ST-21 - exhibited several instances of intra-population diversity, which 
provided the first evidence of genetic heterogeneity amongst routine 
clinical cases. However, it is not clear as to whether this heterogeneity is 
generated during the course of human infection, or simply maintained 
from a genetically variable antecedent population. In order to address 
this, the deep sequencing methodology would need to be applied to the 
original aetiological isolate prior to human infection, to allow an 
appropriate comparison. However, given the sporadic nature of clinical 
campylobacteriosis, source attribution and therefore source sampling 
presents a significant challenge.  
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In the absence of a suitable ancestral isolate, we sought to apply the deep 
sequencing methodology to Campylobacter populations that would 
typically be encountered by the public, and logically may lead to 
infection. Given that poultry – and specifically chicken meat - is the 
largest single source of human campylobacteriosis, we collected 
Campylobacter spp. isolates from samples of fresh retail chicken to 
provide a comparison between a potentially pre-infectious source, and 
the post-infectious clinical datasets.  
5.3. Methods 
5.3.1. Poultry 
Additional isolates were obtained from fresh retail poultry purchased 
from large-chain retailers. As chicken is widely available and the most 
common poultry meat consumed in the UK, samples were restricted to 
chicken only. Retail chicken sold in the United Kingdom is labelled with 
a mandatory ‘approved premises’ identifier code, which provides 
information on the supplier of the poultry meat. In order to ensure that 
no single batch of poultry meat (and potentially the same microbial 
population) was repeatedly sampled, this code along with the expiry date 
were used to exclude packages that may have originated from a single 
batch. A variety of chicken parts were sampled, including breast, thigh 
and leg meat both with skin intact and removed. All meat was 
transported to the laboratory in under 30 minutes, and stored at 4°C for 
future use.  
 
The chicken meat was weighed, placed inside a sterile stomacher bag, 
and submerged in maximum recovery diluent (Oxoid, United Kingdom, 
CM0733) at a ratio of 1ml:1g. The surface of the meat was manually 
massaged through the stomacher bag for two minutes to increase the 
amount of bacteria shed from the meat surface. The diluent was then 
decanted into sterilised conical flasks, and placed on a shaking platform 
at 100RPM for 1 minute. This stock solution was diluted in serial from 10-1 
to 10-5 using fresh maximum recovery diluent.  
 139 
 
These dilutions were then plated in replicate on to Campylobacter Blood-
Free Selective Agar Base (Oxoid, United Kingdom, CM0739), 
supplemented with 16mg/500ml of Cefoperazone and 5mg/500ml of 
Amphotericin B (Oxoid, United Kingdom, SR0115). These agar plates 
were prepared according to the methodology previously described in 
Chapter 2. Isolates were incubated at 37°C for 48 hours in a microaerobic 
workstation (Don Whitley Scientific, United Kingdom, DG250). 
Campylobacter colonies were selected for deep sequencing analysis 
based on colony morphology and oxidase status. 
	
5.3.2. Clinical Isolates 
Human clinical isolates belonging to non ST-21 CC’s – including four 
isolates from the C. coli complex ST-828 - were selected randomly from 
the genomic dataset produced in Chapter 3. These isolates were then 
prepared for subsequent deep sequence analysis.  
 
5.3.3. Deep Sequencing 
As a brief reminder, the deep sequencing methodology expands on 
conventional WGS analyses (e.g. wgMLST, SNP-calling) by greatly 
increasing the sequencing coverage depth (i.e. number of times a kmer is 
sequenced). This additional coverage confers a greater resolution of 
minor frequency variants that are contained within genetically 
heterogeneous sample populations. The deep sequencing methodology, 
as well as details concerning isolate culture, DNA extraction, WGS, and 
bioinformatics analyses are discussed in greater depth in Chapters 2, 3 
and 4. 
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5.4. Results 
5.4.1. Non ST-21 Isolates 
5.4.1.1. Isolates, sequencing and assembly. 
A total of 11 non ST-21 isolates were sequenced to suﬃcient quality and 
coverage, with an average depth of 241X. All isolates were found to be 
obtained from separate patients by age, sex (Table 5.1) and post code 
(data not shown). 
Table 5.1 Patient demographics of samples belonging to the non ST-21 deep 
sequencing dataset 
Isolate CC Collection Month Patient Sex Patient Age 
Coverage 
Depth 
D1-29	 48	 January	 F	 25	 281	
D1-35	 464	 January	 F	 67	 120	
D3-40	 48	 April	 M	 9	 281	
D4-57	 45	 June	 F	 78	 177	
D6-33	 353	 August	 M	 24	 225	
D7-17	 828	 August	 M	 43	 305	
D7-24	 828	 August	 M	 33	 388	
D7-31	 828	 September	 M	 55	 182	
D7-40	 828	 September	 F	 22	 197	
D8-67	 353	 October	 F	 63	 284	
D9-60	 48	 November	 M	 84	 215	
Samples were screened to determine whether isolates were obtained from separate 
patients. In instances where this was not clear by the provided demographics, geographic 
data was used for exclusion (data not shown). 
 
The non ST-21 deep sequencing dataset had an average N50 of 309,984bp 
(95% C.I: 242,311bp to 377,657bp), a mean total length of 1,816,875bp (95% 
C.I: 1,691,046bp to 1,942,705bp) and a mean number of contigs of 177.2 
(95% C.I: 5.872 to 348.5). Figure 5.1 shows the distribution of these quality 
metrics. 
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Linear regression was used to assess whether the sequencing coverage 
depth, assembly N50 or number of contigs had an impact on the number 
of loci in which minor allele variation was detected (Figure 5.2). These 
analyses revealed no statistical significance (P = 0.6993, 0.9923 and 
0.2322 respectively). 
Figure 5.2 - The statistical impact of sequencing and assembly metrics on the 
number of loci in which minor allele variation was detected 
*Statistical significance calculated using a linear regression analysis, in all instances results 
were statistically insignificant (Coverage: P = 0.6933, N50: P = 0.9923, No. Contigs: P = 
0.2322) 
Figure 5.1 - Quality metrics of draft de novo assemblies of non ST-21 isolates 
Mean inclusive of upper and lower confidence intervals highlighted in orange. 
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5.4.1.2. Minor allele variation 
The non ST-21 deep sequencing dataset contained 20 minor allele 
variants with suﬃcient depth and quality to qualify further analysis. Of 
the 11 isolates sequenced, 36% (N=4) did not yield any minor allele 
variants that passed the quality filtering process  
 
18 of the 20 variants were contained within identified loci. The loci in 
which minor allele variation was detected are detailed below in Table 5.2.
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Table 5.2 - Genes in which minor allele variation was detected within non ST-21 dataset, grouped according to putative function 
Isolate Locus 
Functional 
Residue 
Codon Amino Acid Mapping 
Quality* 
Coverage 
Depth MAF
† 
Group Ref  Alt Ref  Alt 
D1-29 CAMP0252 Chemotaxis 34 GGC → AGC Glycine → Serine 66 859 0.17 
D7-40 CAMP0252 Chemotaxis 292 ATG → GTG Methionine → Valine 112 386 0.22 
D1-29 CAMP0410 Chemotaxis 172 GCC → ACC Alanine → Threonine 35 537 0.18 
D1-29 CAMP1031 Chemotaxis 358 GCT → ACT Alanine → Threonine 90 484 0.2 
D3-40 CAMP1460 Chemotaxis 475 AAC → AAT Asparagine → Asparagine 225 416 0.39 
D7-17 CAMP1460 Chemotaxis 482 TCT → TCA Serine → Serine 113 2891 0.27 
D7-17 CAMP1460 Chemotaxis 502 ACC → ACT Threonine → Threonine 208 3241 0.27 
D7-17 CAMP1460 Chemotaxis 534 AAA → AAG Lysine → Lysine 91 3282 0.26 
D7-17 CAMP1460 Chemotaxis 606 AGT → TGT Serine → Cysteine 225 2781 0.48 
D7-17 CAMP1460 Chemotaxis 606 AGT → ACT Serine → Threonine 225 2794 0.48 
D7-17 CAMP1460 Chemotaxis 609 GAA → GAG Glutamic acid → Glutamic acid 225 2548 0.48 
D7-31 CAMP0049 Membrane 18 AGC → AGT Serine → Serine 225 159 0.64 
D7-31 CAMP0049 Membrane 20 GAA → GAG Glutamic acid → Glutamic acid 225 171 0.66 
D3-40 CAMP0922 Membrane 35 GTT → ATT Valine → Isoleucine 129 139 0.2 
D8-67 CAMP1055 Membrane 121 ACA → ACC Threonine → Threonine 225 293 0.5 
D1-29 CAMP0303 Flagellar 190 GTT → GCT Valine → Alanine 177 753 0.29 
D1-35 CAMP1213 Flagellar 279 CTA → CTG Leucine → Leucine 99 110 0.28 
D1-35 CAMP1213 Flagellar 281 GAT → GGT Aspartic acid → Glycine 108 114 0.3 
* - PHRED-quality scores.    † - Minor allele frequency, i.e. proportion of reads supporting the alternative allele.    Colours represent clonal complex. 
Legend: ST-48 ST-828 ST-353 ST-464. 
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5.4.1.2.1. Chemotaxis Loci 
Three isolates yielded variation within four diﬀerent chemotaxis related 
genes: CAMP0252, CAMP0410, CAMP1031 and CAMP1460. The two latter 
loci were previously found to undergo variation in the previous deep 
sequencing dataset (Section 4.4), which applied the same methodology 
to the most common clinically observed CC, ST-21.  
 
Two separate isolates yielded minor allele variation within the 
CAMP0252 locus (Table 5.2). This locus – also referred to as Cj0283c – 
encodes the scaﬀold protein, CheW. Isolate D1-29 varied at amino acid 
residue 34, which is contained with the Hpt domain. Isolate D7-40 was 
found to be variable at residue 292, which is located with the signal 
transducing histidine kinase domain (Figure 5.3). 
 
Figure 5.3 - Topology of the CAMP0252/Cj0284c locus 
Residue numbers provided below domains show regions of Pfam alignment. Residue 34 and 
292 yielded variation at the first base position, shown in Table 5.2. 
Hpt= Histidine Kinase Phosphotransfer 
HK = Histidine Kinase 
ATP = Adenosine Triphosphate 
 
CAMP0410 – also referred to as Cj0448c - encodes the group C transducer 
like protein Tlp6 (Marchant, Wren, & Ketley, 2002). Tlp6 is one of the less 
well characterised chemotaxis proteins, however in general it is believed 
that group C Tlps are responsible for detecting cytoplasmic signals 
(Lertsethtakarn, Ottemann, & Hendrixson, 2011; Zautner, Malik Tareen, 
Groß, & Lugert, 2012).  
 
 145 
A single isolate (D1-29) was found to contain a minor allele variant at 
amino acid residue 172. Protein sequence alignment to the Pfam database 
revealed that this variant was contained within a conserved methyl 
accepting signalling domain. 
 
Figure 5.4 - Topology of the CAMP0410/Cj0448c locus 
Residue numbers provided below domains show regions of Pfam alignment. Residue 172 
yielded variation at the base position, shown in Table 5.2. 
 
CAMP1031 – or Cj1110c – encodes Tlp8 (CetZ). Residue number 358 
contained a minor frequency variant in the first codon position, causing 
a non-synonymous mutation from alanine to threonine. This residue is 
located within the methyl-accepting signalling domain of the protein. 
This locus was also observed to undergo variation at residue 343 in ST-21 
isolate D5-69, represented by the blue demarcation in Figure 5.5. 
 
 
Figure 5.5 - Topology of Tlp8 (CetZ) encoded by the CAMP1031/Cj1110c locus 
with SNP data from ST-21 and Non ST-21 isolates. 
Residue numbers provided below domains show regions of Pfam alignment. Residue 358 
yielded variation at its first base position, shown in Table 5.2.This locus also contained a 
minor allele variation in Chapter 4’s ST-21 dataset, with the variant residue shown in blue. 
Per-ARNT-Sim (PAS). 
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Two non ST-21 isolates yielded minor allele variants within the 
CAMP1460 locus. CAMP1460 – also referred to as Cj1564 or ccmL – 
encodes transducer like protein 3 (Tlp3). All minor allele variants were 
contained within methyl-accepting signalling domain, as shown in 
Figure 5.6. Two variants occurred at the same amino acid residue (606), 
and at the same minor allele frequency (0.48) in isolate D7-17.  
 
* - Residue 606 identified as variable at the first two codon positions. 
TM1 and 2 = transmembrane helixes.  
HAMP1 and 2 = histidine kinases, adenylyl cyclases, MCPs and phosphatases. 
Residue positions provided in bold italicised font adjacent to red lines correspond to minor 
allele variations detected and listed in Table 5.2. 
Residues highlighted in blue provide approximate locations of variable residues identified in 
Chapter 4’s ST-21 dataset.  
Topology adapted from Liu et al., 2015 and Pfam alignment (Finn et al. 2016).  
 
 	
Figure 5.6 - Topology of Transducer-like protein 3 (CcmL) 
highlighted with positions of variable residues as provided in Table 
5.2 
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5.4.1.2.2. Membrane Loci 
 
Three isolates were found to contain minor allele variation within loci 
that have gene products related to the cellular membrane. 
 
CAMP0049 (Cj0057) encodes a putative periplasmic protein. Isolate D7-
31 contained two minor allele variants within this locus at positions 18 
and 20 (Table 5.2). Protein alignment to the Pfam database did not 
identify any conserved domains.  
 
CAMP0922 – also referred to as Cj0999c – encodes a putative integral 
membrane protein. Protein alignment revealed a single conserved 
domain – 698 – in which a minor allele variant was discovered (Figure 
5.7). This domain has no resolved function, however it belongs to a group 
of proteins involved in transport (CL0064). CAMP0922 has yet to be 
characterised, and no studies have been performed on the locus to date 
 
 
Figure 5.7 - Topology of the CAMP0922/Cj0999c locus encoding a putative 
integral membrane protein 
Residue numbers provided below domains show regions of Pfam alignment. Residue 35 
yielded variation at first base position (Table 5.2) contained within a conserved domain 
linked to membrane transport. 
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CAMP1055 – also referred to as Cj1134 or htrB - encodes a putative 
acyltransferase involved in lipid A biosynthesis. This locus contained a 
single synonymous mutation at the 121st amino acid residue, which is 
located within the conserved Acyltransferase domain that spans the 
majority of the CDS (Figure 5.8). 
Figure 5.8 – Topology of the CAMP1055/Cj1134 locus, encoding HtrB - an 
acyltransferase involved in lipid A biosynthesis 
Residue numbers provided below domains show regions of Pfam alignment. Residue 121 
contained a minor allele variant at the third codon position (Table 5.2). 
 
5.4.1.2.3. Flagellar Loci 
Two isolates were found to contain minor allele variation within loci 
associated with flagella. These isolates: D1-29 and D1-35, belong to CC’s 
ST-48 and ST-464 respectively. 
 
CAMP0303 (Cj0337c) encodes MotA – a putative flagellar motor proton 
channel protein. Isolate D1-29 - belonging to CC ST-48 – contained a 
single minor allele variant at residue number 190. This variant is located 
within a MotA proton channel protein identified by Pfam protein 
sequence alignment (Figure 5.9). The arrangement of the MotA protein in 
the greater flagellar motor stator ring complex is displayed in Figure 5.10  
Figure 5.9 - Topology of the CAMP0303/Cj0337c locus encoding the flagellar 
motor proton channel protein, MotA 
Residue numbers provided below domains show regions of Pfam alignment. Residue 190 
yielded variation at the second codon position (Table 5.2).  
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CAMP1213 (Cj1295) encodes an aminopeptidase that is linked to flagellar 
glycosylation. Two minor allele variants were detected at residues 279 
and 281, which were mapped to a domain of unknown function with 
putative peptidase activity (Figure 5.11). The domain of unknown 
function (DUF4910) showed homology to a putative peptidase identified 
in Clostridium acetobutylicum. 
 
Figure 5.11 - Topology of the CAMP1213/Cj1295 locus 
Residue numbers provided below domains show regions of Pfam alignment. Residue 279 
and 281 yielded variation at the third and second base position respectively (Table 5.2). 
 	
Figure 5.10 –Topology and arrangement of C. jejuni’s flagellar motor 
apparatus 
Image adapted from figure 6 in Beeby et al., (2016).  
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5.4.1.3. Non ST-21 loci relative to NCTC11168 
In order to provide a common reference point, loci exhibiting minor 
allele variation were mapped against the reference assembly of C. jejuni 
strain NCTC11168. The positions of these loci relative to NCTC11168 are 
provided in Figure 5.12.  
Figure 5.12 - Circular chromosome of NCTC11168 with annotated CDS* and 
chromosomal positions of variable loci detected within the non ST-21 dataset 
CDS as defined in the updated re-annotation of the complete NCTC11168 genome 
sequence (Gundogdu et al. 2007). Highlighted CDS were found to contain minor allele 
variation at one or more amino acid residues.  
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5.4.2. Poultry Isolates 
5.4.2.1. Isolates, sequencing, and assembly 
Out of 12 sequenced isolates, a total of 5 poultry sequences with suﬃcient 
quality, purity and depth were produced to an average depth of 164X. 
These isolates belonged to 3 CC’s: ST-257, ST-464 and ST-828 (Table 5.3).  
Table 5.3 - Sequencing coverage depth and clonal complex of the five isolates 
belonging to the poultry deep sequencing dataset 
Isolate Coverage Depth Clonal Complex 
DC1 281 257 
DC2 120 257 
DC3 281 464 
DC5 177 828 
DC7 225 828 
 
The poultry deep sequencing dataset had an average N50 of 298,027bp 
(95% C.I: 197,953bp to 398,100bp), a mean number of contigs of 30 (95% 
C.I: 7.98 to 52.02), and a mean total length of 1,711,249bp (95% C.I: 
1,612,504bp to 1,809,994bp). Figure 5.13 shows the distribution of these 
quality metrics. 
Figure 5.13 - Quality metrics of draft de novo assemblies, with mean inclusive 
of upper and lower confidence intervals highlighted in orange 
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Linear regression was used to assess whether the sequencing coverage 
depth, assembly N50 or number of contigs had an impact on the number 
of loci in which minor allele variation was detected (Figure 5.14). These 
analyses revealed no statistical significance (P = 0.2784, 0.1993 and 
0.6737 respectively). 
Figure 5.14 - The statistical* impact of sequencing and assembly metrics on 
the number of loci in which minor allele variation was detected 
*Statistical significance calculated using a linear regression analysis, in all instances results 
were statistically insignificant (Coverage: P = 0.2784, N50: P = 0.1993, No. Contigs: P = 
0.6737). 
 
5.4.2.2. Minor allele variation 
 
The poultry deep sequencing dataset contained 10 minor allele variants 
with suﬃcient depth and quality to qualify further analysis. Of the 5 
isolates sequenced, 2 did not yield any minor allele variants that passed 
the quality filtering process. 
 
All variants were detected within identified loci. The loci in which minor 
allele variation was detected, as well as their relative position and eﬀect, 
were grouped according to the gene product function (Table 5.4).  
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Table 5.4 - Genes in which minor allele variation was detected within poultry isolates, grouped according to putative function 
Isolate Locus 
Functional 
Residue 
Codon Amino Acid Mapping 
Quality* 
Coverage 
Depth MAF
† 
Group Ref  Alt Ref  Alt 
DC4 CAMP1196 Membrane 26 TTT → TTC Phenylalanine → Phenylalanine 167 36 0.40 
DC1 CAMP1255 Flagellar 263 GTC → GTT Valine → Valine 221 133 0.49 
DC1 CAMP1255 Flagellar 271 AAC → AAT Asparagine → Asparagine 221 136 0.48 
DC7 CAMP1910 Hypothetical 100 CAC → AAC Histidine → Asparagine 106 193 0.31 
DC7 CAMP1910 Hypothetical 100 CAC → CAT Histidine → Histidine 98 216 0.30 
DC7 CAMP1910 Hypothetical 164 GAG → AAG Glutamic acid → Lysine 186 378 0.26 
DC7 CAMP1910 Hypothetical 164 GAG → GAA Glutamic acid → Glutamic acid 174 376 0.25 
DC7 CAMP1910 Hypothetical 171 AGC → AGT Serine → Serine 224 344 0.27 
DC7 CAMP1910 Hypothetical 179 GAA → GAG Glutamic acid → Glutamic acid 224 344 0.17 
DC7 CAMP1910 Hypothetical 180 GCT → CCT Alanine → Proline 78 260 0.17 
* - PHRED-quality scores 
† - Minor allele frequency, i.e. proportion of reads supporting the alternative allele. 
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5.4.2.2.1. Membrane 
A single isolate contained a minor allele variant within the putative 
membrane locus CAMP1196. CAMP1196 – also referred to as Cj1277c – 
encodes a putative ABC transporter protein. This locus has not been 
characterised, and as such its exact function is unknown. Generally, ABC 
transporters are a family of membrane bound proteins, and in bacteria 
are involved in the active transport of molecules across the membrane 
surface (Garmory & Titball 2004). 
 
Protein sequence alignment to the Pfam database revealed a single 
conserved ATP binding domain (Figure 5.15), in which a synonymous 
mutation was discovered at residue number 26. 
Figure 5.15 - Topology of the CAMP1196/Cj1277c locus 
Residue numbers provided below domains show regions of Pfam alignment. Residue 26 
yielded variation at its third base position, shown in Table 5.4. 
 
5.4.2.2.2. Flagellar 
A single isolate was found to contain two minor allele variations within 
the flagellar locus CAMP1255. This locus is commonly referred to as flaA, 
and encodes one of two flagellin subunits present in Campylobacter spp. 
(Power et al. 1994). FlaA is the predominant flagellin protein, and has 
been shown to be essential for cellular invasion (Wassenaar et al. 1991).  
 
This locus was found to contain two synonymous variations occurring at 
intermediate frequency within a flagellar hook motif (Figure 5.16). 
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Figure 5.16 - Topology of the flaA flagellin locus 
Residue numbers provided below domains show Pfam identified alignments. 
Residue 263 and 271 yielded a minor allele variant at the third base position (Table 5.4).  
 
5.4.2.2.3. Hypothetical 
Isolate DC7 contained 7 minor allele variants within the CAMP1910 locus. 
This locus encodes a hypothetical protein exclusively found in C. coli, 
and contains no conserved domains or assigned putative function.  
 
The number of variants detected within this locus may be spuriously 
represented. Residue 100 was found to have two polymorphic bases in 
the first and third codon positions. Given their similar minor allele 
frequencies, these variants may in fact be representative of a single 
alternative codon, which in this instance would be asparagine (AAT). 
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5.4.2.3. Poultry loci relative to NCTC11168 
In order to provide a common reference point, loci exhibiting minor 
allele variation were mapped against the complete published assembly of 
C. jejuni strain NCTC11168 (J Parkhill et al. 2000).  
 
Where possible, the positions of these loci relative to NCTC11168 is 
provided in Figure 5.17. CAMP1910 is a putative protein only identified in 
C. coli and as such could not be mapped to the 11168 chromosome.  
 
 
Figure 5.17 - Circular chromosome of NCTC11168 with annotated CDS* and 
chromosomal positions of variable loci detected within the Poultry dataset 
CDS as annotated in the updated re-annotation of the complete NCTC11168 genome 
sequence (Gundogdu et al. 2007). *Highlighted CDS were found to contain minor allele 
variation at one or more amino acid residues.  
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5.4.3. Cumulative Statistics 
Due to the diﬀerent sizes of the three datasets (i.e. ST-21, Poultry and non 
ST-21), and the large variance between assembly metric distributions 
(Figure 5.18), the datasets were tested as a whole to ensure there was no 
statistically significant diﬀerence between them. The coverage, N50 and 
total number of contigs were considered along with the number of 
variable loci detected. Using linear regression, no statistical diﬀerence 
was detected (Figure 5.19). 
Figure 5.18 - Distribution of assembly metrics between the three deep 
sequencing datasets 
Non ST-21 (N=11), Poultry (N=5) and ST-21 (N=17). 
Point provides the mean, with whiskers displaying the 95% confidence interval.  
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Figure 5.19 - The statistical* impact of sequencing and assembly metrics on 
the number of loci in which minor allele variation was detected 
*-Statistical significance calculated using a linear regression analysis, in all instances results 
were statistically insignificant (Coverage: P = 0.3558, N50: P = 0.2114, No. Contigs: P = 
0.3105) 
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5.4.4. Comparison of Diversity 
 
To allow comparison between datasets, key indicators were calculated 
based on the average number of loci, variants, intergenic variants, and 
percentage of each data set that did not yield any variation Table 5.5. Due 
to the diﬀerences in the number of isolates constituting each data set, 
these values are provided as average number per isolate. 
 
 
Table 5.5 - Measures of the diversity observed in three deep sequencing 
datasets, normalised to account for the variance in sample size 
 Dataset 
 Non ST-21 ST-21 Poultry 
Variable Loci* 0.82 0.35 0.60 
Minor allele variants† 1.80 2.11 1.60 
Intergenic variants 0.18 0.24 0.00 
Grouped locus functions‡   
 Chemotaxis variants 1.00 0.71 0.00 
Membrane variants 0.36 0.35 0.20 
Flagellar variants 0.27 0.53 0.20 
Total 1.63 1.59 0.40 
Syn/Non-syn ratio§     
 Chemotaxis variants 0.45 0.15 0.00 
Membrane variants 0.75 0.17 1.00 
Flagellar variants 0.33 0.30 1.00 
Total 0.50 0.21 1.00 
No variation detected|| 36% 35% 40% 
* - Number of loci identified as containing variants on a per isolate basis (i.e. loci containing 
variants in multiple isolates amongst a dataset are counted multiple times). 
† - All variants, inclusive of intragenic and intergenic positions. 
‡ - Variants are grouped according to putative gene product function. 
§ - The ratio of variants observed to cause synonymous vs. non-synonymous changes to the 
amino acid residue, again grouped according to putative gene product function.  
|| - Percentage of the isolates amongst datasets that did not yield any minor allele variants. 
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5.4.5. All loci relative to NCTC11168 
In order to ease comparison between the Non ST-21 and poultry datasets 
presented within this chapter and Chapter 4’s ST-21 dataset, variable loci 
were mapped to the NCTC11168 reference genome (Figure 5.20) where 
possible. Two loci were found to contain minor allele variants in both the 
Non ST-21 and ST-21 datasets. Intergenic variants (including those 
contained within intergenic homopolymeric tracts) as well as the C. coli 
specific locus CAMP1910 are not shown. 
Figure 5.20 - Circular chromosome of NCTC111168 with approximate* 
locations of variable loci detected across all deep sequencing isolates 
*Some loci are shifted from their precise location to increase legibility.  
CDS as annotated in the updated re-annotation of the complete NCTC111168 genome 
sequence (Gundogdu et al. 2007). Highlighted CDS were found to contain minor allele 
variation at one or more amino acid residues. 
Loci highlighted in bold indicate a locus that was found to be variable in multiple datasets. 
	
 161 
 
Table 5.6 - Locus tag*, function and known aliases of loci containing minor 
allele variation across all deep sequencing datasets 
Locus  
Tag* 
Functional 
Group Locus Aliases 
Datasets† 
Non 
ST-21 ST-21 Poultry 
CAMP0049 Membrane cj0057    
CAMP0252 Chemotaxis cj0283c, cheW    
CAMP0303 Flagellar cj0337c, motA    
CAMP0410 Chemotaxis cj0448c, Tlp6    
CAMP0586 Membrane cj0628, capA    
CAMP0922 Membrane cj0999c    
CAMP1031 Chemotaxis cj1110c, cetZ    
CAMP1055 Membrane cj1134, htrB    
CAMP1109 Chemotaxis cj1190c, cetA    
CAMP1178 Membrane cj1259, porA    
CAMP1196 Membrane cj1277c    
CAMP1213 Flagellar cj1295    
CAMP1255 Flagellar cj1339c, flaA    
CAMP1257 Flagellar cj1341c, maf6    
CAMP1460 Chemotaxis cj1564, CcmL    
 * - As defined in the PubMLST C. jejuni and C. coli database (Jolley & Maiden 2010)  
† - Datasets found to contain variation within specified locus, as shown in Figure 5.20. 
 
The common reference tag of all loci identified as variable within the 
deep sequence data, as well as their common aliases and putative 
function are provided in Table 5.6. 
 
Figure 5.21 shows synonymous and non-synonymous variants detected 
across all of the deep sequence data within loci mapped to the 
NCTC11168 genome. This reveals a higher number of non-synonymous 
mutations in the ST-21 dataset across all three functional groupings of 
loci. The non ST-21 dataset yields a more diﬀuse pattern of diversity, with 
variants spread across several loci. 
 162 
Figure 5.21 – Loci containing synonymous and non-synonymous minor allele variants across all deep sequencing datasets. 
Line representing a linearised Campylobacter chromosome with genes displayed in their relative positions and coloured according to product function. Variants 
detected within the dataset are displayed as circles above the genes, with non-synonymous variants containing a filled centre and synonymous variants hollow. 
Variants are also colour coded to represent their constituent clonal complex. 
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5.5. Discussion 
The findings presented in this chapter show that intra-population 
diversity is not unique amongst the ST-21 clonal lineage. In fact, many  
C. jejuni complexes, and the C. coli complex ST-828 also contain variation 
within a single infectious population. Additionally, minor allele variation 
is present amongst populations isolated from fresh retail poultry, albeit 
in a reduced capacity.  
 
To aid in the navigation of this discussion, it is important to note the 
three datasets that are considered. Namely: the clinical ‘non ST-21’ and 
the fresh ‘poultry’ datasets presented within this chapter, and - as the 
results are inherently linked - the results from the clinical ‘ST-21’ dataset 
presented in Chapter 4. 
5.5.1. Non ST-21 Isolates 
This dataset expands on the work presented in the previous chapter by 
including a variety of additional clonal lineages. The sampled isolates 
represent a further five CC’s from clinical infections: ST-828, ST-48,  
ST-353, ST-464 and ST-45. These complexes were among the most 
abundant lineages identified in Chapter 3’s genetic epidemiology 
dataset, and represent examples of lineages that are successful human 
pathogens. 
5.5.1.1. Chemotaxis Genes 
In both this dataset, and Chapter 4’s ST-21 dataset, chemotaxis genes are 
the most common functional grouping of loci that are found to undergo 
minor allele variation. The one commonality that both sets of isolates 
share is that they are of clinical origin, and as such represent populations 
that were successful in propagating a human infection. Furthermore, 
these isolates originate from cases that occur with a severity that is 
suﬃcient to warrant medical intervention. In the United Kingdom, it is 
estimated that 1 in 9.3 cases of campylobacteriosis go unreported (Tam et 
al. 2012), and as such the constituent clinical cases represent isolates that 
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generate a greater level of pathogenicity compared to the wider 
Campylobacter spp. population as a whole. The repeated variation within 
genes pertaining to chemotaxis functions would suggest that these loci 
are coming under strong selective pressure within the context of the 
human gut environment.  
 
The intragenic location of the detected minor allele variants was resolved 
using amino acid sequence alignment to the Pfam protein database (Finn 
et al. 2016). This revealed that in several of the identified chemotaxis loci 
(i.e. CAMP0410, CAMP1031, CAMP1460) minor allele variation was 
located within a methyl-accepting (MA) signalling domain. This domain 
is conserved across all of Campylobacter’s ligand sensing transducer like 
proteins (Tlps) and is responsible for signal transduction as part of the 
greater chemotaxis response (discussed in greater detail in Chapter 1). 
Briefly, the MA-signalling domain acts as a binding site for the 
scaﬀolding protein CheW, which forms a quaternary structure with 
histidine kinase CheA. This ultimately leads to phosphorylation of CheY, 
which mediates directional switching of the flagellar motor apparatus 
(Korolik et al. 2008, Zautner et al. 2012).  
 
Variation was also discovered within the CheW scaﬀolding protein itself 
(CAMP0252). The diversity present in the cheW locus may represent a 
diﬀerent mechanism that is achieving the same end result as variation in 
the MA-signalling domain of transducer like proteins (i.e. altered 
sensitivity to flagellar motor switching in response to specific ligands). 
By altering the binding aﬃnity of the MA-signalling domains (e.g. 
causing a conformational change to the CheW receptor site), or indeed by 
altering the scaﬀolding proteins themselves, the response to a given Tlp 
and its ligands may be modulated. This could for example occur in 
response to the colonisation of a novel host, where the abundancy and 
distribution of ligands may be diﬀerent to that of the originating host 
species. 
 
One isolate (D1-29) expressed variation at both the cheW locus, and in the 
MA-signalling domain of Tlp8 (CAMP1031) and Tlp6 (CAMP0410), which 
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reinforces the proposition that chemotaxis loci – and specifically the 
signal transduction pathway - are coming under strong selective 
pressures within the human host. This particular isolate belongs to the 
ST-48 lineage, which is strongly associated with beef (Rotariu et al. 2009, 
Kärenlampi et al. 2007). ST-48 is also the 5th most common CC identified 
in genetic epidemiology studies of UK Campylobacter populations (Cody 
et al., 2012), and the fifth most abundant lineage amongst isolates 
submitted to the PubMLST C. jejuni and C. coli database (4.94% of total). 
The lineage’s abundance in beef, and relative success as a human 
pathogen may in part be due to its ability to adapt to multiple host 
environments, with the identified variation potentially acting as a 
driving mechanism by which novel host colonisation occurs. 
 
In addition to the commonality of the functional group as a whole, two of 
the chemotaxis loci – CAMP1031 and CAMP1460 - were also found to 
contain variation within the previous chapter’s dataset. These loci 
encode transducer like proteins (Tlps) belonging to groups C and A 
respectively. The former group represents genes that are relatively 
uncharacterised, and as such, in depth discussion is limited. In contrast, 
the CAMP1460 locus has undergone extensive study. The CAMP1460 
locus encodes Tlp3 , which has been shown to interact with several 
chemo-attractants simultaneously, providing its alternative alias, CcmL, 
or Campylobacter chemoreceptor for multiple ligands (Marchant et al. 
2002, Rahman et al. 2014).  
 
Analysis of the BigsDB database for C. jejuni and C. coli isolates reveals 
683 unique CAMP1460 alleles. Of these alleles, only 247 have associated 
sequence data. The remaining alleles with no sequence data may be a 
result of automatic processing of submissions before manual curation 
and subsequent exclusion. The 247 alleles are distributed across 361 
isolate sequences. The majority of these alleles are unique, with 76.5% 
(n=189) of alleles only observed in a single isolate. In comparison, 45% of 
alleles constituting the housekeeping locus pgm are unique, with a much 
larger sample size (10,688 isolate sequences). This would suggest that the 
CAMP1460 locus is inherently highly variable. When considering the 
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main sources of isolates containing a confirmed allele for the CAMP1460 
locus, 60.94% are of human origin (N=220), which further supports the 
hypothesis that this locus – and other similar chemotaxis loci – undergo 
selection in the human gut.  
 
The CAMP1460 locus has also been shown to be variable in other 
genomic studies. Results from passaging C. jejuni isolate 11168 in mice 
yielded variation in the CAMP1460 locus at codon 59 (Jerome et al. 2011). 
This was not investigated, as the frequency occurred at <5% (4.9%), 
however it does support the observation that this locus undergoes 
variation during the host infection process. The variable codon was not 
in the same domain as variants identified in the ST-21 and non ST-21 
datasets, and instead is located within the extracellular ligand binding 
domain. This could reflect a diﬀerence in host adaptation to mice rather 
than humans. This poses the question as to whether the variation 
observed within the MA-signalling domain of CAMP1460 (and other 
Tlps) is not only a product of human infection and its relative selective 
pressures, but perhaps specific to the human host entirely. 
 
Evidence for the validity of this is provided in the analysis of an 
accidental infection of a laboratory worker, with the same C. jejuni 
reference isolate 11168 (Thomas et al. 2014). This study again revealed 
variation within the CAMP1460 locus following human passage, with a 
single polymorphic base conferring an amino acid substitution at residue 
511. In this instance, the variable residue is located within the methyl-
accepting signalling domain and exists in close proximity to the minor 
allele variants detected in the clinical deep sequencing datasets. The 
researchers in this study went on to passage the strain isolated from the 
laboratory worker in interleukin-10 deficient mice, which resulted in a 
reversion of the observed polymorphism. The researchers conclude that 
the variation at residue 511 may be specific to the human host, which has 
important implications for the highly similar variations detected within 
the clinical datasets. It would be interesting to passage the clinical 
isolates exhibiting variation within chemotaxis loci in mice to see if these 
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variants also revert, and whether the variation observed is indeed 
specific to the human host as these results would suggest.  
5.5.1.2. Membrane and Flagella 
Several variants were detected within loci encoding gene products 
related to Campylobacter’s membrane and flagellar. Notably, variation 
was found in the locus encoding MotA (CAMP0303), which assembles as 
part of the larger flagellar stator ring apparatus that ultimately mediates 
flagellar rotation (Beeby et al. 2016). The variable residue that undergoes 
a non-synonymous mutation is located within one of three predicted 
transmembrane regions (Mohawk et al. 2014), which would be likely to 
aﬀect protein function, and specifically may modulate proton transport 
across the membrane. This would result in altered motor function, and 
may reflect an additional mechanism by which a modulated chemotactic 
response to ligands is achieved as discussed in relation to the chemotaxis 
loci. 
 
The motA locus has been identified as undergoing significant variation in 
other genetic studies. Resequencing of a well characterised outbreak 
strain, 81-176, revealed multiple instances of genetic variation amongst 
colony variants (Mohawk et al. 2014). These colonies displayed alternate 
phenotypes that varied in opacity and mobility. In future studies,  
re-culture of this isolate to screen for variant colonies may reveal a 
phenotype for the genetic variation observed, which would aid in 
determining the biological eﬀect of the minor allele variant. 
 
Two of the three variable membrane related loci (CAMP0922 and 
CAMP0049) are uncharacterised, and as such little information is 
available on the protein function or structure. However, the bacterial 
membrane is a notable source of genomic variation within 
Campylobacter spp. in general ( Cody, Maiden, and Dingle 2009; Q. 
Zhang et al. 2000). The final membrane locus (CAMP1055) encodes the 
putative acyltransferase, HtrB, which is involved in lipid A biosynthesis. 
Lipid A is one of two constituent parts of Camplyobacter’s lipo-
oligosaccharide. This locus has been linked to cell wall formation, and is 
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essential for cellular survival in stress conditions (Phongsisay et al. 
2007). C. jejuni LOS structures have been shown to be highly diverse, 
arising from diﬀerences in the moieties and linkages of individual sugars 
that are conferred via transferases within the LOS operon (Gilbert M et al. 
2008). The htrB locus has been proposed to add two secondary acyl 
groups to the lipid A molecule, and as such variation within this locus 
may result in an altered LOS phenotype. 
 
Loci pertaining to membrane and flagellar functions were also identified 
with a similar relative frequency in the ST-21 clinical dataset, which - as 
is seen in the case of chemotaxis loci – suggests these functional groups 
are undergoing selection within the human gut. Several membrane and 
flagellar gene products are shown to be highly immunogenic (Baqar et al. 
2008, Poly et al. 2007a, Shoaf-Sweeney et al. 2008, Burnens et al. 1995, 
Nielsen et al. 2012), which may explain the variation observed.  
5.5.1.3. C. coli  
Four isolates analysed within the non ST-21 dataset belong to the 
Campylobacter coli CC, ST-828. When comparing the variation within ST-
828 isolates to other non ST-21 C. jejuni isolates, a similar pattern of 
diversity can be observed. Again, the most common functional grouping 
of loci (in order of abundance) encode chemotaxis, membrane and 
flagellar associated proteins.  
 
The ST-828 isolates yielded variation in three loci: CAMP1460, 
CAMP0252, and CAMP0049. CAMP1460 and CAMP0252 are involved in 
chemotaxis, and were also found to contain variation in clinical C. jejuni 
isolates. Notably, CAMP1460 represents a locus that has been identified 
as containing variation across multiple C. jejuni CC’s, and now also 
across multiple species of Campylobacter (i.e. C. coli). This further 
emphasises the frequency at which this locus is encountering selective 
pressure within human hosts.  
 
The final locus (CAMP0049) is exclusively found in C. coli isolates. Whilst 
the gene itself is uncharacterised, the presence of diversity at this locus 
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highlights the importance of including ST-828 isolates in the non ST-21 
dataset. Further study of the genetic heterogeneity of C. coli may reveal 
additional species-specific loci that are involved in the generation of 
clinical disease that are yet to be elucidated.  
5.5.2. Poultry Dataset 
The purpose of this dataset was to provide an insight into the level of 
genetic heterogeneity amongst pre-infectious Campylobacter 
populations. As poultry is a major source of human campylobacteriosis 
(Wilson et al. 2008), these isolates represent typical isolates that the 
public may encounter, and which ultimately may generate an infection. 
The poultry isolates all belong to CC’s that are abundant in human 
disease, and as such are an appropriate sample to compare with the 
clinical datasets.  
 
Isolating Campylobacter spp. from retail poultry meat proved to be 
challenging, due to significant contaminant growth. Several variations 
on the culturing methodology were tested for their eﬃcacy at reducing 
contamination, including the addition of a supplement intended to 
increase the aerotolerance of Campylobacter spp., as well as altering the 
temperature and duration of incubations. However, these variations had 
little discernible impact and ultimately, it was not possible to 
consistently produce cultures of pure Campylobacter spp. colonies. In 
the majority of instances, samples were obtained from one of many 
duplicate plates with the least contaminant growth, and with suﬃcient 
separation between morphologically distinct colonies. When transferring 
bacterial growth for DNA isolation, great eﬀort was taken to ensure that 
the loop did not make contact with contaminants, whilst still sampling 
all present Campylobacter colonies. Despite this, contaminant reads were 
detected in the final assembly of three additional poultry isolates.  
 
To test whether reads from contaminant bacteria would impact the 
calling of minor allele variation, a mock read community was 
constructed in silico. Briefly, this involved the random interspersion of 
Campylobacter spp. genomic reads with those from example 
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contaminant organisms E. coli and S. enterica in various relative 
abundancies. The main issue revealed with contaminant reads is in the 
generation of a de novo assembly, with increasingly poorer assemblies 
constructed as a result of increasingly contaminated read files. As the 
deep sequencing methodology relies on the alignment of an isolate’s 
genomic read data to their resulting de novo assembly, contaminant 
reads created a significant barrier to analysis. 
 
With this in mind, contaminated poultry read files were excluded from 
analysis, and as such the poultry dataset is smaller than anticipated. 
However, it does provide preliminary evidence that shows clinical 
populations of Campylobacter spp. exhibit a diﬀerent pattern of intra-
population diversity to poultry isolates.  
5.5.2.1. Genetic Diversity 
The poultry dataset exhibited less overall diversity than that observed in 
clinical isolates, as reflected by the number of variable loci, minor allele 
variants and functional variants per isolate. This is reasonable when 
considering the relatively harsh environment retail poultry meat oﬀers. 
Studying the survival of Campylobacter jejuni on refrigerated chicken 
meat revealed it is able to endure long periods of time at 4°C, though 
populations exhibit a reduced cell count (Bhaduri & Cottrell 2004). A 
reduction of the total Campylobacter population may create a genetic 
bottleneck and lead to a smaller number of dominant clones that persist 
and are recoverable during sampling. A similar bottleneck is likely to be 
experienced during slaughter and preparation, either as a consequence 
of the techniques used to handle the carcass (e.g. during feather 
scalding) or via direct interventions used to reduce bacterial 
contamination (e.g. carcass rinses). The combination of these reductive 
events may explain the decrease in diversity observed amongst poultry 
isolates.  
 
A notable diﬀerence amongst the poultry dataset was the lack of 
variation identified within chemotaxis loci, which represented the 
dominant functional grouping of variable alleles in both clinical groups. 
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This is logical, given the abundance of chemotactic ligands would be 
relatively stable and homogenous on poultry meat compared to the 
human gut environment, and as such chemotaxis would confer less of an 
advantage to the resident Campylobacter population. Additionally, 
Campylobacter spp. would not be actively growing and as such would 
have no requirement for chemotaxis for nutritional purposes. These 
results further support the conclusion that variation within chemotaxis 
loci occurs as a result of selective pressures exerted by the human host. 
 
Campylobacter spp. have been shown to produce viable but non-
culturable (VNC) cells under stress conditions (Moore 2001, Murphy et al. 
2006). Many of these stress conditions would be exerted on isolates 
colonising retail poultry meat, including lack of nutrient availability and 
low temperature (Murphy et al. 2006, Lázaro et al. 1999). Passaging this 
stress-associated form of Campylobacter spp. in mice resulted in a 
symptomatic infection, and saw a reversion to a culturable state (Saha et 
al. 1991). As the DNA analysed in the deep sequencing dataset is 
extracted from fresh Campylobacter plate cultures, any cells that are 
present in a viable but non-culturable form would not be represented. 
However, following passage in a human host, these isolates may later 
recover and revert to a culturable form that can be sampled. This may 
suggest that variable loci identified exclusively in the clinical datasets 
are not necessarily invariable in the poultry isolates. Rather, the 
sampling methodology is limited by its reliance on culturable forms of 
Campylobacter spp.  
 
All variants detected within the poultry dataset were synonymous, which 
was not the case with either clinical group. Whilst synonymous 
mutations have less of an immediately apparent eﬀect, emerging 
research shows that there is still an impact associated with alternate 
codon usage. During translation, amino acid sequences are read via 
isoaccepting tRNAs that recognise specific codons. The concentration of 
these tRNAs has been shown to be highly variable (Dong et al. 1996), and 
as such translation of a synonymous codon with fewer complimentary 
tRNAs is found to occur at a slower rate, which can ultimately influence 
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the eﬃciency of protein folding (Zhang et al. 2009). Synonymous 
mutations have also been shown to aﬀect the level of transcription 
(Agashe et al. 2016). With this in mind, the synonymous mutations 
observed within the poultry loci may have modulated their rate of 
transcription, potentially in response to the stressful conditions present 
on retail poultry meat (e.g. temperature, amino acid availability). The 
bias towards synonymous mutations may also be reflective of alternative 
codon usage in the chicken gut, which is later undergoing variation as a 
result of novel host infection.  
5.5.3. Comparing deep sequence datasets 
5.5.3.1. Distribution of Loci 
Figure 5.20 provides the approximate positions of all variable loci 
detected amongst the deep sequencing isolates. The majority of loci 
appear to be distributed equally across the 11168 chromosome, however 
there is one region that is found to contain numerous loci. This region, 
starting with the CAMP1178 locus at chromosomal position 118921 and 
ending with the CAMP1257 locus at position 1274684, contains 40% of the 
variable loci identified across all datasets. All of the genes contained 
within this region are functionally related to either the flagella or 
membrane, which is a noted area of hyper-variability within the 11168 
genome (J Parkhill et al. 2000), and contains gene products that have 
shown to illicit a highly immunogenic response (Burnens et al. 1995, 
Nuijten et al. 1991, Huang et al. 2007). 
5.5.3.2. Differences in the clinical datasets 
The non ST-21 dataset exhibited a decreased number of variants per 
isolate compared to ST-21 isolates (~1.80 vs ~2.11 variants per isolate 
respectively, Table 5.5). Conversely, the non ST-21 variants were 
distributed across more than double the number of ST-21 loci, when 
factoring in the diﬀerence in dataset size (0.82 vs 0.35 respectively). This 
may suggest that the ST-21 lineage has a gene repertoire with specific 
alleles that are more adapted to the human host than non ST-21 isolates, 
and as a result do not experience variation is as many genes in response 
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to selective pressure. This would make sense given that ST-21 is the most 
commonly identified CC in human infection. 
 
When considering the functional grouping of loci in relation to the 
observed variation, both ST-21 and non ST-21 isolates contain 
approximately the same number of per-isolate variants (1.59 and 1.63 
repsectively). This disparity between total variation, and variation 
specific to the chemotaxis, membrane and flagellar genes is mainly due 
to the presence of variation within a single homopolymeric tract 
identified within several ST-21 isolates. This tract mediates the 
expression of a flagellar glycosylation locus (CAMP1239, discussed in 
Chapter 4), and was identified as variable in 23% (n=4) of the ST-21 
dataset. The non ST-21 dataset did not reveal any variation within this 
tract - which given its abundance in ST-21 isolates - would suggest the 
observed variation is exclusive to the ST-21 CC. 
 
There are also important diﬀerences observed between the two clinical 
datasets in relation to the most frequently identified variable loci: 
CAMP1460. This locus is found to contain variation within 29% (n=5) of 
ST-21 isolates, compared to 18% (n=2) of non ST-21 isolates. Further, there 
is a notable diﬀerence in the number of synonymous and non-
synonymous variants between these groups. ST-21 isolates yielded a total 
of 11 minor allele variants, of which ~82% (n=9) were non-synonymous. 
In comparison, non ST-21 isolates yielded 7 variants, with just 29% 
resulting in a non-synonymous substitution. This may also be 
compounded by the fact that a single isolate (D7-17) yielded two minor 
allele variants at positions 1 and 2 of amino acid residue 606. Both 
variants occurred at a minor allele frequency of 0.48, and therefore likely 
occur concurrently in a single haplotype. This would result in the 
reference serine codon AGT undergoing a synonymous mutation to 
alternative serine codon TCT, rather than the two non-synonymous 
mutations detailed in Table 5.2.  
The bias in ST-21 variants towards non-synonymous mutations is also 
apparent in other chemotaxis and membrane loci, and indeed in 
comparison of the functionally grouped loci as a whole, with 79% of all 
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ST-21 variants resulting in non-synonymous changes vs. 50% in non-ST-
21 complexes. These results indicate that ST-21 isolates are encountering 
a stronger selective pressure during human infection, and undergoing an 
increased level of genomic variation in a smaller range of loci as a result. 
This is not to say that the synonymous mutations are not important – as 
discussed above, synonymous codon usage impacts transcription rate 
and protein expression (Dong et al. 1996, Zhang et al. 2009). It is also 
important to consider the typical duration of a symptomatic 
Campylobacter spp. infection, which lasts for approximately 2-7 days. 
This relatively short period of exposure is generating large amounts of 
diversity, with both synonymous and non-synonymous eﬀects. 
 
Across all datasets, the proportion of isolates that did not reveal any 
minor allele variation is highly similar (~37%). This does not necessarily 
mean that these isolates did not contain any variation. Rather, the 
stringent quality filtering employed by the analysis pipeline did not yield 
any results. Several variables may impact the level of diversity present in 
an isolate’s population. In the context of clinical isolates, there is little 
control over when the sample is collected with regards to disease 
progression. An infectious population that is sampled immediately after 
symptoms manifest may for example vary in its diversity, when 
compared to a population that is sampled after many days. Furthermore, 
clinical samples are provided on cryopreserved beads - the capture and 
subsequent re-culturing provides additional points at which a bottleneck 
in actual representation of diversity may occur. If these factors that are 
unique to the clinical datasets did have an impact on the observed 
diversity, there would likely be a diﬀerence in the number of non-variant 
containing poultry isolates. In reality this is not the case, suggesting that 
the prevalence of invariable populations amongst Campylobacter isolates 
in general is conserved.  
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5.5.4. Future Work 
The datasets discussed within this chapter provide a novel insight into 
the diversity of clinical and poultry Campylobacter spp. isolates. 
However, it is important to consider the diﬀerences between clinical 
isolates, poultry isolates that may generate a clinical infection, and the 
ancestral populations they both may originate from. Figure 5.22 (below) 
follows a hypothetical Campylobacter spp. isolate as it moves from a 
chicken host to its eventual recovery from a human clinical infection. In 
the context of this figure we have characterised the diversity of clinical 
Campylobacter populations (D), and produced a preliminary overview of 
the diversity of isolates from retail poultry (C). However, both 
populations may have undergone significant changes from the original 
ancestral isolate (A). Whilst tracking an individual population of 
Campylobacter spp. from a chicken host to a clinical infection is 
unrealistic, it does highlight additional opportunities for future study. 
For example, it would be interesting to apply the deep sequencing 
methodology to additional non-clinical sources (e.g. live poultry). This 
data would allow comparison between the variable loci observed in the 
clinical and retail poultry datasets, and aid in delineating alleles that are 
specific to human infection, specific to the poultry host, and perhaps loci 
that are persistently variable across all hosts.  
 
The clinical datasets show several instances of loci undergoing selective 
pressure within the human host environment. However, it is not known 
as to whether these mutations are beneficial, deleterious, or are a result 
of co-dominant haplotypes, as the clinical isolates represent a single 
patient sample at a single time point. To investigate this concern, it 
would be useful to sequence isolates obtained from a single patient, 
across multiple time points throughout the course of infection. If 
polymorphisms are seen at increasing or decreasing frequencies it would 
suggest that variation in this locus is a result of positive or purifying 
selection. Alternatively, if frequencies are found to occur at stable 
intermediate levels, it would suggest that multiple lineages are 
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concurrently present. This data would also aid in the resolution of host 
specific variation, as outlined above.  
 
Figure 5.22 – A representation of how haplotypes amongst a hypothetical 
Campylobacter spp. population may change as it moves from a chicken host 
to causing human infection 
A – The starting population inside a chicken host.  
The starting population may contain several haplotypes. In this example, the starting 
population contains colonies representing three haplotypes, denoted by their colours 
(Orange, Red and Blue). Sequencing this population would recover all haplotypes present at 
this time.  
B – The population during slaughter. 
Following a bottleneck event (i.e. a reduction in the population), the number of haplotypes 
that are represented amongst the population may be reduced (e.g. during carcass rinsing). 
In this example, the Blue haplotype is no longer present amongst the population – 
sequencing this population would only detect the Red and Orange haplotypes. 
C – The population on retail poultry meat.  
If exposed to stress conditions, some colonies may form viable but non culturable cells 
(grey). In this scenario, the VNC cells originated from a single haplotype (Orange). These 
colonies would not be analysed by the deep sequencing methodology, which relies on fresh 
cultures from which DNA is prepared. Sampling at this stage would only reveal the Red 
haplotype.  
D – The population recovered from a clinical infection.  
During infection, the VNC cells are resuscitated and now produce culturable forms, restoring 
the Orange haplotype. During the infection, some cells undergo variation, forming a new 
haplotype, Green. Deep sequence analysis at this stage would reveal all haplotypes present. 
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6. Chapter Six: Conclusion 
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Campylobacter spp. is the leading cause of bacterial mediated enteritis in 
the developed world, and yet the genetic epidemiology of 
campylobacteriosis is not conclusively defined. Existing studies suggest 
that the majority of cases are sporadic in nature, with no case linkages 
demonstrated in routine clinical datasets. As an organism, 
Campylobacter spp. undergo a vast amount of genomic variation, and as 
such it was unclear as to whether the lack of observed case linkage can be 
truly defined using the assembly based comparative techniques (e.g. 
wgMLST) that many existing studies employ.  
 
To investigate this further, the work presented in Chapter Three applied 
a read mapping approach to clinical Campylobacter spp. isolates, 
collected from a single health trust site in Nottinghamshire during 2014. 
The results from this work presented many novel findings. 
 
Firstly, several instances of case linkage were apparent amongst the 
dataset, which represents the first description of case linkage between 
routine clinical isolates. The lack of reported case linkage in previous 
studies is likely a result of the notable genetic diversity that 
Campylobacter spp. exhibits, as well as the limited sensitivity of the 
comparative techniques (i.e. wgMLST). In the context of several studies 
discussed (i.e. non-specialised clinicians), utilising this methodology is 
entirely appropriate, and preferential to the far more resource intensive 
read-mapping approach. However, where possible (particularly in 
research environments) it would be advisable to utilise read mapping 
methods to provide an objective, qualitative measure of true genetic 
homology. The results presented within this chapter act as a proof of 
concept, and provide a greater resolving power of both true case linkage, 
and greater discrimination between false-positives.  
 
This work also identified a period of enhanced incidence during 
February, 2014. Upon further inspection, this peak in incidence was also 
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apparent in national data from 2008-2011, which suggests that this effect 
is not limited to the Nottinghamshire area. This period of increased 
incidence was also found to contain a higher proportion of linked cases. 
However, it is not clear as to whether the increase in observed case 
linkage is genuine, or potentially a result of the increase in percentage of 
isolates sequenced. In hindsight, it would have been prudent to also 
sample a week-long tranche of isolates that did not exhibit unexpected 
incidence to act as a negative control, which would address this concern.  
 
Additionally, the linking of social events to the increase in incidence is 
purely circumstantial, and it is not clear as to whether patients engaged 
in any of the described risk factors that may have increased their 
likelihood of contracting campylobacteriosis. To address this, it would 
have been useful to obtain additional data from the sampled patients 
(e.g. questionnaire data). 
 
Due to ethical limitations, this was not possible. The addition of this 
information would aid in addressing this, as well as many other 
questions. Campylobacteriosis is a severely underreported disease, and 
as such a greater incidence of same-source infections may occur at a 
transient level in a patient’s social network. Questionnaire data could 
reveal whether other friends or family members also fell ill in a capacity 
that did not provoke the need for medical aid, revealing additional 
incidence of sporadic case linkage. Additional risk factors could also be 
investigated with this information (e.g. recent foreign travel), and as such 
future work may consider obtaining this information. 
 
Following the genomic analysis of isolate pairs, further information 
detailing patient demographics was made available to the study. This 
revealed that the most genetically homologous isolate pair was in fact 
isolated from the same patient. Importantly, this isolate pair was not 
entirely homologous. In fact, over the course of a single day, genetic 
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variation was apparent. This generated further questions as to whether 
Campylobacter spp. may undergo intra-population variation within a 
single host.  
 
To investigate this, a subset of clinical isolates was analysed using a 
deep-sequencing methodology, which greatly increases the coverage 
depth of sequencing reads and increases the ability to resolve minor 
allele variation. Initially, this was conducted on the most abundant 
clinical complex of C. jejuni isolates: ST-21, revealing a surprising 
amount of genetic diversity amongst single clinical populations. This 
diversity is even more impressive when considering the time scales of 
typical Campylobacter spp. infections, with sampled isolates 
representing organisms that have been in contact with the human host 
for ~1-2 weeks. 
 
The deep sequencing methodology uses the de novo assembly of each 
isolate’s read data as a reference to which the read data is again mapped 
against. This is of particular benefit in an organism such as 
Campylobacter that exhibits a vast amount of genetic variation, and as 
such limits the usability of common reference sequences. However, 
relying on de novo assemblies does present its own issues. Firstly, any 
areas of the genome that are not appropriately resolved will result in a 
break of contiguous sequence. This may interrupt CDS, and lead to areas 
of the genome for which no sequence is defined, preventing alignment. 
The access and commonality of long-read sequencing has undergone a 
drastic change since the inception of this study, with the release and 
constant revisions of technologies such as Oxford Nanopore 
Technology’s MinION device. In future studies, it would be preferable to 
allocate additional resources to the generation of isolate reference 
sequences, which would ideally be resolved to a single, high quality 
contig through a combination of short and long read data. This would 
also allow an additional layer of verification of called minor allele 
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variants via mapping of long reads to the generated assembly, and aid in 
the detection of variants in repetitive sequence elements. 
 
Campylobacter spp. contain several instances of homopolymeric tracts, 
which are noted sources of genetic diversity. Across all deep-sequenced 
samples, only four ST-21 isolates revealed variation within these tracts. 
As discussed in Chapter 4, additional variation may be present amongst 
the sampled populations, however the strict quality thresholds employed 
by the deep-sequencing analysis pipeline, coupled with the relatively 
poor quality of repetitive stretch sequencing on Illumina platforms mean 
these variants may have been excluded from the final dataset. This may 
be mitigated by utilising long-read sequencing technologies which offer 
greater sequencing accuracy of repetitive tracts. 
 
The variants that were identified within the deep sequencing datasets 
are representative of a population at a single time point. As such, it is not 
clear as to whether these variants are sweeping to fixation. This provides 
a key area for future research, wherein repeat samples obtained from a 
single patient would be analysed using the deep sequencing 
methodology, allowing observation of changes to the minor allele 
frequency of identified variants. In the genetic epidemiology work 
presented in Chapter 3, one such instance of same-patient sampling was 
revealed. Unfortunately, the patient demographic data was provided 
after the deep sequencing datasets were generated, and as such it was not 
possible to include these isolates within the sample.  
 
In an expansion to the ST-21 deep sequencing dataset, isolates from 
additional CC’s were also analysed. Whilst this data identified several 
interesting points of comparison, it is partially limited by the sample 
size. In future work, additional sequencing of key lineages (e.g. ST-828) 
would aid in delineating the differences in genomic variation between 
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clinical isolate complexes. This limitation is also apparent in the poultry 
dataset. 
 
To detect whether the level of diversity that was observed in single 
clinical populations of Campylobacter, isolates obtained from fresh retail 
chicken samples were also analysed. This revealed a notable decrease in 
diversity compared to clinical samples, suggesting that variation is 
driven within the human host. The reliance on retail chicken isolates was 
necessary, as an appropriate pre-infectious sample was not available. It 
would be preferable to analyse an isolate population before and after 
human passage – future work may consider applying the deep sequence 
methodology to a confirmed point-source outbreak. 
 
The majority of loci identified as undergoing variation in clinical isolates 
encode proteins related to chemotaxis functions. Furthermore, many of 
these variants were found to be contained within the protein’s Methyl-
accepting signalling domains. The repeated variation within this domain 
suggests the selective pressure present in the human host is driving 
variation at these specific locations, and provides an interesting topic for 
future study. At this stage, it is unclear as to whether this particular 
pattern of diversity is exclusive to the human host – an absence of similar 
variants in the poultry dataset, as well as results from an independent 
study would suggest this is the case, however additional work is required 
to draw any conclusions. Future studies may consider sampling isolates 
from live poultry flocks, as well as additional chicken meat samples, 
environmental isolates, and isolates obtained from animal passage 
experiments. This data would allow the separation of loci that undergo 
variation as a result of novel colonisation in general, colonisation of the 
human host specifically, and loci that may be variable across 
Campylobacter populations in general. 
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In summary, this work presents several novel findings: Sporadic case 
linkage can be observed with enhanced comparative techniques, a third 
peak in incidence is observable across national data when appropriately 
normalised, and Campylobacter spp. exhibits clear patterns of intra-
population diversity. This body of work acts as a key foundation for 
further investigation, with a focus on expansion of the deep sequencing 
methodology to include additional isolate types and sources, and has 
important implications for clinical investigation of related cases. 
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9. Appendix
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9.1. Accession Numbers of 16S rRNA Genes 
Table 9.1 - Strain and Genbank accession numbers for 16S rRNA genes used in 
the generation of Figure 1.2. 
Species Strain 16S rRNA gene  
A. butzleri ATCC 49616 AY621116.1 
C. fetus subsp. fetus ATCC 27374T DQ174127 
C. fetus subsp. venerealis NCTC 10354 T DQ174131 
C. coli LMG 6440 T AF372092 
C. jejuni subsp. jejuni NCTC 11351 T AF372091 
C. jejuni subsp. doylei LMG 8843 T DQ174144 
C. lari NCTC 11352 T DQ174145 
C. sputorum LMG 7795 T DQ174149 
C. showae CCUG 30254 T DQ174155 
C. upsaliensis CCUG 14913 T DQ174157 
C. helveticus NCTC 12470 T DQ174161 
C. curvus ATCC 35224 T DQ174165 
C. concisus ATCC 33237 T DQ174166 
C. gracilis ATCC 33236 T DQ174168 
C. rectus CCUG 20446 BT DQ174169 
C. mucosalis ATCC 43264 T DQ174173 
C. hyointestinalis subsp. hyointestinalis NADC 2006 M65009.1 
C. hyointestinalis subsp. lawsonii CCUG27631 AF097683.1 
C. lanienae NCTC 13004 T DQ174181 
C. hominis NCTC 13146 T DQ174182 
C. insulaenigrae NCTC 12927 T DQ174183 
C. avium 86/06 EU623473 
C. subantarcticus LMG 24377 NR_115081 
C. peloridis 2314BVA NR_042684 
C. cuniculorum 150B DQ400345 
C. canadensis L266 EF621894 
C. volucris LMG 24380 NR_116923 
C. lari subsp. concheus 2897R NR_042683 
* - Genbank accession numbers. 
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9.2. Campylobacter spp. incidence at Queen’s 
Medical Centre 2012-2014. 
Table 9.2 - Campylobacter spp. incidence at Queen's Medical Centre, 2012-2014. 
Month 
Cases Per Year 
2012 2013 2014 
Jan 48 50 39 
Feb 40 47 66 
Mar 38 58 57 
Apr 57 48 54 
May 82 70 50 
Jun 119 89 103 
Jul 116 103 78 
Aug 87 87 63 
Sep 89 104 90 
Oct 95 75 68 
Nov 51 54 49 
Dec 28 37 42 
Total 850 822 759 
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9.3. Autospades.py 
#!/usr/bin/env python 
import os 
import glob 
import subprocess 
print '' 
print '' 
print '######################' 
print 'Welcome to AutoSPAdes' 
print '######################' 
print '' 
print '' 
# User input 
directory = raw_input("Path to directory containing FastQ reads: ") 
outputpath = raw_input("Path to output Fasta assemblies in: ") 
print 'Assemblies will be collectively copied into your output path with logical 
filenames' 
print 'Do you want to remove assembly subdirectories after use?' 
choice = raw_input("Y/N: ").lower() 
print 'Use the careful flag?' 
careful = raw_input("Y/N: ").lower() 
if not os.path.exists(outputpath): 
    os.makedirs(outputpath) 
# List comprehension 
r1files = list(glob.glob(os.path.join(directory,'*_R1_*'))) 
r1files.sort() 
r2files = list(glob.glob(os.path.join(directory, '*_R2_*'))) 
r2files.sort() 
yes = set(['yes','y','ye']) 
no = set(['no','n','']) 
rawname = [x.split(directory)[1].split('_')[0] for x in r1files] 
rawname.sort() 
subdirectoriesraw = [directory + x + '_' for x in rawname] 
subdirectoriesraw.sort() 
subdirectories = [x.split('_')[0] + '/' for x in subdirectoriesraw] 
fastadirectories = [x + 'scaffolds.fasta' for x in subdirectories] 
fastanames = [x + '.fasta' for x in rawname] 
fastaoutput = [outputpath + x for x in fastanames] 
# Spades invocation 
if careful in yes: 
    for opt1, opt2, opt3, in zip(r1files, r2files,subdirectories): 
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        subprocess.call(['spades.py', '--careful', '--pe1-1', opt1, '--pe1-2', 
opt2, '-o', opt3]) 
if careful in no: 
    for opt1, opt2, opt3, in zip(r1files, r2files,subdirectories): 
        subprocess.call(['spades.py', '--pe1-1', opt1, '--pe1-2', opt2, '-o', 
opt3]) 
# FASTA organisation (rename and collect) 
for var1, var2, in zip(fastadirectories, fastaoutput): 
    subprocess.call(['cp', var1, var2]) 
# End 
if choice in yes: 
    for remove, in zip(subdirectories): 
        subprocess.check_call(['rm','-r', remove]) 
    print '' 
    print '' 
    print '' 
    print '#' 
    print '##' 
    print '###' 
    print '####' 
    print '#####' 
    print '######' 
    print '#######' 
    print '########' 
    print '#########' 
    print '##########' 
    print '###########' 
    print '############' 
    print '#############' 
    print '##############' 
    print '###############' 
    print 'Job Completed!' 
    print '###############' 
    print '' 
    print '' 
    print 'Subdirectories scrubbed.' 
    print '' 
    print '' 
    print 'Fasta files located in:', 
    print outputpath 
    print '' 
    print '' 
    print 'FastQ files unzippd and stored in: ', 
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    print directory 
    print '' 
    print '' 
    print '' 
    print '' 
    print 'Goodbye!' 
    print '##############' 
if choice in no: 
    print '' 
    print '' 
    print '' 
    print '#' 
    print '##' 
    print '###' 
    print '####' 
    print '#####' 
    print '######' 
    print '#######' 
    print '########' 
    print '#########' 
    print '##########' 
    print '###########' 
    print '############' 
    print '#############' 
    print '##############' 
    print '###############' 
    print 'Job Completed!' 
    print '###############' 
    print '' 
    print '' 
    print 'Fasta subdirectories and FastQ reads located in: ', 
    print directory 
    print '' 
    print '' 
    print 'Fasta files collected and stored in: ', 
    print outputpath 
    print '' 
    print '' 
    print '' 
    print '' 
    print 'Goodbye!' 
    print '##############' 
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9.4. Autoprokka.py 
#!/usr/bin/env python 
import os 
import subprocess 
import glob 
import shutil 
 
 
directory = raw_input("Path containing FASTA assemblies: ") 
outputraw = raw_input("Path to output annotation directories: ") 
if not os.path.exists(outputraw): 
    os.makedirs(outputraw) 
fasta = list(glob.glob(os.path.join(directory,'*.fasta'))) 
output = [x.replace(directory, outputraw).replace('.fasta', '/') for x in fasta] 
prefixis = [x.replace(directory, '').replace('.fasta', '') for x in fasta] 
 
 
print '' 
print '' 
print 'Do you want to copy .gff into a single directory?' 
print '' 
choice = raw_input("Y/N? :").lower() 
positive = set(['yes', 'ye', 'y', 'ys', '']) 
if choice in positive: 
    print '' 
    print 'Which directory shall I place them in?', 
    print '' 
    outputgff = raw_input('Path to directory:') 
    if not os.path.exists(outputgff): 
        os.makedirs(outputgff) 
 
 
for fastain, fastaout, pre in zip(fasta, output, prefixis): 
        subprocess.call(['prokka', fastain, '-o', fastaout, '--prefix', pre]) 
 
 
if choice in positive: 
    gffnames = [x.replace(directory, '').replace('.fasta', '.gff') for x in fasta] 
    gfflocations = [''.join(x) for x in zip(output, gffnames)] 
    gffoutput = [outputgff + x for x in gffnames] 
    for gffin, gffout in zip(gfflocations, gffoutput): 
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        try: 
            shutil.copyfile(gffin, gffout) 
        except IOError as e: 
            print 'The following files were not found, indicating that prokka did 
not finish correctly.' 
            print e 
            print 'Please check FASTA input.' 
 
 
print '' 
print '' 
print '' 
print '########' 
print 'Finished' 
print '########' 
 
 
